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SUMMARY
It was shown that T.b. brucei plasma membranes 
isolated after cell breakage with a tight fitting Dounce 
type homogeniser, were essentially free of cytosolic 
and mitochondrial contamination, but retained residual 
glycosomal contamination.
Dihydrolipoamide dehydrogenase (normally associated 
with pyruvate, 2-oxoglutarate and branched chain 2-oxoacid 
dehydrogenase complexes), was demonstrated to co-purify 
with the plasma membranes. The enzyme was released from 
its site of attachment by various detergents (but not 
by salt), and was readily reconstituted into lipid 
vesicles.
Three techniques; sodium hydroxide, calcium 
ion, and freeze/thaw treatments were applied to the 
plasma membrane vesicles. Only the freeze/thaw procedure 
produced vesicles with a fully functional D-glucose 
transporter.
Reconstitution experiments involving various 
techniques and detergents proved successful in 
reconstituting a fully functional erythrocyte D-glucose 
transporter and trypanosome dihydrolipoamide dehydrogenase. 
The trypanosome D-glucose transporter, however, could 
not be reconstituted in a functional form.
An infinite-trans sugar transport protocol was 
developed to study transport of D-glucose, 1-deoxy-D- 
glucose and 6-deoxy-D-glucose in the plasma membrane 
vesicles. Significantly higher Km values for D-glucose, 
1-deoxy-D-glucose and 6-deoxy-D-glucose, but similar
Vmax values, were found in the plasma membrane vesicle 
preparation, compared to intact trypanosomes. Sugar 
transport inhibition studies suggested that there was 
spatial freedom around the carbon C2 position of the 
plasma membrane vesicle D-glucose transporter, and that 
the sugar binding requirements were less specific than 
those of the D-glucose transporter in the intact 
trypanosomes.
Covalent modification studies indicated that 
a tryptophan residue was required for an active D-glucose 
transporter. Dihydrolipoamide and NAD+ (both substrates 
for dihydrolipoamide dehydrogenase) were found to alter 
the kinetics of D-glucose transport in the plasma membrane 
vesicle preparation. The NAD+ effect could be negated 
by phenylarsine oxide. The possible involvement of 
dihydrolipoamide dehydrogenase in D-glucose transport 





CNS Central nervous system
DDI^O Double distilled water
DHAP Dihydroxyacetone phosphate









KRB Krebs Ringer phosphate buffer
MEGA 10 Decanoyl-N-methyl-glucamid
NAD+ Nicotinamide adenine dinucleotide (oxidised
form)
NADH Nicotinamide adenine dinucleotide (reduced
form)
NADP+ Nicotinamide adenine dinucleotide phosphate
(oxidised form)
NADPH Nicotinamide adenine dinucleotide phosphate
(reduced form)
+ + 2 +OL ATPase Oligomycm sensitive Na K Mg stimulated
ABBREVIATIONS (continued)
OsO. Osmium tetroxide4
OU ATPase Ouabain sensitive Na+K+ ATPase 








Tes N-tris [hydroxymethyl ] methyl-2-a'minoethane
sulphonic acid U
Temed N, N, N', N-Tetramethylethylenediamine
Tris Tris(hydroxymethyl) aminomethane
VSG Variable surface glycoprotein
CMC C r i t ic a l  Micelle C oncentra t ion
INTRODUCTION
11.0 GENERAL INTRODUCTION
Trypanosomes are flagellated protozoa about 
10 to 30|jm long responsible for many parasitic diseases 
of humans, domestic animals and wild animals, presenting 
severe problems both economically and medically to the 
Third world countries where they are prevalent. The 
World Health Organisation has rated Trypanosomiasis 
amongst the top six tropical diseases selected for study, 
with a view to developing more effective treatments 
(Trigg, 1979). Trypanosomes belong to the class 
Zoomastigophora, order Kinestoplastida, so named because 
they possess a mitochondrial associated kinetoplast.
They are characterised by 5 main structural features 
(Fairlamb, 1982), fig. 1,
(1) a single flagellum,
(2) a complex skeletal array of subpellicular microtubules,
(3) microbody-like organelles called glycosomes, containing 
the first nine enzymes of glycolysis,
(4) a single but often highly branched mitochondrion 
containing,
(5) a dense network of DNA called the kinetoplast.
The kinetoplast distinguishes various stages of
the organisms lifecycle, ie. trypanomastigote (kinetoplast 
posterior to the nucleus), and epimastigote (kinetoplast 
anterior to the nucleus), fig. 2.
Kinestoplastida display various lifecycles, from 
simple free living forms, the Bonidaes, to those that 









Fig. 1 The gross morphology of T.b. brucei (intermediate 
bloodstream form, Vickerman, 1965), showing 





Fig. Two examples of stages in the life cycle of 
Trypanozoon species showing the position of 
the kinetoplast (Newton, 1968).
2and plants. Many of the infective species have complex 
life cycles involving a host vertebrate and an insect 
transmitting vector. The latter falls into two main 
groups, salivarian (salivary transmission) via blood 
sucking insects (flies, bugs and fleas) or stercorarian 
(faecal transmission). Uncommonly, mechanical transmission 
occurs via the mouth parts of biting insects in which 
the trypanosomes have a very short life. Exceptions 
include leaches which transmit the disease to fish and 
amphibians, the vampire bat (Desmodius rotundus) which 
has been implicated in the transmission of T. evansi 
and T. equiperdum , which has no intermediate host, 
transmission occuring during coitus (Jordan, 1986) .
1.1 SOUTH AMERICAN TRYPANOSOMIASIS
The most important stercorarian trypanosome 
is T. cruzi, found in South America where it causes 
Chagas' disease. T. cruzi inhabits the Reduviid bug 
midgut (after ingestion in a blood meal) during the 
insect stage of its life cycle, fig. 3, and is excreted 
in the bug faeces. Infection of the host occurs by faeces 
entering the hosts skin via skin abrasions, through 
the mucous membranes, particularly the eye (Fairlamb, 
1982), or by blood transfusions.
Trypanomastigotes penetrate the host cells of 
the infection site, where they transform into amastigotes 
which multiply within the host cells before being 
released into the blood stream as trypanomastigotes.
/Tty









Fig. 3 Life cycle of T. cruzi (Fairlamb, 1982).
3These non-dividing forms either penetrate new host cells 
particularly muscle, or are ingested during a blood 
meal by an uninfected reduviid bug during a blood meal. 
Unlike T.b. brucei there are no striking changes in 
morphology of the mitochondrion during the life cycle 
and their metabolism is essentially similar to the insect 
procyclic forms of T.b. brucei (Fairlamb, 1382).
In 1980 The World Health Organisation estimated 
that 35 million people were exposed to the infection, 
with 13 to 14 million carrying the disease. Untreated 
Chagas' disease is not inevitably fatal, but young 
children often die during the initial febrile stages 
(Fairlamb, 1982) . Many adult victims survive the disease 
indefinitely but up to 20% of patients develop the final 
stage of the disease in which trypanosome antigens bind 
heart and nerve cells, stimulating an autoimmune response 
by the host, leading to the most common cause of death, 
congestive heart failure (Boreham, 1979). Current drug 
treatment is unsatisfactory with the two available drugs, 
a 5-nitrofuran derivative, and a 2-nitroimidazole 
derivative having such severe side effects that a full 
course of treatment is very rarely administered (Gutteridge, 
1985) . Toxicity and commercial considerations have halted 
the development of the most promising nitro-compound 
drugs.
1.2 AFRICAN TRYPANOSOMIASIS
In Africa the most important trypanosomes are
4of the salivarian type transmitted by the Tsetse flies 
of the genus Glossina, to the normal vertebrate hosts, 
the large African wild mammals. These mammals generally 
show no pathogenic effects of the infection until stressed, 
and are thus able to harbour trypanosome infections 
for long periods of time, perhaps indefinitely, from 
which Tsetse flies acquire the trypanosomes. Four subgenera 
of salivarian trypanosomes are recognised, Table 1, 
however, the subgenus Pycomonus which contains only 
one species, T. suis, is very limited in distribution 
and importance. The three forms of the Trypanozoon 
subgenera, T.b. rhodesiense, T.b. gambiense and T.b. brucei, 
are thought to be identical both morphologically and 
biochemically (Hoare, 1964),however, some biochemical 
differences may exist. Epidemiological differences 
definitely exist, particularly with their infectivity 
to man, T.b. brucei being non-infective. It has been 
suggested by Vickerman (1965) that T.b. rhodesiense 
and T.b. gambiense are variants of T.b. brucei.
The human trypanosomiases (T.b. rhodesiense 
and T.b. gambiense), cause the fatal disease sleeping 
sickness which bears little in common with Chagas' 
disease. Up to 35 million Africans are at risk of catching 
the disease, with about 10,000 new cases reported each 
year (De Raadt, 1976) , a figure that is almost certainly 
an underestimate because of the poor reporting conditions 
and medical services found in the affected areas. When 
medical surveillance and controls break down, as in 
Uganda (Gashumba, 1981), the disease reaches epidemic
Table 1 The tsetse-transmitted trypanosomes of African mammals (Jordan, 1986)
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Unlike Chagas' disease, African trypanosomiasis 
if left untreated always leads to death due to invasion 
of the central nervous system. The period of time until 
death is variable, from weeks to months, in the case 
of T.b. rhodesiense, following an acute course (Wakelin, 
1984), to years in T.b. gambiense infections, following 
a chronic course.
In the acute form of the disease the first signs 
are a swollen chancre at the site of infection and/or 
a general oedema of the face. After several weeks an 
intermittent and irregular fever develops along with 
other general symptoms such as headaches, pains in the 
joints, loss of weight and severe toxaemia. Diagnosis 
of both forms may take several examinations because 
of the fluctuating nature of the disease. Chronic forms 
can be diagnosed by examination of cervical lymph node 
contents.
Invasion of the central nervous system is 
accompanied by epileptic fits, loss of apetite, and 
languor. Death is caused by many factors influenced 
by central nervous system deterioration, ije. respiratory 
failure, altered heart rhythm and beat, and by secondary 
infections caused by the immunosuppressive activity 
of the trypanosomes.
In animals, salivarian trypanosomes cause nagana 
in cattle (T.b. brucei, T. vivax and T. congolense) 
and surra in horses and camels (T. evansi), this leads 
to the death of over 3 million cattle every year making
6it impossible to rear milk-producing cattle, sheep and 
goats in 10 million square kilometers of Africa (Fairlamb, 
1982), fig. 4. Infection follows the same course as 
in humans. For instance, T. vivax and T. congolense 
can be acute with fulminating parasitaemia and death 
within two weeks of infection, or chronic showing no 
symptoms, lasting for months or years, with the acute 
stage brought on by stress. Wild animals generally have 
the chronic form.
The problems associated with trypanosomiasis 
have increased with attempts to eradicate the insect 
vector and wild animal parasitereservoirs failing, and 
increased drug resistance occurring.
1.3 LIFE CYCLE OF T.B. BRUCEI
T.b. brucei and other salivarian trypanosomes 
are injected into the host animal fly when the fly takes 
a blood meal. The lifecycle then follows the scheme 
shown in fig. 5 (Vickerman, 1985) . Metacyclics injected 
into the host along with its salivary secretions are 
a heterogeneous population with a variety of glycoprotein 
coats. They multiply into trypanomastigotes at the bite 
site forming a chancre, before migration to the lymph 
nodes and then into the bloodstream. Once in the 
bloodstream they multiply rapidly invading the 
intracellular spaces of other tissues, including the 
central nervous system and cerebrospinal fluid.
The trypanosome's ability to evade the hosts
Fig. 4 Main cattle producing regions of Africa I— I 
Tetse fly areas of Africa c m  
and areas where the two are found H  ,
demonstrating virtual elimination of cattle from 
Tsetse fly areas (Donelson & Turner, 1985).
















Fig. 5 Life cycle of the African trypanosome,T .b . brucei 
(Vickerman, 1985).
7immune response arises from their ability to change 
their surface glycoproteins or VSGs.
Early in the course of an infection the immune 
system generates a complement-mediated response to the 
most common VSG on the surface of the invading organism, 
ensuring up to 99% of the organisms are killed. A few 
individual trypanosomes escape because they have turned 
on a different VSG gene and are covered by a new coat 
of VSG to which the available antibodies cannot bind 
(Donelson & Turner, 1985). These variants give rise 
to a new population expressing the new VSG of which 
up to 99% are ultimately killed by the host immune system. 
The remaining parasites multiply and trigger the host 
response. Once again the small number that have changed 
their protein coat survive and multiply. This gives 
rise to the undulating nature of the disease, fig. 6, 
ultimately leading to the host's death, if untreated.
In a chronic relapsing infection, bloodstream 
and tissue trypanosomes display various different 
morphological forms ranging from the long slender to 
the short stumpy forms, fig. 5. The short stumpy form 
is believed to be a preadaptation for survival in the 
insect vector. After ingestion by a Tsetse fly the short 
stumpy form transforms in the fly mid-gut into procyclic 
trypomastigotes, which multiply and migrate to the 
salivary glands, undergoing further transformations 
into epimastigotes and finally, infective metacyclic 
forms.
The life cycle is associated with many changes
8in mitochondrial morphology and oxidative metabolism.
In the bloodstream form the mitochondrion is a simple 
tube containing a few tubular cristae, no cytochromes, 
and cyanide insensitive respiration (Grant & Sargent,
1960? Flynn & Bowman, 1973; Fairlamb & Bowman, 1977). 
D-glucose is the sole energy source in the mammal and 
pyruvate the end product of aerobic metabolism, since 
the enzymes of the tricarboxylic acid cycle are absent. 
Transition to the short stumpy form involves the synthesis 
of TCA cycle enzymes including the pyruvate and 
ot-ketoglutarate decarboxylases. Low levels of citrate 
synthetase, and succinate dehydrogenase, however, make 
the TCA cycle inoperative in vivo (Flynn & Bowman, 1973K
In axenic culture at 25°C bloodstream forms 
transform into an organism indistinguishable from the 
procyclic trypanomastigote. The mitochondrion becomes 
a complex branched network containing plate-like cristae 
(Vickerman, 1965; Bohringer & Hecker, 1974, 1975), 
synthesising cytochromes which become sensitive to 
cyanide under pure culture conditions. Proline, which 
is found in the insect hemolymph where D-glucose is 
in short supply, can replace D-glucose as the main energy 
source.
1.4 METABOLISM IN LONG SLENDER FORMS (fig. 7)
The bloodstream form is entirely dependent on 
D-glucose for energy supply. It has no energy reserves 
(Opperdoes et al., 1976), and cannot respire on fatty
g l u c o s e
| glycosome
glucose
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Fig. 7 Glycolytic pathway of T.b. brucei, showing the
glycolytic activity and associated mitochondrial 
activity.
9acids and amino acids (Bowman & Flynn, 1976). Aerobic 
respiratory activity is extremely high, about 60 to 
90 nmol 0 2/min/mg protein at 37°C, compared to 1 to 
10 nmol 02/min/mg protein, in mammalian cells.
Reoxidation of NADH produced during glycolysis 
in the glycosome is mediated through the activity of 
the mitochondrial sn-glyceroi-3-phosphate oxidase 
(glycerophosphate oxidase), (Grant & Sargent, 1960?
Opperdoes et al., 1977a, b; Fairlamb & Bowman, 1977).
For each mole of triose phosphate converted to pyruvate 
a mole of NAD+ is reduced to NADH which is reoxidised 
by a mole of DHAP being converted to glycerol-3-phosphate 
in the glycosome.GlyceroK3-phosphate is then reoxidised 
to DHAP by the glycerophosphate oxidase in the mitochondrion. 
This process forms the glycerophosphate oxidase shuttle, 
continually replenishing the NAD+, and allowing all the 
D-glucose to be metabolised via glycolysis to pyruvate.
Net ATP production in the glycosome is zero but the 
overall net production is 2 ATP per D-glucose molecule 
metabolised.
Under anaerobic conditions, or when SHAM is 
administered to inhibit the terminal oxidase, equimolar 
amounts of glycerol and pyruvate are produced (Ryley,
1956; Opperdoes et al., 1976), with D-glucose utilisation 
at the same rate as that found aerobically (Opperdoes 
et al., 1976). Unlike all the other glycolytic inter­
mediates, L-glycerol-3-phosphate rises between 4-fold 
(Visser & Opperdoes, 1980), and 30-fold (Hammond & Bowman, 
1980) , giving high local concentrations in the glycosome.
1 0
Under these conditions the highly active glycerol kinase 
can act in reverse, catalysing the formation of glycerol 
and ATP from ADP and glycerol-3-phosphate. This hypothesis 
is supported by Gruenberg et al.(1980), who demonstrated 
that the Km for efflux of glycerol is lower than that 
for influx, suggesting an effluxing system for glycerol 
removal from the cell. The net ATP production is therefore 
one per D-glucose molecule.
1.5 TREATMENT OF AFRICAN TRYPANOSOMIASIS
Table 2 outlines the treatment of African 
trypanosomiasis.
The incidence of human trypanosomiasis is generally 
low and drug use correspondingly limited; in contrast 
some six million treatments are given annually to domestic 
animals, the vast majority for bovine trypanosomiasis 
(Jordan, 1986) . In many African countries drug treatment 
is the only method of control, but its use is often 
under such inadequate supervision that drug resistance 
has evolved. No new drug for use in the field has been 
developed for many years.
Treatment of human African trypanosomiasis 
involves three main drugs, fig. 8? pentamidine in the 
prophylactic role, suramin and pentamidine in the early 
stages of the disease, and melarsoprol when the disease 
has spread to the CNS (Jordan, 1986).
Suramin is the most efficient in the prevention 
and early stages of the chronic form of T.b. gambiense
Table 2 Drugs for the treatment of African trypanosomiasis in man and domestic animals 
C = Curative; P = Prophylactic. (Jordan, 1986).
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Fig. 8 Drugs currently used in the treatment of African 
trypanosomiasis.
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infections, and is useful in the acute disease caused 
by T.b, rhodesiense. Suramin administration involves 
a thirty day intravenous treatment, compared to one 
week for pentamidine. The mode of action of pentamidine 
is thought to be by interruption of the synthesis of 
DNA, particularly in the kinetoplast. There are few 
side effects, but the drug is useless once the central 
nervous system is invaded, as it cannot cross the 
blood-brain barrier.
Suramin, a sulphonated napthylamine is a competitive 
inhibitor of glycerophosphate oxidase with respect to 
oc-glycerophosphate. Its slow mode of action is a result 
of it being taken up by endocytosis as a protein bound 
complex (Fairlamb, 1982), and not by a transport process.
Its effectiveness is limited by its inability to cross 
the blood-brain barrier.
Melarsoprol cures all stages of sleeping sickness 
because it is able to cross the blood-brain barrier.
It is administered under strict hospital supervision 
because of the severe side effects, normally after the 
use of suramin which has a tonic effect. The trivalent 
arsenical has a high affinity for sulphydryl groups, 
particularly in kinases. Flynn and Bowman (1974),have 
demonstrated that pyruvate kinase is particularly 
sensitive, with inhibition resulting in a net zero a t p  
production by the cell, ultimately leading to its death. 
Where melarsoprol resistance occurs nitrofurazone, (which 
is even more toxic) is administered.
As recently as 1979 five main drugs were used
1 2
in the treatment of animals; homidium, quinapyramine, 
diminazene, pyrithidium and isometamidium. Since that 
time resistance has developed to all but isometamidium 
and diminazene. Isometamidium has prophylactic and 
curative properties, but diminazene is so rapidly eliminated 
from the animal that it has curative properties only.
To overcome the drug resistance all of the above, 
particularly isometadium and diminazene, are used in 
combinations.
1.6 CARBOHYDRATE TRANSPORT IN T.B. BRUCEI AND THE RELATED 
STRAINS T.B. GAMBIENSE, T. LEWISI AND T. EQUIPERDUM
Much work has been published on the nature and 
function of glycolysis in the Trypanosomes, but the 
transport of carbohydrates across the plasma membrane 
of the cell has been poorly studied.
Early studies of carbohydrate transport were 
carried out on T.b. gambiense by Southworth and Read 
(1969 and 1970). D-glucose (Km 1.35mM, Vmax 47.9),
D-mannose (Km 0.84mM, Vmax 48.3), D-glucosamine (Km 1.2mM, 
Vmax 28.5), N-acetyl-D-glucosamine, 2-deoxy-D-glucose 
(Km 0.16mM, Vmax 30.4), D-fructose (Km 1.58mM, Vmax 20.1, 
where Vmax is pmoles substrate/g dry weight/2min), were 
all transported by the trypanosomes, and, with the exception 
of N-acetyl-D-glucpsamine followed saturation kinetics. 
D-glucose,D-mannose and glycerol transport were inhibited 
by each of the other 2 substrates, and each inhibited 
D-fructose. However, D-fructose did not inhibit the
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transport of the other three. Both D-fructose and D-glucose 
inhibited D-glucosamine. Southworth and Read suggested 
two transport sites existed, one for D-glucose, D-mannose 
and glycerol, with a second for fructose, which was able 
to transport D-glucosamine.
Analogues of glycerol, D-glucose, D-fructose, 
various disaccharides and miscellaneous compounds were 
tested as inhibitors of glucose and fructose transport, 
but apart from those already mentioned, no inhibition 
was found (see Table 3). Glycerol analogues were, 
1,3-propanediol, 1,2-propanediol, 1-propanol, lactic 
acid, propionic acid and glycerol. D-glucose analogues 
were, D-allose, D-galactose, L-fucose, D-sorbitol, 
D-mannitol, D-gluconic acid, D-gluconic acid lactone, 
glucuronic acid, glucuronic acid lactone,tf-methyl-D- 
glucoside, phenyl-D-glucopyranoside and 3-0-methyl-D- 
glucose. Fructose analogues were, D-tagatose, L-sorbose; 
Disaccharides, cellulose, lactose, maltose and sucrose, 
and the miscellaneous compounds, inositol, ethylene 
glycol and D-arabinose.
The inhibition characteristics demonstrated 
a highly specific transporter, since analogues with 
only one altered hydroxyl group, i,e. D-allose (C3) , 
D-galactose (C4), and 3-0-methyl-D-glucose (C3) did 
not inhibit transport. C2 analogues including N-acetyl- 
D-glucosamine with a bulky side-group did inhibit transport, 
suggesting this position was less important for binding.
Sanchez and Read (1969) demonstrated transport 
of radiolabelled D-fructose, D-galactose, 3-0-methyl- 
D-glucose, D-mannose, D-glucosamine and D-glucose
Table 3 Carbohydrates tested as inhibitors of D-glucose 
and D-fructose transport in T.b. gambiense 






Lactic acid - -








D-gluconic acid - -
D-gluconic acid lactone - -
Glucuronic acid - -
























Ethylene glycol - -
D-arabinose - -
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(Km 1.25mM, Vmax 37.04pmols/g dry weight/lOmin), in 
Trypanosoma Lewisi , see Table 4. D-glucose was inhibited 
by all the sugars except D-glucosamine. D-fructose inhibited 
all of the sugars tested, particularly D-glucosamine, 
D-glucose and D-mannose. D-galactose, 3-O-methyl-D-glucose 
and D-mannose had their greatest effects on D-glucosamine, 
and lesser effects on D-glucose and D-fructose. D- 
glucosamine inhibited D-fructose and D-mannose (53%) , 
whilst D-glucose inhibited D-fructose, 3-0-methyl-D-glucose, 
D-mannose and D-glucosamine, but not D-galactose. When 
D-glucose and D-glucosamine were combined at a concentration 
equivalent to the concentrations when used singly, 
inhibition of D-mannose rose to 88%.
*
Two transport sites explained these observations. 
Firstly a "D-glucose site" through which D-glucose was 
the preferential substrate and through which other sugars 
could enter. Secondly a "D-glucosamine site" for which 
D-glucosamine had the greatest affinity and D-fructose, 
D-galactose, 3-0-methyl-D-glucose, and D-mannose seemed 
to have a preference over the "D-glucose site".
The inhibition of transport of D-glucose, D- 
fructose, D-mannose and glycerol by a wide range of 
carbohydrates was carried out on T. eguiperdum by Ruff 
and Read (1974) . The carbohydrates tested included those 
used on TJd.gambiense by Southworth and Read (1970,
Table 4), excluding lactic acid, propionic acid, D-allose, 
glucuronic acid, glucuronic acid lactone, cellulose 
and inositol. These were replaced by L-rhamnose, 
D-mannosamine, D-galacitol,L-fructose, D-ribose, D-xylose,
Table 4. % inhibition of the various hexoses on one another at a fixed 
inhibitorrsubstrate ratio of 8:1 . Taken from Sanchez and Read (1969). 







Fructose — 44(±17) 57(±20) 89(±15) 65(±15) 92(±1)
Galactose 0 - 0 0 0 0
3-0-methyl
0 0 - 0 0 25(±11)
glucose
Mannose 39(±5) 21(±6) 43 (±22) - 46(±17) 86(±3)
Glucosamine 90(±1) 68(±6) 79(±6) 88(±1) - 94(±2)
Glucose 55(±4) 50(±15) 56(±12) 79(±5) 0 1
Table 4 Reciprocal effects of the various hexoses on one another at a fixed
inhibitor:substrate ratio of 8:1 . Taken from Sanchez and Read (1969). 







Fructose — 44 (±17) 57 (±20) 89(±15) 65(±15) 92(±1)
Galactose 0 - 0 0 0 0
3-0-methyl
0 0 - 0 0 25(±11)
glucose
Mannose 39(±5) 21(±6) 43 (±22) - 46 (±17) 86(±3)
Glucosamine 90(±1) 68(±6) 79 (±6) 88(±1) - 94(±2)
Glucose 55(±4) 50(±15) 56(±12) 79(±5) 0 1
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D-xylitol, glucoheptulose, mannoheptuiose, trehalose,
D-propanol and glyceraldehyde, see Table 5.
14The inhibition studies of C radiolabelled 
D-glucose, D-fructose, D-mannose and glycerol transport, 
were measured by incubation of the trypanosomes in 0.5mM 
radiolabelled substrate and 20mM inhibitor. Total 
radiolabelled sugar was measured in the trypanosomes 
after 2 minutes incubation.
The transport of D-glucose, D-fructose and D-mannose 
was inhibited by D-glucose, D-mannose, D-glucosamine, 
D-mannosamine, 2-deoxy-D-glucose, D-fructose, glycerol, 
glyceraldehyde, N-acetyl-D-glucosamine, 3-0-methyl-D-glucose, 
D-tagatose, mannoheptuiose and maltose. Glycerol transport, 
however, was inhibited by the first eight of these 
carbohydrates but not the last five, see Table 5.
Ruff and Read (1974) concluded that three sites 
existed for carbohydrate transport. A hexose site, through 
which D-glucose, D-mannose and D-fructose were transported 
and two glycerol transport sites, site I and site II.
Glycerol transport was inhibited by up to 80% by D-glucose 
(D-glucose:glycerol ratio 400:1), but never 100% unless 
unlabelled glycerol was added to the assay. Glycerol 
site I was therefore the hexose inhibitable site and 
site II the glycerol andglyceraldehyde inhibitable 
site, since both these compounds gave greater than 80% 
inhibition of glycerol transport.
The hexose transport site was distinct from 
glycerol site I because 3-0-methyl-D-glucose and N-acetyl-D- 
gLucosamLaeinhibited D-glucose transport but not glycerol
Table 5 Effectiveness of various compounds as inhibitors
of substrate transport in T.equiperdum (% inhibition) 
(Ruff & Read, 1974).
Inhibitor Substrate (0.5mM)
(20mM) Glucose Fructose Mannose Glycerol
Glucose analogues
D-glucose 92.8 99.0 87.4 79.3
D-mannose 96.4 99.3 94.1 72.3
D-galactose 0 0 0 0
D-fucose 0 0 0 0
L-rhamnose 0 0 0 0
D-glucosamine 60.8 86.6 58.8 31.4













D-mannitol 0 0 0 0
D-galacitol 0 0 0 0
2-deoxy-D-glucose 99.0 100.0 99.2 48.8
3-0-methyl-D-glucose 63.1 58.2 51.0 0
D-gluconic acid 0 0 0 0
D-gluconic acid 
lactone
0 0 0 0
rt-methyl-D-
glucoside
0 0 0 0
Phenyl-D-
glucopyranoside
0 0 0 0
Fructose analogues




(20mM) Glucose Fructose Mannose Glycerol
Fructose analogues
L-sorbose 0 0 0 0
L-fructose 80.2 90.7 82.0 62.9
D-sorbitol 0 0 0 0
Pentoses
D-ribose 0 0 0 0
D-arabinose 0 0 0 0
D-xylose 0 0 0 0
L-xylose 0 0 0 0
D-xylitol 0 0 0 0
Heptoses
Glucoheptose 0 0 0 0
Mannoheptuiose 28.4 73.7 23.6 0
Disaccharides
Sucrose 0 0 0 0
Lactose 0 0 0 0
Maltose 41.5 47.1 32.0 0
Trehalose 0 0 0 0
Glycerol analogues
Glycerol 87.4 92.7 84.9 96.5
1-propanol 0 0 0 0
2-propanol 0 0 0 0
1,2-propanediol 0 0 0 0
1,3-propanediol 0 0 0 0
Ethylene glycol 0 0 0 0
Glyceraldehyde 95.9 55.8 89.3 35.7
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transport. Inhibition of glycerol transport by D-glucose 
was caused by non-productive binding of D-glucose to 
the glycerol transport site without itself being transported. 
This conclusion was reached because D-glucose (O.lmM) 
transport was totally inhibited by 5mM phloridzin and 
glycerol transport by 89%. Addition of O.lmM cold D-glucose 
inhibited the residual glycerol transport by 12.4%, 
under conditions where D-glucose was not transported.
The inhibition of the D-glucose transporter by glycerol 
in intact trypanosomes has been studied by Game (1988) 
and in a plasma membrane vesicle system in this thesis.
An explanation of glycerol inhibition of D-glucose 
transport is given in the discussion, section 6.1.
The carbohydrates transported by T. eguiperdum 
and the inhibition of their transport by the inhibitors 
tested suggested that the hexose transport site could 
tolerate significant alteration of substituents at carbon 
C2 of D-glucose without affecting binding to the 
transporter. Carbon 4 was at least partially specific 
since D-galactose was not effective as an inhibitor.
Carbons 1 and 6 could not be altered without affecting 
binding to the transporter.
The preceding transport characteristics of
T.b. gambiense, T. lewisi and T. eguiperdum can be
summarised as follows. T. lewisi has two hexose transport
sites, one with a high affinity for D-glucose and one
with a high affinity for D-fructose and D-mannose (Sanchez
& Read, 1969) . T.b. gambiense has one site for D-glucose
and D-mannose transport, with a second for D-fructose 
transport (Southworth & Read, 1970). T. eguiperdum has
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three transport sites, a D-glucose/hexose transport 
site and two glycerol transport sites (Ruff & Read,
1974)• All three organisms have an ability to bind and 
transport D-glucose molecules altered at carbon 2.
Gruenberg et al. (1978) studied sugar transport
in T.b. brucei, particularly the transport of D-glucose 
and 2-deoxy-D-glucose. They determined that D-glucose 
transport involved a carrier mechanism based on the 
following observations.
(1) The transport was saturable.
(2) Phloridzina potent inhibitor of D-glucose transport, 
inhibited 2-deoxy-D-glucose transport.
(3) There was specific trans acceleration of efflux.
(4) L-glucose was not transported into the cells.
(5) p-Hydroxymercuribenzoate demonstrated a concentration- 
dependent inhibition of 2-deoxy-D-glucose transport.
D-glucose transport was not concentrative since 
the internal D-glucose concentration was always lower 
than the extracellular concentration of D-glucose, nor 
energy-dependent since under conditions where no ATP 
was produced (in the presence of sal icy1 hydrcxamic 
acid), 2-deoxy-D-glucose penetrated the cells at a rate 
close to that of D-glucose in the absence of inhibitor.
Furthermore, D-glucose transport was the rate- 
limiting step in glycolysis. Gruenberg determined the 
maximum velocity of D-glucose transport over a period 
of one minute to be 25nmol/mg dry cells/min which
p
approximates to 12.5nmol/10 cells/min. This value compares
o
with 50-100nmol/min/10 cells (120-180nmol/mg protein/min) 
calculated by Flynn and Bowman (1973). Trypanosomal
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hexokinase activity was calculated to be 790nmol D-glucose/ 
min/mg protein, in a whole cell homogenate of T.b. brucei 
by Opperdoes and Borst (1977c). Using the D-glucose 
transport/utilisation figures of Gruenberg et al. (1978) 
or Flynn and Bowman (1973), hexokinase activity is greater 
than D-glucose transport. Gruenberg et al. (1978) also 
determined that in efflux experiments greater than 50% 
of D-glucose and 2-deoxy-D-glucose was phosphorylated 
in the incubation time.
Gruenberg et al. (1978) suggested therefore 
that D-glucose was phosphorylated as soon as it entered 
the cell with the net uptake driven by the difference 
between intracellular and extracellular D-glucose 
concentration, ite . down a D-glucose gradient. The transport 
was therefore facilitated diffusion.
The most recent study of sugar transport in 
T.b. brucei by Game et al. (1986) utilised the D-glucose
analogue, 1-deoxy-D-glucose.
The previously quoted transport studies have 
utilised various carbohydrates that have in some way 
been open to limited metabolism. Further to this, Visser 
et al. (1981) have pointed out that the high glycolytic
flux poses a problem in interpreting uptake experiments 
since most of the results represent the steady-state 
rather than the initial rate. These problems could only 
be overcome using an efficient assay technique, and 
a D-glucose analogue not phosphorylated by hexokinase, 
nor metabolised by the cell.
Game et al. (1986) demonstrated that 1-deoxy-D- 
glucose gave no detectable ADP production by hexokinase
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in a coupled system (<0.1% of the rate with D-glucose) 
at concentrations up to lOmM. At concentrations of lOmM 
1-deoxy-D-glucose and 0.25mM D-glucose, no inhibition 
of D-glucose activity with hexokinase could be detected. 
Oxidation of D-glucose by the trypanosomes was inhibited 
by 1-deoxy-D-glucose presumably at the level of the 
membrane transporter.
1-Deoxy-D-glucose influx followed Michaelis- 
Menten kinetics with a Km of 4.03mM and Vmax 0.052mMs 
D-glucose was a competitive inhibitor of 1-deoxy-D-glucose 
transport with a Ki of 0.33mM. In contrast the rate 
of 3-O-methyl-D-glucose uptake into the trypanosomes 
was less than 10% of the rate of 1-deoxy-D-glucose 
uptake.
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2.0 RECONSTITUTION OF MEMBRANE PROTEINS
Reconstitution involves the incorporation of 
proteins or protein complexes into phospholipid or lipid 
mixtures containing phospholipids, to form bilayers 
with inserted proteins, as either vesicles or planar 
membranes. It may or may not involve the use of 
detergents.
Incorporation of membrane proteins involves 
two kinds of proteins. Firstly the incorporation of 
a peripheral protein that relies on a lipid mixture 
for stability, orientation e.tc. These proteins can often 
be dissociated using chelating agents, lowering or 
increasing ionic strength and pH, without disrupting 
the membrane structure, e.g. cytochrome c. The proteins 
do not span the membrane and have non-vectoral activity.
In the microsomal electron transfer chain, the amphipathic 
proteins cytochrome b^ and NADH-cytochrome b^ reductase, 
(Rogers & Strittmatter, 1973 , Dailey & Strittmatter,
.1981) , have a hydrophilic moiety free in solution and 
a hydrophobic one anchored in the membrane. In contrast 
to the transmembrane proteins, insertion occurs with 
no demand for either detergents or specific lipids, 
the amount of insertion relying primarily on available 
membrane area.
The second type of protein spans the membrane 
matrix, permitting the translocation of solutes and 
possibly generating chemical and potential gradients, 
ije. the mitochondrial proton translocating ATPase
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(Kagawa & Racker, 1971). These proteins very often 
require detergents, specific lipids and various techniques 
for reconstitution.
Reconstitution is an important technique in 
the study and elucidation of function of transmembrane 
proteins since it provides the membrane matrix for protein 
orientation and activity, and the production of separated 
compartments to allow the monitoring of solute exchanges 
between the two faces of the bilayer.
The D-glucose transporter fits into the second 
category of membrane proteins? hence reconstitution 
of transmembrane proteins will be stressed.
2.1 TECHNIQUE FOR PROTEIN RECONSTITUTION
2.1.1 Detergent dialysis and dilution reconstitution 
procedures
Detergent dialysis using cholate was the original 
method of reconstitution, developed by Kagawa & Racker 
(1971), for the reconstitution of the Na+K+ ATPase of 
bovine heart mitochondria. The technique has since been 
applied to other proteins and detergents. The protein 
or mixture of proteins is extracted by high critical 
micelle concentration detergents such as sodium cholate 
and n-octyl-p-D-glucopyranoside. The detergent and 
protein extract is mixed with an excess of phospholipid 
forming a suspension of mixed micelles containing protein, 
lipid and detergent, lipid and detergent, and protein 
and detergent. Detergent is removed by dialysis over a
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period of 12 to 48 hours, allowing proteoliposomes 
containing the transport protein to "self assemble" 
as shown in fig. 9.
Detergent dialysis has been applied successfully 
with sodium cholate and more recently n-octyl-p-D- 
glucopyranoside in the reconstitution of the D-glucose 
transporter of red blood cells by Shelton and Langdon 
(1983). A refinement of the technique replaces dialysis 
of the detergent-phospholipid-protein mixture by rapid 
dilution with appropriate buffer, resulting in a detergent 
concentration, which, if not negligible, is significantly 
below the critical micelle concentration.
Detergent dilution has been applied to reconstitution 
of the Ca^+ pump of sarcoplasmic reticulum by Racker 
et al. (1975) and the asymmetric insertion of the phage 
M13 coat protein of E.coli by Racker (1979) using sodium 
cholate. More recent applications of the dilution procedure 
replace cholate with n-octyl-B - D-glucopyranoside. Newman 
and Wilson (1980) solubilised and reconstituted the 
lactose transport system of E. coli and Chia-Chen Chen 
et al. (1986) solubilised and reconstituted the erythrocyte
D-glucose transporter.
Fig. 10 demonstrates a possible system for protein 
incorporation by detergent dilution (Eytan, 1982).
2.1.2 Physical reconstitution procedures
Physical reconstitution methods involve primarily 
sonication and freeze-thaw techniques . Sonication was 




Fig. 9 A possible sequence of events leading to
reconstitution by detergent dialysis. Initially 
mixed micelles of lipids and detergents and lipid- 
detergent-protein are formed. As detergent is 
gradually removed lipid-detergent micelles coalesce 
to form loose structures resembling liposomes. 
Further reduction in detergent causes 1ipid-protein 
micelles to adhere to the liposomes. The remaining 
detergent catalyses fusion of the lipids surrounding 
the protein with the liposome matrix resulting in 
asymmetric insertion of the protein into the 
liposome (Eytan, 1982).
Fig. 10 The figure represents a possible scheme for
reconstitution by detergent dilution. Initially 
the proteins, lipid and detergent form mixed 
micelles. Rapid removal of detergent produces a 
structure containing lipids and proteins, which 
upon reorganisation is transformed into tight 
proteoliposomes. Rapid detergent removal prevents 
the gradual building of proteoliposomes 
(Eytan, 1982).
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the transport protein or plasma membrane particles in 
the presence of lipid, over long periods of time, up 
to 30 minutes. This time can be reduced if liposomes 
are wholly formed by sonication of the lipids, with 
subsequent addition of the transport protein, and further 
brief sonication, or if the liposome protein mixture 
is sonicated in the presence of a solvent ije. 1-bromohexane 
(Racker et al., 1979).
Sonication avoids the problems of detergent 
inactivation, disassembly of protein complexes, and 
the need to remove detergents. It has however been 
demonstrated that some irradiation harms proteins (Carroll 
Racker, 1977; Banerjee et al., 1977). In the case of 
Bacteriorhodopsin sonication proved superior to cholate 
dialysis (Racker, 1973), but inferior to n-octyl-B- 
D-glucopyranoside dilution (Racker et al., 1979), and 
is the only method for reconstituting the Na+K+ATPase 
from the electric eel (Racker & Fisher, 1975).
An improvement in the sonication method was 
developed by Kasahara and Hinkle (1976) in which the 
D-glucose transporter of red blood cells was incorporated 
into liposomes by a freeze/thaw, sonication procedure.
A Triton X-100 extract of red blood cell "ghosts" was 
treated to remove the detergent and the resulting 
suspension of protein and lipid added to an excess of 
phosphatidyl choline vesicles (prepared by sonication). 
Rapid freezing of the mixture and thawing at room 
temperature fused the natural protein:lipid micelles 
with the prepared vesicles. Brief sonication (20 seconds)
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broke up lipid aggregates and conferred greatly improved 
transport activity on the proteoliposomes• To date the 
main problem with this technique has been its 
reproducibility, and possible inactivation of proteins 
by detergent. It has been used successfully in 
reconstituting the purified Na+K+ pumps from the electroplax 
of Electrophorus electricus (Hokin & Dixon, 1979) , and 
electric eels (Racker, 1979), Bacteriorhodopsin (Racker,
1979) and the D-glucose transporter of Saccharomyces 
cerevisiae (Franzusoff & Cirillo , 1983a) .
One of the advantages of the Kasahara and Hinkle 
reconstitution procedure is its application to whole 
or fragments of plasma membrane. Since the technique 
does not involve special lipids or detergents the 
transporter protein remains in its native environment 
when inserted into the artificial liposome membrane 
matrix. Wheeler (1986) reconstituted human erythrocyte 
"ghost " (erythrocytes emptied of their contents) membranes 
into artificial liposomes. Fanzusoff and Cirillo (1983b) 
and Ongjoco etal. (1987) reconstituted D-glucose transport 
of Saccharomyces cerevisiae by freeze/thaw sonication 
of yeast plasma membrane particles with preformed 
liposomes.
2.1.3 Direct incorporation reconstitution procedures
Membrane components can be incorporated directly 
into preformed liposomes without detergent? or with detergents 
at low concentrations, that catalyse the incorporation 
of the protein into the lipid bilayer. Fig. 11 demonstrates
protein
liposome
Fig. 11 A possible scheme for direct incorporation of
membrane proteins into liposomes. Upon addition 
of liposomes to delipidated membrane proteins, 
part of the liposomes are broken down and lipid- 
protein complexes are formed, with non-vectorial 
functions. If an excess of liposomes are present 
the proteins are adsorbed to them. Fusion of 
the liposome lipid matrix and the lipids enveloping 
the proteins then occurs, provided that either 
low detergent concentrations, or a specific 
lipid composition are present. The protein is 
preferentially inserted with its more hydrophilic 
pole exposed to the exterior (Eytan, 1982).
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a possible mechanism for the insertion process.
2.1.3.1 Direct incorporation reconstitution procedure 
with detergent
In this procedure the preformed liposomes are 
exposed to the transport protein in the presence of 
very small amounts of detergent for up to several hours, 
at temperatures from 0°C to 20°C. Detergents such as 
cholate, n-octyl-p-D-glucopyranoside and lysolecithin 
(formed by the action of phospholipases on phospholipids) 
have been used successfully.
Early attempts by Eytan et al. (1975) utilised
lysolecithin because of its closer resemblance to natural 
lipids than detergents. Bovine heart mitochondrial 
cytochrome c oxidase incubated with liposomes containing 
10% (w/w) lysolecithin in the total lipids required 
20 hours for maximum incorporation. Most importantly 
the protein was asymmetrically inserted, which is not 
the case with most reconstitution techniques. Similar 
results were obtained when lysolecithin was replaced 
by cholate at the low concentration of 0.1% (w/v) when 
incubated for 20 hours.
2.1.3.2 Direct incorporation reconstitution procedure 
without detergents
Direct incorporation of proteins into liposomes 
without detergents* has proved possible, if the correct 
mixture of phospholipids, particularly acidic phospholipids, 
is used in the preparation of the liposomes. Racker 
(1979) found that cytochrome c oxidase required 30%
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phosphatidyl choline, 20-30% phosphatidyl inositol, 
and 10% cardiolipin for optimum incorporation . In 
contrast to low levels of detergent, the incorporation 
was rapid, requiring minutes rather than hours, and 
could be stimulated by magnesium ions. Temperatures 
lower than room temperature, EDTA and low levels of 
detergents such as cholate and lysolecithin slowed down 
or inhibited incorporation.
The most important aspect of this technique
was the unidirectional orientation of the proteins,
and the option of sequentially incorporating proteins
into the liposomes. Miller and Racker (1976) reconstituted
bacteriorhodopsin by sonication in liposomes containing
acidic phospholipids to which was added oligomycin
sensitive ATPase, which incorporated into the liposomes
with no additional procedures. The proteoliposomes so
formed catalysed the light-dependent formation of ATP.
A modification of this system using 30% phosphatidyl
serine or cardiolipin (but not phosphatidyl inositol)
produced vesicles that fused rapidly in the presence 
2 +of Ca . This system allowed fusion of vesicles containing 
proteins reconstituted by different techniques, ije. 
cytochrome c oxidase by cholate dialysis and the 
hydrophobic protein of mitochondria produced by sonication 
(Racker, 1979) .
The most recent direct incorporation method 
(Dencher,1986) used the short chain lecithin diheptanoyl 
phosphatidyl choline (20mol % lipid) to incorporate
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the purple membrane from Halobacterium halobium into 
long chain lecithin vesicles, !e. dipalmitoyl phosphatidyl 
choline. Incorporation required temperatures above the 
transition temperature of the preformed liposomes, 
incubation with purple membranes and 20mol % diheptanoyl 
phosphatidyl choline. Total incorporation of the purple 
membrane was achieved with dimyristoyl phosphatidyl 
choline, but not if dipalmitoyl phosphatidyl choline 
was used.
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3.0 USE OF DETERGENTS IN PROTEIN EXTRACTION AND 
RECONSTITUTION
To study effectively membrane proteins, biological 
membranes need to be dissociated and the protein 
components reassembled to study activity and function. 
Detergent solubilisation represents the most useful 
and applicable approach. The complexity of native membranes, 
and the interactions of proteins, and proteins and lipids 
means that no one detergent can be effective for all 
proteins. Ideally the detergent should give maximum 
dissociation of the membrane whilst preserving the 
enzymic, antigenic, or other activity/function of the 
protein. Four other criteria are also desirable in an 
effective detergent (Hildreth, 1982).
(1) Electrical neutrality to avoid alteration of the 
charge properties of the solubilised protein.
(2) A high critical micelle concentration, ije. the 
concentration above which the detergent forms 
micelles, producing two populations of detergent, 
monomers and micelles. Further addition of detergent 
forms more micelles rather than monomers. A high 
critical micelle concentration (CMC) facilitates 
the removal by dialysis or dilution.
(3) Optical transparency in the ultra-violet region to 
permit spectrophotometric detection of the protein.




Some of the most widely used detergents are
the neutral non-ionic polyoxyethylene ether detergents,
fig. 12, which have several variations on the basic
structure, two of the most important being the Brij
series (alkyl polyoxyethylene ethers), fig. 12(1),
with the general formula C H- ,(OCH~CH~) OH, and then 2n+i 2 2 x
Triton X series of detergents (p-tert-octylphenyl- 
polyoxyethylene ethers), fig. 12(3), containing a phenyl 
ring between the alkyl group and the polyoxyethylene 
head group.
Both of these detergents have good solubilising 
characteristics, and non-denaturing properties, particularly 
the Triton series of detergents; however, they absorb 
light at 280nm, and are poor detergents for breaking 
protein-protein interactions. The major drawback to 
their use is the large micelle size making them 
incompatible with gel filtration procedures (Hildreth,
1982) and the low critical micelle concentration, ije.
Triton X100, critical micelle concentration 0.3mM (Helenius 
& Simons, 1975), precluding removal by dilution or dialysis. 
Removal therefore requires polystyrene beads (Hollaway, 
1973). Triton X-100 has been used to solubilise the 
D-glucose transporter of erythrocytes by Kasahara and 
Hinkle (1976).
The p-D-alkyl glucosides and N-D-Gluco-N-methyl 
alkanamides (MEGA) compounds, fig. 12(5) and (6), represent 
the latest detergents introduced in the non-ionic range.
Both detergents are good solubilisers, with no absorption
Fig.
,0 — fCH, — CH,— OJjjH
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n = 5, 6 or 7
12 Non ionic detergents. l)alkyl polyoxy ethylene 
ethers (BRIJ series). 2) alkyl phenyl polyoxy­
ethylene ethers (Triton N series). 3) p-tert- 
octylphenylpolyoxyethylene ethers (Triton X 
series and Nonident P40). 4) Polyoxyethylene 
sorbitol esters (Tween series). For all the above 
x = total number of oxyethylene units ije. 9.6 for 
Triton X100. 5) n-octy1-B-D-glucopyranoside, 
and 6) N-D-gluco-N-methy1 alkanamides.
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at 280nm, but most importantly a high critical micelle 
concentrationallowing removal by dilution or dialysis. 
N-octyl-p- D-glucopyranoside (8 carbon chain tail) has 
a critical micelle concentration of 25mM, which decreases 
with increasing chain length; C^q critical micelle 
concentration is 2.2mM, and C^2 0.19mM (Helenius et 
al., 1979). The critical micelle concentration of MEGA 9 
and 10 where 9 and 10 refer to the number of carbons 
on the hydrophobic tail, have not been determined, but 
are believed to be similar to n-octyl-p - D-glucopyranoside 
(Hildreth, 1982).
N-octyl-p — D-glucopyranoside represents the 
most widely used detergent of the series for solubilisation 
and reconstitution as outlined previously, but its 
expense prevents large scale use. The MEGA series of 
detergents have not been widely used, but have been 
successful in solubilising and reconstituting antigenic 
determinants from B lymphoblast cells. MEGA 9 (and 10) 
released protein as efficiently as n-octyl-p - D-gluco- 
pyranoside, sodium cholate and Nonident P40 (at 0.5% w/v). 
MEGA 10 proved more efficient at releasing protein than 
other non-ionic detergents including Nonident P40, Triton 
X-100 and Brij 96 (Hildreth, 1982). To date the main 




Zwitterionic detergents are detergents with 
a hydrophobic tail and a head group containing a negative
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and positive charge. Lysophospholipids, fig. 13(1), 
represent the most lipid-like detergents, with powerful 
solubilising power. Navarette and Serrano (1983) compared 
the solubilising power and retention of ATPase activity 
in detergent extracts of yeast plasma membrane and 
mitochondria. In the plasma membrane,egg lysolecithin 
solubilised up to 75% of the total membrane protein 
with retention of ATPase activity. Taurodeoxycholate,
Triton X-100 and n-octyl-p— D-glucopyranoside released 
no more than 30% of the plasma membrane protein, but 
released the same amount of ATPase activity.
Egg lysolecithin has a critical micelle concentration 
of 20 to 200pmolar.(Helenius et al. , 1979) and a 
large critical micelle size. These properties make 
the detergent extremely difficult to remove from the 
detergent extracts, however it has been used in protein 
purification and reconstitution systems.
Serrano (1984) successfully purified the 
plasma membrane ATPase from oat root and reconstituted 
it into liposomes using a freeze-thaw technique.
More recently synthetic zwitterionic detergents 
have been synthesised, most notably the sulphobetaines, 
fig. 13(2) (Gonenne & Ernst, 1978), containing a tertiary 
amine and sulphate head group (and hence overall 
neutrality) connected to a variable length alkyl hydrophobic 
tail. The overall neutrality of the head group is stable 
over a wide pH range.
In their general properties the sulphobetaines 
resemble the non-ionic detergents, with a critical micelle
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concentration altered little by ionic strength, but 
decreasing logarithmically with increasing tail length.
They also avoid the problems of absorbance at 280nm.
Using 3T6 mouse fibroblasts Gonenne and Ernst 
(1978), utilising sulphobetaine detergents, found that 
increasing tail chain length resulted in increasing 
solubilising power (n=8 to 16 total chain length) with 
a maximum reached at C ^ .  Above this value the detergent 
precipitated from solution at 4°C. At Cg and tail
chain length 5'-nucleotidase was activated but not 
released, and with to c^8 5'-nucleotidase was activated
and released, results unobtainable using Triton X-100.
In the solubilisation of the yeast plasma membrane, 
Navarrete and Serrano(1983) found similar properties.
Plasma membrane protein and ATPase were most effectively 
extracted with Zwittergent 14 and Zwittergent 16 
(Zwittergent is the common name for sulphobetaine 
detergents), far in excess of that released by taurodeoxy- 
cholate, n-octyl-p— D-glucopyranoside and Triton X-100, 
and comparable with that released by lysolecithin. 
Zwittergents have been demonstrate3to denature proteins, 
e.g. Zwittergent 14 on cytochrome P450 (Hjelmeland et 
al., 1979) and an oat root ATPase (Vara & Serrano,
1982) .
3.3 BILE SALT DETERGENTS
Bile salts such as cholate, fig. 13(3), differ 
from the detergents so far mentioned in that they are a 
rigid steroid structure with hydroxyl groups (3 for cholate,
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2 for deoxycholate) arranged on one surface of the
molecule, producing a hydrophilic and hydrophobic face.
There is no hydrophilic head or hydrophobic tail.
The bile salts are optically clear at 280nm
with small micelle sizes and high critical micelle
concentration; sodium cholate, approximately lOmM,
sodium glycocholate, 13mM and other derivatives with
critical micelle concentrations of 1 to 3mM (Helenius
et al., 1979).
The effectiveness of all the bile salts is
susceptible to ionic strength which alters the critical
micelle concentration. Lowering the pH leads to
precipitation of the detergent (pH6.5 for sodium cholate,
#
pH 6.9 for sodium deoxycholate; Helenius & Simons, 1975).
2 + 2 +Counterions such as Ca and Mg precipitate cholate
and deoxycholate and total bile salt concentration affects
the CMC, since both monomer and micelle forms increase
with concentration.
Bile salts, particularly cholate, have proved very
useful detergents in protein extraction and reconstitution
2 +ejg. in the reconstitution of the Ca pump of 
sarcoplasmic reticulum by Racker et al.(1975). They 
have the ability to dissociate some protein interactions, 
unlike the alkyl polyoxyether detergents, and are easily 
removed by dialysis or dilution.
3.4 ALKYL IONIC DETERGENTS
These detergents such as sodium dodecyl sulphate 
and cetyl-trimethyl ammonium bromide, fig. 14, 1 and 2
Fig. 14 Alkyl ionic detergents.
1. Sodium dodecyl sulphate
2. Cetyl trimethyl ammonium bromide
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respectively, completely solubilise membranes, usually 
dissociating complex proteins into constituent polypeptide 
chains resulting in denaturation of the protein (Helenius 
et al., 1979). They are never the choice detergent for 
reconstitution? however, mycoplasma membranes solubilised 
by sodium dodecyl sulphate, spontaneously reaggregated 
to form vesicles with a structure similar to the original 
mycoplasma membrane, provided that a divalent metal 
ion was present (Rottem et al., 1968).
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4.0 OCCURENCE AND FUNCTION OF DIHYDROLIPOAMIDE 
DEHYDROGENASE
Dihydrolipoamide dehydrogenase is an integral 
component of the pyruvate, 2-oxoglutarate and branched 
2-oxoacid dehydrogenase complexes (Reed, 1974? Perham,
1975; Pettit et al., 1978) and of the glycine enzyme 
cleavage system (Kikuchi & Hiraga , 1982). Apart from 
the above, recent evidence suggests that the enzyme 
has another role specific to a location in the plasma 
membrane of the cell with as yet undefined function.
Dihydrolipoamide dehydrogenase catalyses the 
NAD+-dependent oxidation of dihydrolipoamide (Williams, 
1976), involving the alternate oxidation and reduction 
of an intrachain disulphide bond, and a base (B) on 
the enzyme, see fig. 15. The enzyme's role in association 
with the 2-oxoacid dehydrogenase complexes has only 
been found in aerobic respiratory organisms. Its role 
cannot be associated with 2-oxoacid dehydrogenase complexes 
in archaebacteria because they lack this enzyme complex. 
Kerscher & Oesterhelt (1982) suggested that the 
association with 2-oxoacid dehydrogenase complexes evolved 
after the development of oxidative phosphorylation, 
taking dihydrolipoamide dehydrogenase from another role 
in the cell.
Archaebacteria possessing no 2-oxoacid dehydrogenase 
complexes convert their pyruvate and 2-oxoglutarate 
to the corresponding acylCoA thioesters using 
oxidoreductases containing no lipoic acid (Kerscher &
(Dihydrolipoamide) (Oxidised lipoamide)
FAD FAD





NADH ♦ H 4 NAD4
Fig. 15 Enzymic action of dihydrolipoamide dehydrogenase.
Oxidation of dihydrolipoamide results in reduction 
of an intrachain disulphide bond and a base (B). 
The disulphide bond is then reformed and the 
base deprotonated during the production of NADH 
from NAD +.
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0 esterhelt,1982) . Dihydrolipoamide dehydrogenase has 
however been found in the archaebacteria (Danson et 
al., 1984; Smith et al., 1987; Danson, 1988).The purified 
enzyme from H. halobium exhibits alternate oxidation 
and reduction of disulphide bonds (Danson et al., 1986) 
and sensitivity to dithiol specific reagents, displaying 
similar properties to the dihydrolipoamide dehydrogenases 
from eubacteria and eukaryotes.(Danson, unpublished 
data). More importantly the enzyme from Thermoplasma 
acidophilum appears to be associated with the plasma 
membrane.
Respiratory eubacteria contain dihydrolipoamide 
dehydrogenase in several multienzyme complexes, but not 
exclusively so. Owen et al.(1980) demonstrated that 
in Escherichia coli the enzyme fractionates to similar 
extents between membrane and cytoplasm, with a membrane 
vesicle system that suggested dihydrolipoamide 
dehydrogenase was responsible for the NADH-dependent 
transport of amino acids.
E. coli deficient in the synthesis of lipoic 
acid grow in the presence of acetate and succinate, 
with functional lactose permease and PEP-glucose 
phosphotransferase, but with greatly reduced binding- 
protein dependent transport of ribose, galactose and 
maltose (Richarme, 1985). When lipoic acid is supplied 
in the growth media, the lipoic acid dependent transports 
are completely inhibited by the dithiol-specific arsenate. 
Richarme and Heine (1986) demonstrated that dihydrolipoamide 
dehydrogenase activity can be detected in an E. coli
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strain deleted for the 1pd gene which codes for the 
enzyme in the 2-oxoacid dehydrogenase complexes. Residual 
activity was 15% of that in the parental strain and 
was stimulated by galactose and maltose. No stimulation 
was observed in mutant deficient in the corresponding 
binding-protein dependent transport system. This evidence 
suggests that lipoic acid and dihydrolipoamide 
dehydrogenase are connected with these sugar transport 
systems.
Dihydrolipoamide dehydrogenase has recently 
been found in Eukaryotic cells in the plasma membrane fraction 
of rat adipocytes (A-R. Karim, G.D. Holman and M.J.
Danson, unpublished data). Mitochondrial contamination 
as determined by succinate dehydrogenase activity and 
plasma membranes by the marker 5'-nucleotidase, produced 
a succinate dehydrogenase to dihydrolipoamide dehydrogenase 
ratio in the plasma membranes, one fifth that found 
in the mitochondrial fraction. This suggested dihydro­






1.0 INFECTION AND ISOLATION OF T.B. BRUCEI 
Materials
Potassium dihydrogen orthophosphate, magnesium 
sulphate, potassium chloride and D-glucose were analar 
grade from BDH Chemicals Ltd. Sodium chloride was analar 
grade from Fisons PLC and T.b. brucei were strain MITat
1.1 (supplied by Dr. H.P. Voorheis, Trinity College,
Dublin). Adult male or female, Wistar and/or Sprague- 
Dawley rats of weight 200-800 grams, were supplied by
the University of Bath animal house. Krebs Ringer phosphate 
buffer (KRB) consisted of potassium dihydrogen ortho­
phosphate (22mM), sodium chloride (98mM), potassium 
chloride (2mM) and magnesium sulphate (ImM), made up 
in double distilled water, taken to pH8.0 with 10M 
sodium hydroxide. Heparin (Sigma, grade I, porcine 
intestinal mucosa) was made up at 200 units per millilitre 
with Krebs Ringer phosphate buffer.
Whatman pre-swollen DE52 diethylaminoethyl cellulose 
anion exchanger was equilibrated in KRB (15 to 30ml 
of KRB per gram of DE52) and taken to pH8.0 with the 
addition of 10M sodium hydroxide. "Fines" above the 
slurry were removed by aspiration, and the "slurry" 
washed thrice with KRB. After each wash "Fines" were 
removed by aspiration, and the resulting DE52 "slurry" 
stored at 4°C until required. SABRE sterile hypodermic 
needles, 0.8mm x 40mm, were used for infection and bleeding 
into Gillette 20ml plastic disposable syringes. Diethyl 
ether was supplied by James Burrough, England.
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Method
T.b. brucei (stored in whole rat blood, 12%(w/v)
glycerol in heparinised capillary tubes, at -196°C),
were taken up in Krebs Ringer phosphate buffer, pH8.0,
lOmM D-glucose at 4°C. Adult rats were innoculated with 
7
1 to 3 x 10 long slender blood stream form T.b. brucei 
by intraperitoneal injection (Eisenthal & Panes, 1985), 
with total innoculation volume 0.5 to 0.75ml per rat.
Seventy-one hours post-infection the rats were 
anaesthetised under ether and the abdominal cavity cut 
open. The rats were bled of 8 to 20ml of blood into 
a 20ml syringe containing 1 to 2ml of heparin solution 
by insertion of the hypodermic needle into the bifurcation 
of the common iliac artery.
T.b. brucei were removed from the rat blood 
components by centrifugation of whole blood at 1000£,
4°C, in an IEC CENTRA-3R refrigerated centrifuge. Blood 
plasma was removed by aspiration and the trypanosomes 
overlying the packed erythrocytes gently aspirated into 
Krebs Ringer phosphate buffer, pH8.0, lOmM D-glucose,
4°C, and removed from the erythrocytes. The trypanosomes 
were washed once with Krebs Ringer phosphate buffer, 
pH8.0, lOmM D-glucose, and resuspended to approximately 
10ml with KRB, lOmM D-glucose.
Platelets, residual red blood cells and white
\
blood cells were separated from the trypanosomes by 
passage through a DEAE 52 cellulose column (5 to 10ml 
packed volume), equilibrated with KRB, lOmM D-glucose, 
at 4°C. The cells were washed once with KRB, lOmM D-glucose
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and resuspended in the same buffer to approximately 
9
1 x 10 cells/ml at 4°C and kept at 4°C until required.
Cell counts were determined on a Gallenkamp 
haemocytometer.
41
2.0 T.B. BRUCEI PLASMA MEMBRANE ISOLATION AND PURIFICATION
The process principally follows that developed 
by Voorheis et al. (1979) involving the osmotic swelling 
of the trypanosomes and disruption by the mechanical 
shear force developed in a tight fitting Bounce type 
homogeniser.
Materials
Tes (N-tris[hydroxymethyl]methyl-2 -aminoethane 
sulphonic acid), EDTA (disodiumethylenediaminetetra- 
acetic acid), PMSF (phenylmethylsulphonylfluoride) 
and leupeptin (synthetic hemisulphate) were supplied 
by Sigma Chemical Company. Analar 2-mercaptoethanol, 
potassium chloride, magnesium chloride and potassium 
dihydrogen orthophosphate were supplied by B.D.H. Chemicals 
Ltd., and sucrose from Fisons PLC. Deoxyribonucleotidase 
class I was purchased from Cooper Biomedical supplies.
Tes buffer (Tes/EDTA) consisted of Tes (2mM), potassium 
chloride (150mM), EDTA (ImM), 2-mercaptoethanol (ImM),
PMSF (O.lmM) dissolved in double distilled water taken 
to pH7.5 with 1M sodium hydroxide. "Swelling" buffer 
consisted of Tes (ImM), 2-mercaptoethanol (ImM), PMSF 
(O.lmM) and leupeptin (5yg/ml). Leupeptin was dissolved 
in methanol and added to buffers with vigorous stirring, 
and PMSF (in lOOpl of dimethyl sulphoxide) added to 
warmed buffers with vigorous stirring. DNAase treatment 
buffer (Tes/MgCl2) was the same as Tes/EDTA, except 
EDTA was replaced with magnesium chloride(5mM).
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Analar sucrose was supplied by Fisons PLC. A stock 
solution of 80% (w/v) sucrose in Tes/EDTA, was diluted 
with Tes/EDTA, 0.2mM PMSF to give 5 x 5ml concentrations 
of sucrose and 60% (twice), 55%, 50% and 45% (w/v) and 6ml 
of 40% (w/v) sucrose. The 40% to 60% sucrose gradients 
were produced by gently pipetting the 5 x 5ml concentrations 
of sucrose (60% first) into Beckman nitrocellulose 
ultracentrifuge tubes, topped with 2ml of 40% (w/v) sucrose. 
The sucrose grdient was subsequently refined by replacing 
one of the 60% (w/v) sucrose layers with a 52% (w/v) 
sucrose layer, such that the 5 x 5ml sucrose layers 
were 60%, 55%, 52%, 50% and 45% (w/v) sucrose, topped 
with 2ml of 40% (w/v) sucrose. A continuous gradient was 
formed by standing the tubes in ice for 3 hours.
In later experiments the buffer system was changed 
to phosphate buffered saline (PBS), sodium dihydrogen 
orthophosphate (12.5mM), sodium chloride (150mM), and 
PMSF (O.lmM). Tes/EDTA was replaced by PBS, O.lmM EDTA 
pH7.4, Tes/MgC^ by PBS, 5mM MgC^# and swelling buffer 
by double distilled water, O.lmM PMSF, 5pg/ml leupeptin. 
Methods
T.b. brucei in KRB, lOmM D-glucose, 1-4 x 1 0 ^  cells 
were spun down at 1000£, lOmin, 4°C.
Cell pellet
(1) Cells suspended in 10ml Tes/EDTA, 4°C.
(2) Up to 30ml of swelling buffer added to 
the cells with stirring, to give swollen 






(3) Cell suspension homogenised by one 
stroke of a tight fitting Dounce 
homogeniser.
(4) 2ml of 3M KC1 added for each 40ml 
of homogenate
(5) Homogenate centrifuged 7500g,
10 sec (8x50ml rotor, MSE 18 
centrifuge), 4°C.
Pellet PI
Membranes resuspended in 50ml Tes/EDTA, 
5pg/ml leupeptin and collected by 
centrifugation 75002 ' lOsec, 4°C 
(8x50ml rotor, MSE 18 centrifuge)








Plasma membranes collected by 
centrifugation 7500g , lOsec, 4°C 
(8x50ml rotor, MSE 18 centrifuge).
>3
(1) suspended in 4-8ml 40% (w/v) sucrose at 4 °C
(2) layered on 40-60% sucrose gradient
(3) centrifuged 70000g, 3h, 4°C (SW 28 
rotor, in Beckman L65 ultracentrifuge)
Prominant dense band at 51.3% (w/v) sucrose
(1) diluted with 50ml Tes/EDTA 4°C.
(continued)
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(2) plasma membranes collected by 
centrifugation 7,500g, 4°C, 2min. 
(8x50ml rotor, MSE 18 centrifuge)
(3) 1 and 2 repeated twice
Supernatant S4 Plasma membrane pellet P4 used fresh 
discarded for experiments, or rapidly frozen in
liquid nitrogen and stored at -90°C until 
required.
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3.0 MARKER ENZYME ASSAYS TO DETERMINE PLASMA MEMBRANE 
PURITY
Plasma membranes and various fractions taken 
from the plasma membrane isolation and purification 
procedure, were assayed for organelle marker enzymes 
to determine plasma membrane purity. The enzymes assayed 
were, hexokinase, L-glycerol-3-phosphate dehydrogenase, 
D-glucose-6-phosphatase, pyruvate kinase, D-glucose-6- 
phosphate isomerase, malate dehydrogenase, oC-giUCos.idase 
(suggested by Opperdoes et al., 1976, to be a plasma 
membrane marker enzyme), myokinase (adenylate kinase), 
ouabain sensitive Na+K+ATPase, oligomycin sensitive 
Na+K+Mg^+ stimulated ATPase and the sn-glycerol-3-phosphate 
oxidase.
Materials
Disodium adenosine triphosphate (ATP, equine 
muscle), dihydroxy acetone phosphate, imidazole, 
glycylglycine, ascorbic acid, D-fructose-6-phosphate 
(F^ -P) , oxaloacetate, D,L-dithiothreitol, adenosine 
monophosphate (A-5-MP, acid form Type I from yeast),
Fiske and Subbarow reducer (l-amino-2-napthol-4-sulphonic 
acid, 0.8% sodium sulphite and sodium bisulphite, 5g/31.5ml 
double distilled water), acidmolybdate (ammonium molybdate. 
4H20, 1.25g/l in 2 k.5N sulphuric acid), L-eC-glycerophosphate 
(di[monocyclohexylammonium] salt) , D-glucose-6-phosphate 
(G-6-P), ouabain (strophanthin G octahydrate), oligomycin, 
pyruvate kinase (rabbit muscle type II 465u/mg protein,
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4.3mg protein/ml), D-glucose-6-phosphate dehydrogenase 
(leuconostoc mesenteroides Type XXIII NADP+dependent, 
275-400u/mg protein), were all supplied by Sigma Chemical 
Co, (Poole, Dorset).
Phosphoenol pyruvate (PEP, monohexylamine salt), 
disodium adenosine diphosphate (ADP), analar trisodium 
citrate, trichloroacetic acid and maltose were purchased 
from BDH Chemical Co.
Nicotinamide adenine dinucleotide phosphate 
(oxidised form, NADP+ ), nicotinamide adenine dinucleotide 
(oxidised and reduced forms, NAD+ and NADH respectively), 
hexokinase (140u/mg protein, lOmg protein/ml), and lactate 
dehydrogenase (pig heart, 300u/mg protein, 5mg protein/ml) 
were supplied by Boehringer Mannheim, Germany.
Analar sucrose, triethanolamine hydrochloride 
(TEA), sodium arsenite and ammonium molybdate were 
purchased from Fisons PLC., and Ultrapure Triton X-100 
from Pierce Chemical Co., U.S.A. Dihydrolipoamide was 
a gift from Dr. M.J. Danson, Bath University, Bath,
United Kingdom.
All absorbance measurements were carried out 
on a Phillips Unicam SP6-450 spectrophotometer, or Cecil 
CE 212 ultra-violet spectrophotometer and recorded on 
a Rikadenki chart recorder.
Methods
All the enzymes were assayed at 37°C, pH7.6, 
in the presence and absence of 0.1% (w/v) Triton X-100 and
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initiated by addition of sample to the reagents at the 
concentrations below, unless otherwise stated. All samples 
were assayed for background and endogenous rates, which 
were subtracted where necessary.
Hexokinase (Bergemyer , 1974a)
In the presence of D-glucose and ATP, hexokinase 
produced D-glucose-6-p'hosphate which was then oxidised 
by D-glucose-6-phosphate dehydrogenase, concurrently 
NADP+ was reduced to NADPH, allowing the reaction to 
be followed by the increase in absorbance at 340nm.
D-glucose + ATP ■—» D-glucose-6-phosphate + ADP
hexokinase
glucose-6-phosphate
D-glucose-6-phosphate + NADP --------------------NADPH
dehydrogenase
+ H+ + 6-phosphogluconolactone 
non-enzymatic
6-phosphogluconolactone + H^O ------------ ► 6-phosphogluconate
H life 20min
The assay contained NADP (0.13mM), D-glucose (lllmM),
ATP (0.5mM), magnesium chloride (5mM), D-glucose-6- 
phosphate dehydrogenase (lOpg/ml), TEA (50mM, pH7.6), 
and 5 to 50pl of sample, in a total volume of 1ml.
L-glycerol-3-phosphate dehydrogenase (Panes, 1988)
Dihydroxyacetone phosphate was reduced by the 
activity of G-3-P dehydrogenase in the presence of NADH 
producing «*C-glycerol phosphate and NAD+. The loss in 
absorbance at 340nm allows the reaction to be followed.
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L-glycerol-3-phosphate
DHAP + NADH + H  ---------------------- ►ot-glycerol phosphate
dehydrogenase
+ NAD
Assay reagents were NADH (0.14mM), dihydroxyacetone 
phosphate (ImM), TEA (50mM, pH7.6) and sample, 5 to 
50|j 1 in a total volume of 1ml.
Glucose-6-phosphatase (Bergemyer, 1974b)
Inorganic phosphate was released from D-glucose-6- 
phosphate by the action of the phosphatase, and was 
measured colourimetrically by addition of molybdate.
This yields a molybdate-phosphate complex producing 
a blue colour upon reduction. Excess molybdate was bound 
by citrate/arsenite solution, preventing interference 
from background inorganic phosphate released from ATP 
under the acidic conditions.
Glucose-6-
D-glucose-6-phosphate -----------► D-glucose + Pi
phosphatase
The assay was carried out in sucrose (62.5mM),
EDTA (0.25mM), D-glucose-6-phosphate (25mM), imidazole/ 
glycylglycine (50mM/50mM, pH7.0), with 50pl of sample 
to start the reaction, in a total volume of 200|j 1. 
Incubation was at 37°C, for lOmin, and the assay stopped 
by the addition of 1ml of ascorbic acid/trichloro - 
acetic acid (2%(w/v)& 1Q%- (w/v)respectively). Precipitated 
protein and lipid were removed by centrifugation at 
10,0002, 5min, and 500pl of the supernatant added to 
250pl of ammonium molybdate solution (1% (w/v)).The tube
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was mixed well and 500pl of arsenite/citrate solution 
(2% (w/v) respectively) added to stabilise the colour.
Absorbance at 700nm was read after lOmin.
Pyruvate kinase (Bergemyer, 1974c)
Pyruvate released by the activity of pyruvate 
kinase was reduced to lactate by lactate dehydrogenase, 
whilst NADH was oxidised to NAD+. The reaction was followed 
by the loss in absorbance at 340nm.
pyruvate
Phosphoenolpyruvate + ADP » pyruvate + ATP
kinase
lactate
pyruvate + NADH + H ------------- ► lactate + NAD
dehydrogenase
The assay contained PEP (0.5mM), TEA (50mM, 
pH7.6), ADP (5mM), potassium chloride (lOOmM), magnesium 
chloride (5mM), NADH (0.14mM), lactate dehydrogenase 
(50|jg/ml) , and 5 to 25pl of sample in a total volume 
of 1ml.
D-glucose-6-phosphate isomerase
D-fruetose-6-phosphate was converted to D-glucose- 
6-phosphate by the isomerase, which was then oxidised 
by glucose-6-phosphate dehydrogenase reducing NADP+ 
to NADPH. The reaction was followed by the increase 
in absorbance at 340nm.
glucose-6-phosphate
D-f ructose-6-phosphate ■ ■    ► D-glucose-6-phosphate
isomerase
+ glucose-6-phosphate +





Final reagent concentrations were D-fructose-6- 
phosphate (lOmM), NADP (0.13mM), D-glucose-6-phosphate 
dehydrogenase (lOpg/ml), TEA (50mM, pH7.6) and 5 to 
20pl of sample in 1ml.
Malate dehydrogenase (Danson et al., 1987)
Malate dehydrogenase was assayed by the reduction 
of oxaloacetate to malate, with the concurrent oxidation 
of NADH to NAD*. The reaction was followed by the decrease 
in absorbance at 340nm of oxidised NADH.
malate
oxaloacetate + NADH + H ----------- ► malate + NAD
dehydrogenase
The assay was carried out in potassium phosphate 
buffer (50mM, pH7.0), EDTA (2mM), NADH (O.lmM), and 
oxaloacetate (0.2mM), in a total volume of 1ml, at 30°C.
oC-glucosidase (Bergemyer, 1974d)
oC-Glucosidase was monitored by the cleavage 
of the ct-1,4 glucose linkages in maltose producing two D- 
glucose molecules. D-glucose was assayed in the presence 
of ATP, hexokinase, glucose-6-phosphate dehydrogenase 
and NAD* and determined by the increase in absorbance 
at 340nm.
ot -glucosidase 
Maltose + H2O  --------------► 2 D-glucose
The enzyme was assayed at 20°C, for 24 hours, 
in the presence of potassium phosphate buffer (lOOmM, 
pH7.0), dithiothreitol (ImM), maltose (22.5mM),
Triton X-100(0.1%(w/v)with 200p 1 of sample in a total 
volume of 1ml. Thirty microlitre aliquots were assayed for 
D-glucose in potassium phosphate buffer (lOOmM, pH7.0),
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ATP (0.5mM), NADP+ (0.47mM), magnesium chloride (3.5mM), 
and 10|jg/ml of hexokinase and glucose-6-phosphate 
dehydrogenase, total volume 1ml.
Myokinase (Adenylate kinase)
Two techniques were used to measure the enzyme
activity, the production of ADP from ATP and a -5-MP
and the production of ATP and A-5-MP from 2ADP.
i) Production of ADP from A-5-MP and ATP (Bergemyer,1974e)
The scheme for monitoring the reaction is shown
below. Myokinase catalyses the production of 2ADP from
1ATP and 1A-5-MP, which was then acted upon by pyruvate
kinase in the presence of PEP to produce ATP and 2 pyruvate.
Lactate dehydrogenase reduced the pyruvate to lactate,
whilst oxidising NADH to NAD+. The subsequent decrease
in absorbance at 340nm with the loss of NADH allowed
the reaction and hence myokinase activity to be monitored.
myokinase 
A-5-MP + ATP ---------► 2ADP
pyruvate
2ADP + 2PEP  ► 2ATP + 2 pyruvate
kinase
lactate +
2H + 2NADH + 2 pyruvate ----------- ► 2 L-lactate + 2NAD
dehydrogenase
The assay was carried out in a total volume of 1ml at 
20°C containing sodium phosphate (50mM), EDTA (ImM) 
pH7.6, A-5-MP (ImM), ATP (ImM), PEP (ImM), magnesium 
chloride (ImM), potassium chloride (80mM), NADH (0.14mM), 
Triton X-100 (0.1% (w/v))pyruvate kinase (5 j j 1, 10 units), 
lactate dehydrogenase (10pl, 15 units) and 10 to lOOpl
of plasma membranes.
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ii) Production of ATP and A-5-MP from ADP
This assay was an adaption of the hexokinase/
glucose-6-phosphate dehydrogenase assay (see o(.-glucosidase
assays) in which ATP for the phosphorylation of D-glucose
was provided by myokinase action on ADP.
myokinase 
2ADP --------- ► ATP + A-5-MP
hexokinase
D-glucose + ATP -----------► D-glucose-6-phosphate + ADP
glucose-6-phosphate





The enzyme was assayed at 20°C, in a total volume of 
lml containing sodium phosphate buffer (50mM), EDTA 
(ImM) pH7. 6, Triton X-100 (0.1% (w/v)) ADP (l.OmM),
NADP (0.47mM), magnesium chloride (3.5mM), D-glucose 
(lllmM), hexokinase (lOpg/ml), and D-glucose-6-phosphate 
dehydrogenase (lOpg/ml).
Ouabain-sensitive Na* K* ATPase and oligomycin-sensitive
+ + P *f
Na K Mg stimulated ATPase
The activities of these ATPases were measured 
using the method of Post and Sen (1967), following the 
release of inorganic phosphate (Pi) from ATP. Total 
Pi was measured by its reaction with molybdate to form 
phosphomolybdate which was reduced to a phosphomolybdenum 
blue complex by a mixture of sodium bisulphite, sodium 
sulphite and l-amino-2-napthol-4-sulfonic acid according 
to the method of Fiske and Subbarow (1925).
Ouabain-sensitive plasma membrane ATPase was
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assayed in glycylglycine/Lmidazole buffer (20mM respectively 
pH7.0), ATP (3mM), EDTA (O.lmM) in a total volume of 
1.5ml. Enzyme activity was taken as the release of 
Pi in the presence of NaCl (lOOmM) and KC1 (20mM), and 
the release of Pi in the presence of 0.17mM Ouabain 
with no NaCl or KC1 at 37°C for 20 min with gentle 
agitation. For experiments where ATPase activity was 
required in fractions taken from the homogenate through 
to the final plasma membrane pellet, choline replaced 
sodium and potassium in the Tes/EDTA/MgC^ buffers, 
and EGTA replaced EDTA, to avoid the sodium in the EDTA.
Ouabain was bound to the plasma membrane ATPase 
by preincubation with the membranes for 20 minutes,
37°C as suggested by Voorheis (personal communication).
Oligomycin-sensitive ATPase was assayed under 
the same conditions as the plasma membrane ATPase, except 
sodium and potassium (lOOmM and 20mM respectively) were 
always present, and the release of inorganic phosphate 
was measured in the presence and absence of oligomycin 
(0.67jjg/ml) . Assays were started by the addition of 
ATP, with total protein of 200pg to lmg.
Enzyme activity was halted by addition of 
trichloroacetic acid (final concentration 10%(w/v)) . 
Precipitated protein and phospholipid was removed by 
centrifugation at 20,000g, 30 seconds, room temperature, 
and to 1ml of the supernatant added acid molybdate 
solution (final concentration 0.15%(w/v) and Fiske and 
Subbarow solution (final concentration 0.04%(w/v)- The 
tubes were mixed gently and allowed to stand for lOmin,
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and the absorbance at 660nm read- Total inorganic phosphate 
was determined from a standard curve of potassium phosphate 
(monobasic) treated as above.
Sn-glycerol-3-phosphate oxidase
Sn-glycerol-3-phosphate oxidase was measured
by the reduction in oxygen concentration (in an oxygen
electrode) during the oxidation of glycerol-3-phosDhate
to d i h y d r o x y  acetone phosphate by the oxidase.
*>2 H20
G-3-P ----^  ^ ---- ► DHAP
G-3-P oxidase
The assay was carried out in a Rank type oxygen electrode 
at 20°C, total volume 2ml in sodium phosphate (50mM) 
pH7.4, EDTA (O.lmM), PMSF (O.lmM) and L-ot-glycerophosphate 
(5mM). The assay was started by addition of 10 to 100^1 
of sample.
3.1 DIHYDROLIPOAMIDE DEHYDROGENASE ASSAY PROTOCOL 
Method
Fractions taken from stages during the purification 
of the trypanosome plasma membranes were stored on ice 
until tested for dihydrolipoamide dehydrogenase activity. 
Fractions assayed were the pellet PI, the final plasma 
membrane pellet P4, and the homogenate and supernatant 
SI (both taken to 2mM Tes pH7.5, with lOOmM Tes pH7.5, 
to increase the buffering capacity).
The enzyme was assayed by following the oxidation
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of dihydrolipoamide to lipoamide, with the concurrent 
reduction of NAD+ to NADH, resulting in an increase 
in absorbance at 340nm.
dihydrolipoamide
dihydrolipoamide + NAD —  --- lipoamide +
dehydrogenase
NADH + H
The assay took place in 1ml total volume at 30°C, containing 
potassium phosphate (50mM) pH7.0, EDTA (2mM), dihydro­
lipoamide (0.14mM), and NAD+ (ImM). The assay was started 
by the addition of enzyme, normally 5 to lOOpl depending 
upon the fraction tested.
3.2 HEXOKINASE PHOSPHATE DONOR SPECIFICITY ASSAY 
Materials
Potassium pyrophosphate was supplied by Sigma
14Chemical Co., and D-[U-C ] glucose (lmCi/ml, 280mCi/mmol) 
was supplied by Amersham International Ltd., U.K.
Butan-l-ol (SLR), Ammonia (SLR, 0.88 specific gravity) 
were purchased from Fisons PLC. Glacial acetic acid (GPR) 
was supplied by BDH Chemical Co., and acetone and ethanol 
by BP Chemicals and James Burroughs, England, respectively. 
Thin layer chromatography plates, Kieselgel 60F' 2.4 
were purchased from Merck, Darmstadt, Germany.
Polyethylene standard size scintillation vials were 
supplied by United Technologies, Packard, and scintillant 
used contained Toluene (70%) : Triton X-100 (30%) :
2,5 diphenyloxazole (PPO, 5g/l).
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Method
Plasma membranes (400pl) in Tes/EDTA buffer 
and supernatant SI (taken to 2mM Tes with lOOmM Tes 
pH7.5), from the plasma membrane isolation and purification 
process were incubated in Tes buffer (50mM,pH7.5), lOmM 
phosphate donor (ATP, ADP, PEP, inorganic phosphate 
(Pi) and pyrophosphate ( PPi ) , magnesium chloride (5mM), 
and radiolabelled D-glucose (ImM, 0.6pCi), in a total 
volume of 500jj1. The assay was initiated by addition 
of D-glucose and incubated for 2.5minutes at 37°C. The 
assay was terminated by aliquotting 300pl of sample 
into 700|j1 of absolute ethanol.
Precipitated protein was removed by centrifugation 
in an OLE DICH microcentrifuge, 20,000g, 5min, 20°C.
Five microlitres of supernatant was applied to a Kieselgel 
T.L.C. plate and run in a solvent system containing 
35ml butan-l-ol, 10ml acetic acid, 5.0ml 10%(v/v) 
ammonia, 20ml double distilled water and 25ml acetone, 
in a total volume of 95ml (Biochemica, Merck).
D-glucose ran to an Rf value of 0.47 and D-glucose- 
6-phosphate to an Rf value of 0.21. The plates were 
scraped directly into scintillation vials at the origin 
± 5mm, at the mid point of the Rf values ± 5mm, and the top 
of the plate ± 5mm (as a background estimation). Five 
millilitres of scintillant was added to each scintillation 
vial, stored overnight, and counted in a Packard liquid 
scintillation counter.
57
3.3 DETERMINATION OF THE MICHAELIS CONSTANT AND MAXIMUM 
VELOCITY OF THE PLASMA MEMBRANE ASSOCIATED HEXOKINASE
Method
Plasma membranes in Tes/EDTA, were incubated 
at 3.9mg protein/ml in 80mM Tes buffer pH7.5, 5mM MgC^/
ImM A.TP (or ImM ADP) , at D-glucose concentrations of 50pM, 
500pM and 5mM, total volume 2ml. The assay was initiated 
by addition of D-glucose and incubated at 37°C with 
gentle agitation. Aliquots of 540pl were taken at 10 
second, 20 second and 60 second intervals and pipetted 
directly into a plastic 1.5ml centrifuge tube containing 60pl 
of 80% (w/v) trichloroacetic acid. Denatured protein 
was removed by centrifugation at 20,000g, 5min, 20°C 
and 550pl of supernatant added to 750pl of diethyl ether 
in a 1.5ml plastic centrifuge tube. The two phases were 
vortex mixed, allowed to separate and the ether phase 
containing trichloroacetic acid discarded. The ether 
wash was repeated, and residual ether in the aqueous 
phase removed by standing the centrifuge tube in a fume 
cupboard for one hour.
Total D-glucose-6-phosphate was determined using 
the hexokinase marker enzyme assay, with the difference 
that enzyme activity was continued for 20 minutes until 
all D-glucose-6-phosphate had been utilised (determined 
by no increase in absorbance at 340nm). Total D-glucose- 
6-phosphate was calculated from the absorbance 
measurement.
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4.0 PREPARATION OF PLASMA MEMBRANES FOR EXAMINATION 
BY ELECTRON MICROSCOPY
The trypanosome plasma membranes were fixed with 
both osmium tetroxide and glutaraldehyde. Osmium tetroxide 
was used primarily to bind lipid double bonds and hence 
crosslink neighbouring lipid molecules, but also to 
fix proteins via sulphydryl groups and side chain amino 
groups.
Glutaraldehyde was used for more efficient 
fixation of the plasma membrane proteins via side chain 
amino groups. Most importantly glutaraldehyde preserved 
microtubules (Weakley, 1981) important for plasma membrane 
identification.
Lead acetate was used to increase the contrast 
of the plasma membranes by binding the reduced osmium 
and also sulphydryl,tyrosyl , carboxyl (anion form)and 
ionised phosphate groups. Uranyl acetate was used 
to bind phosphate and carboxyl groups and was particularly 
useful in visualising the plasma membranes (Hayat, 1981). 
Cacodylate buffer replaced phosphate buffer to prevent 
precipitation of lead citrate stain.
Materials
Electron microscopy grade reagents (glutaraldehyde, 
osmium tetroxide (OsO^), uranyl acetate, TAAB resin, 
lead citrate) and copper grids were supplied by the 
University of Bath Electron Microscopy Unit. Analar 
grade cacodylate (sodium dimethyl arsenic acid) was
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supplied by Sigma Chemical Co., Poole, Dorset.
Method
When required plasma membrane sheets were 












Suspended in 4% v/v glutaraldehyde, 0.1M 
cacodylate buffer pH7.2, 12h, 20°C, then 
collected by centrifugation.
Pellet
Pellet washed thrice with 0.1M cacodylate 
buffer pH7.2, 20°C.
Pellet
Pellet resuspended in 1% (w/v) OsO^, lh, 20°C, 
centrifuged and washed thrice with DDt^O, 
20°C, to remove OsO^, and cacodylate buffer, 
the latter to prevent precipitation of 
uranyl acetate.
Pellet
Pellet resuspended in 1% (w/v)aqueous uranyl 
acetate, lh, 20°C, in the absence 
of light to prevent precipitation of uranyl 




Dehydrated, 20°C, in 30% (v/v) acetone twice 
(10mir^ 70fe {w/v) acetone twice (lOmin) and 
4^ 100% thrice, then collected by centrifugation.
Pellet
Pellet suspended in 50:50(v/v) acetone/TAAB 
resin, stood 20°C, 12h. Acetone/resin 
replaced by 100% resin, stood 48h, replaced 
by 100% resin 12h, and then hardened in 
+ an oven, 60°C, 48h.
Resin block
Thin sections taken from resin blocks with 
a glass knife and Reichart OM U3 cutting 
microtome, were placed on copper grids and 
stained with a saturated ethanolic solution 
of uranyl acetate, 5min (absence of light 
to prevent precipitation), followed by lead 
citrate (absence of C02 to prevent precipit­














5.0 SODIUM HYDROXIDE TREATMENT OF PLASMA MEMBRANES TO 
RELEASE THE MICROTUBULAR ARRAY
Materials
Sodium phosphate buffer (5mM) taken to pH8.0 
with 1M sodium hydroxide. Sodium hydroxide solutions 
containing EDTA (2mM), dithiothreitol (0.2mM)added fresh 
on day of experiment), and sodium hydroxide concentrations 
of 5mM, lOmM and 15mM. Sodium phosphate buffer (lOmM), 
adjusted to pH7.4 with 1M sodium hydroxide.
Method
This technique is based on that of Gorga and 
Lienhard (1981) developed for erythrocyte "ghosts".
T.b.brucei plasma membranes produced freshly 
on the day in PBS/EDTA buffer were washed thrice in 
50ml of sodium phosphate buffer (5mM) pH8.0, 4°C, in 
an MSE 18 centrifuge, 7,500g, lOsecs. Washed membranes 
were resuspended in sodium phosphate buffer (5mM) pH8.0, 
4°C at a protein concentration of 4mg/ml.
Five volumes of sodium hydroxide solution were 
added to the trypanosome plasma membranes and allowed 
to stand at 4°C for 10 min. Membranes were collected 
at 48,000gfor 30min, 4°C in a Beckman L5-65 
ultracentrifuge, washed once with 50ml sodium phosphate 
buffer (lOmM) pH7.4, and finally resuspended with lOOpl of 
lOmM sodium phosphate buffer, lOOmM D-glucose, O.lmM EDTA, 
O.lmM PMSF, pH7.4.
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One hundred microlitres of suspension was incubated 
at room temperature for 30min, and then stored on ice 
until used. The remainder was taken to 3ml with lOmM 
sodium phosphate buffer, lOOmM D-glucose pH7.4, and taken 
through the complete freeze/thaw vesiculation procedure 
and assayed for D-glucose transport as outlined in 
"preparation of plasma membrane vesicles", Section 5.2 
and "plasma membrane and reconstituted proteoliposome 
infinite-trans sugar transport protocol", Section 10.3.
5.1 DEPOLYMERISATION OF THE PLASMA MEMBRANE PELLICULAR 
ARRAY OF MICROTUBULES BY CALCIUM ION TREATMENT
Materials
Sodium phosphate-glutamate buffer (20mM Na2HPO^, 
lOOmM glutamic acid (BDH analar grade), ImM mercaptoethanol 
(Sigma Chemical Co.), O.lmM PMSF, 5pg/ml leupeptin), 
taken to pH7.0 with 1M sodium hydroxide. Calcium chloride 
was analar grade from BDH Chemicals Ltd. and defatted 
bovine serum albumin from Sigma Chemical Co. Before 
the experiment glassware to be used was stood overnight 
in concentrated nitric acid and then washed in double distil led 
water and dried before use.
Method
This technique primarily follows that of Dolan 
et al. (1986). Plasma membranes in PBS/EDTA or Tes/EDTA
buffer were washed thrice in phosphate-glutamate buffer, 
collected at 4°C, 9,000g, 20s, in an Ole Dich refrigerated
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centrifuge and finally resuspended in phosphate-glutamate 
buffer at a protein concentration of 2mg/ml, in a total 
volume of 2ml. The experiment was organised such that 
plasma membranes were subjected to calcium ion concentrations 
of 0, O.lmM, 0.5mM and l.OmM in the presence and absence 
of 1%(w/v) defatted bovine serum albumin. Membranes 
were incubated with and without calcium ions and defatted 
bovine serum albumin at 37°C for 30min with gentle 
agitation, and the depolymerisation process monitored 
by microscopic examination. The suspension was then 
cooled on ice for 20min and taken to ImM EDTA by addition 
of lOOmM EDTA. Membranes were collected by centrifugation 
at 9,000g, lOmin, 4°C. Both supernatant (SI) and pellet 
(PI) were assayed for dihydrolipoamide dehydrogenase 
activity and total protein, as outlined previously.
The supernatant (SI) from the process was subjected 
to further centrifugation at 20,000g, lh, 4°C. The 
resulting pellet (P2) and supernatant (S2) were once 
again assayed for dihydrolipoamide dehydrogenase activity 
and total protein.
5.2 PREPARATION OF PLASMA MEMBRANE VESICLES 
Materials
Sodium dihydrogen orthophosphate (BDH Chemicals 
Ltd.) was made up in double distilled water and taken 
to pH7.4 with 1M sodium hydroxide at concentrations 
of 5, 10, 30 and lOOmM, containing O.lmM PMSF, O.lmM 
EDTA. Ethanol was analar grade from James Burroughs,
64
England, and solid carbon dioxide supplied by the
Distillers Company Ltd., Coleshill, England.
3
Unlabelled and radiolabelled [6- H]-6-deoxy-
14-D-glucose (8.13Ci/mmol) and [U- C]-1-deoxy-D-glucose 
(295 mCi/mmol) were synthesised by S. Game (1988).
Plastic centrifuge tubes were purchased from Sarstedt 
Ltd.
Method
Plasma membranes produced as outlined previously 
were washed twice in 50ml of sodium phosphate buffer 
pH7.4, 4°C and collected at 7,500g , 10 sec, 4°C in 
an MSE 18 centrifuge. Membranes were finally resuspended 
in phosphate buffer pH7.4, 4°C, at protein concentrations 
of 5 to lOmg/ml, total volume 3 to 4ml.
Membranes were transferred to a glass Pyrex 
boiling tube and rapidly frozen in solid carbon dioxide/ 
ethanol bath (-72°C). Membranes were thawed by standing 
the tube in a water bath at room temperature. The vesicle/ 
supernatant fraction was separated from other fractions by 
transferral to a 4ml plastic centrifuge tube and 
centrifugation in an OLE DICH , CAMLAB refrigerated 
microcentrifuge (154), for 4min, 9,000g , 4°C.
In total five freeze/thaw cycles were found 
to be most efficient and the supernatants from each 
pooled and taken to 25ml with ice cold phosphate buffer. 
The vesicle fraction was collected at 100,000g, 4°C, 
lh, in a Beckman Model L5-65 ultracentrifuge using a 
Beckman Type 60Ti rotor head.
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The vesicle pellet was resuspended with 10 to 
40pl of sodium phosphate buffer, pH7.4, 4°C, by rapidly 
"taking up" and expelling the fraction using a 200pl 
Gilson automatic pipette, until a homogeneous suspension 
resulted. This suspension was transferred to a sealed 
plastic Eppendorf 1.5ml microcentrifuge tube and stored 
at 4°C until required.
Sodium phosphate buffer concentrations varied 
between 5, 10, 30 and lOOmM. For experiments where preloading 
of the vesicles with D-glucose was required the sodium 
phosphate buffer used for freeze/thawing and resuspending 
the final pellet contained lOOmM D-glucose. In the case 
of 6-deoxy-D-glucose and 1-deoxy-D-glucose, preloading 
the vesicles was carried out by resuspending the pellet 
from high speed centrifugation with 300mM D-glucose 
analogue and adjusting the final concentration to lOOmM 
with sodium phosphate buffer. Preloading took place 
by storing the vesicles at 4°C overnight, 12 to 16h, 
in a sealed Eppendorf 1.5ml microcentrifuge tube. D-glucose 
preloaded vesicles produced by standing with D-glucose 
overnight or by inclusion of D-glucose in the sodium 
phosphate buffer during freeze thawing demonstrated 
identical D-glucose infinite trans^transport with time.
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6.0 PREPARATION OF ERYTHROCYTES
Erythrocytes were prepared according to the 
method of Levine et al. (1971). Outdated human transfusion
blood (1-3 weeks old) was separated from plasma and 
acid-citrate-dextrose by washing with five volumes of 
phosphate buffer (containing 12.5mM Na2HPO^ and 154mM 
NaCl, taken to pH7.2 with 1M sodium hydroxide) followed 
by centrifugation at 2,500g, lOmin, 20°C. The supernatant, 
white cells and platelets were removed by aspiration 
and the erythrocytes washed a further four times in 
phosphate buffer at 20°C. The erythrocytes were then 
left in a packed condition.
6.1 PREPARATION OF ERYTHROCYTE "GHOSTS”
Packed erythrocytes prepared as above at 20°C 
were lysed by plunging them into 15-25 times their volume 
of ice cold haemolysing buffer (containing 5mM Na2HPO^,
ImM EDTA, and O.lmM PMSF, taken to pH8.0 with 1M sodium 
hydroxide) according to the method of Dodge et al. (1963). 
The suspension was stirred gently but thoroughly and 
left at 4°C for 20min. The membrane suspension was 
collected by centrifugation at 16,000g (6 x 300ml angle 
rotor, Sorvall RC-5B centrifuge) at 4°C for 20min with 
the centrifuge brake off. The supernatant was aspirated 
off and discarded, the fluffy membrane pellet removed 
with a pasteur pipette, and the hard pellet removed 
and discarded.
The fluffy membranes were washed once in ice
cold haemolysing buffer, collected by centrifugation 
as previously, the supernatant discarded and the fluffy 
membrane pellet resuspended in ice cold phosphate buffer. 
Two further washes of the membranes were carried out 
at 4°C in phosphate buffer, and the final fluffy pellet 
stored at -90°C until required.
68
7.0 SDS POLYACRYLAMIDE GEL ELECTROPHORESIS 
Materials
Acrylamide, N,N'-methylene bis_ acrylamide (Electran 
grade, purified for electrophoresis) and sodium dodecyl 
sulphate (SDS, specially pure) were from BDH Chemicals. 
Boric acid and Trizma base (analar grade) and glycerol 
(SLR) were from Fisons PLC. Ammonium persulphate (98% 
crystalline) , N,N,N,N-tetramethylethylene diamine (TEMED), 
Brilliant Blue R (C142660), bromophenol blue (3 ' ,3" , 5 ' , 5"- 
tetrabromophenol sulfonphthalein), mercaptoethanol and 
molecular weight standards (myosin (205,000), 
p-galactosidase (116,000), phosphorylase b (97,000), 
bovine serum albumin (66,000), egg albumin (45,000) 
and carbonic anhydrase (29,000)) were all from Sigma 
Chemical Co. Ltd. The gel apparatus and water proof 
tape wpre from Pharmacia.
30% acrylamide solution
Thirty grams of acrylamide and 0.8g of N,N' - 
methylene bis acrylamide were dissolved in 100ml of 
double distilled water to give 30%(w/v) acrylamide and 
0.8%(w/v) N,N'-methylene bis acrylamide.
Gel buffer
Trizma base (90.86g, 1.5M) and SDS (2.0g, 0.4%
(w/v)) were dissolved in 500ml of double distilled water 
and taken to pH8.8 with concentrated hydrochloric acid.
6 9
20% (w/v) acrylamide solution 5% (w/v) acrylamide solution
5ml gel buffer 5ml gel buffer
13.33ml of 30% acrylamide 3.33ml 30% acrylamide
1.67ml double distilled water 11.67ml double distilled
water
Total volume for each solution 20ml
Electrode buffer
Electrode buffer consisted of Tris (25mM), boric acid 
(40mM) and SDS (0.1% (w/v)) in a total volume of 5 litres, 
at pH8.3.
Gel stain and destain
Gel stain consisted of 0.2% (w/v) Coomassie Brilliant 
Blue R in acetic acid:ethanol:double distilled water 
(1:3:6) and destain the same as stain without the 
Coomassie Brilliant Blue R.
Method
Glass gel plates (20cm x 18cm x 0.2cm) were 
soaked in 2M potassium hydroxide in 95% ethanol overnight, 
rinsed with double distilled water and soaked overnight 
in 1% (v/v) decon solution. They were then rinsed thoroughly 
in double distilled water and dried in a warm oven.
Two plates, separated by 1mm teflon spacers 
were taped together with Pharmacia waterproof tape, 
and clamped vertically. A fast setting 20% acrylamide 
solution (2ml) containing 5m 1 of TEMED and 15pl of 10%
(w/v) ammonium persulphate was used to seal the gel 
base. Eighteen mis of 20% acrylamide was added to one
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chamber of a linear gradient mixer, and 20ml of 5% 
acrylamide to the other, and to both 30pl of TEMED 
and 90^1 of 10% ammonium persulphate added with mixing.
The acrylamide was pumped into the gel space by a 
peristaltic pump, (such that the 20% acrylamide was at 
the bottom of the gel and 5% acrylamide at the top), 
via hard rubber tubing, so that the tubing could be
maintained just above the gel slab surface. This pouring 
process normally took approximately 15min.
Wells were produced in the 5% acrylamide using 
an eight tooth teflon comb placed in the gel before 
setting occurred. Double distilled water was layered 
onto the gel to avoid evaporation, and any shrinkage 
of gel during setting remedied by addition of 5% acrylamide 
solution.
Samples to be loaded on the gel were precipitated 
with trichloroacetic acid (5%(w/v)) and protein collected 
at 9,000g, 20°C for 5sec in a microfuge (Dolan et al.,
1986) . The protein pellet was resuspended with lOOpl 
of gel buffer, containing 1.0% (w/v) SDS and 1.0% (v/v) 
mercaptoethanol, to give total protein of up to 200pg, 
and boiled for 3 min. One grain of bromophenol blue 
tracker dye was added to each protein sample and the 
samples applied to the gel.
The gels were run in a Pharmacia electrophoresis 
tank containing electrode buffer, until the tracker 
dye reached the base of the gel. This usually took 14 
to 18h at a current of 22 to 28mA. Each gel was stained 
for 6h in stain and then destained until protein bands
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were clearly visible against a clear background, normally 
36 to 48h.
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8.0 EXTRACTION OF TOTAL TRYPANOSOME LIPID FROM TRYPANOSOMES 
Materials
Analar grade methanol and chloroform were supplied 
by James Burroughs and May & Baker, England, respectively. 
Chloroform was tested for phosgene according to the 
method of Bergelson (1980) by the addition of 1ml of 
solvent to 1ml of 1% (w/v) p-dimethyl-amino-benzaldehyde 
(from Sigma Chemical Co.) in double distilled water.
Any phosgene present would produce an intense yellow 
colour. This was not found in any of the chloroform 
tested.
Method
Lipid extraction followed the method of Bligh 
and Dyer (1959) assuming the trypanosome pellet was 
80% water. Whole trypanosomes in Krebs Ringer phosphate 
buffer, lOmM D-glucose pH8.0 were used fresh or after 
thawing from storage at -90°C in Krebs Ringer phosphate 
buffer, lOmM D-glucose, 12% (w/v) glycerol. Trypanosomes 
were put in a 50ml MSE plastic centrifuge tube, washed 
twice in 50ml of Krebs Ringer phosphate buffer pH8.0,
4*C , collected by centrifugation in an MSE 18 centrifuge 
at 10,000g, 5min, 4°C, and the supernatants discarded.
Double distilled water was added to the packed 
trypanosome pellet according to the pellet weight, see 
table on following page.
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Weight of Vol of 1^0 for Vol. MeOH/CHCl3 Final step vol.
tissue homogenisation for shaking of NaCl & CHC13
(g, wet wt.)
1 0.5 5 1.7
2 1.0 10 3.3
3 1.4 14 4.7





The pellet and double distilled water were vortex 
mixed at room temperature for 20sec. Lipid was solubilised 
by addition of methanol/chloroform (2:1 by volume) 
to the trypanosome/double distilled water mixture, the 
volume determined by reference to the table above, and 
the mixture vortexed for 20 seconds at room temperature.
Insoluble material was removed by filtration 
through Whatman No 1 filter paper (prewashed with methanol/ 
chloroform 2:1 by volume) on a Buchner funnel (prewashed 
with 2:1 by volume methanol/chloroform) under suction, 
and the resulting filtrate transferred to a MSE 50ml 
plastic centrifuge tube. Double distilled water containing 
0.58% (w/v) sodium chloride (Voorheis et al., 1979), 
and chloroform were added to the lipid extract in volumes 
as outlined in the table above. After vortex mixing 
for 5 seconds the resulting milky emulsion was separated 
into two distinct phases by centrifugation in an IEC 
Centra 3R bench centrifuge at 3,000rpm, 5min, room 
temperature. The chloroform phase was removed and kept 
to one side, whilst the methanol/sodium chloride solution
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9.0 RECONSTITUTION OF TRYPANOSOME AND HUMAN ERYTHROCYTE 
PLASMA MEMBRANE PROTEINS
Materials
Soybean L-ot-phosphatidyl choline (L-oUlecithin) 
Type 11 S egg yolk L-ot-phosphatidyl choline (L-oC-iecithin) 
Type V-EA, 99% pure, n-octyl-p-D-glucopyranoside, egg 
yolk L-ot-lysolecithin, catalase (bovine liver, ll,000U/mg 
protein, glucose oxidase (Aspergillus niger, type II,
38U/mg protein), decanoyl-N-methyl-glucamid (N-methyl 
glucamid, MEGA 10) and sodium cholate were supplied 
by Sigma Chemical Co. Non-polar polystyrene beads, 
biobeads SM2 were purchased from Biorad Laboratories 
Ltd., Watford, England, and a Decon FS 100 freguency 
sweep, 100 watt, 1.5 litre bath sonicator from Decon 
Laboratories Ltd., Hove, England.
Zwittergent 14 was supplied by Calbiochem-Behring 
Corp. La Jolla, California, dialysis tubing (size 1-8/32") 
by Medicell International Ltd., London, England, and 
Sepharose C1-6-B by Pharmacia Fine Chemicals A.B.. Uppsala, 
Sweden.
9.1 FREEZE/THAW AND SONICATION RECONSTITUTION OF PLASMA 
MEMBRANE PROTEINS
9.1.1 Detergent extracted proteins 
Method
The technique principally follows that developed 
by Kasahara and Hinkle (1976). T.b.brucei plasma membranes
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and human erythrocyte ghosts, produced as outlined 
previously, were washed thrice in Tris/HCl buffer (lOmM) 
pH7.4, or sodium phosphate buffer (lOmM) pH7.4, at 4°C 
as outlined previously, and finally resuspended in the 
buffers in the presence and absence of EDTA (ImM), 
2-mercaptoethanol (ImM), PMSF (O.lmM) and leupeptin 
(5|jg/ml) .
Membranes (2mg of protein) were incubated with 
0.5% (w/v) Triton X-100 in lOOmM buffer pH7.4, at 4°C 
to give a final protein concentration of 2mg/ml. After 
20 min incubation at 4°C, with occasional- inversion 
to mix, the insoluble material was removed by centrifugation 
in a refrigerated OLE DICH CAMLAB microcentrifuge,
20,000^* lh, 4°C, and discarded. The clear supernatant 
was added to Biobeads SM2 pre-equilibrated in lOmM buffer 
pH7.4 (0.3g beads/ml supernatant) and agitated gently 
at 4°C overnight to remove the detergent.
Biobead treated extract, 0.5ml, was added to 
250^1 of preformed liposomes (Soybean L-ct-lecithin 
50mg/ml vortex mixed and sonicated to clarify in lOmM 
buffer pH7.4) to give 15 to 20mg of lipid and 300 to 
600pg of protein in 750|j 1. This mixture was frozen 
rapidly in an ethanol/dry ice bath, and thawed at room 
temperature. Resulting proteoliposomes were sonicated 
in a Decon FS 100 bath sonicator (adjusted for maximum 
agitation of the proteoliposomes), for 10 seconds, and 
then stored on ice until required.
The above procedure of solubilisation and 
reconstitution was applied to plasma membranes extracted
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with Zwittergent 14 at 2 and 3mM final concentrations 
and to n-octyl-p-D-glucopyranoside at 50mM final 
concentration in place of 0.5% (w/v) Triton X-100. 
Zwittergent 14 was removed by Biobeads SM2 as for Triton 
X-100, and n-octyl-p — D-glucopyranoside by dialysis 
for 12h at 4°C, against 1 litre of lOmM Tris/HCl buffer, 
pH7.4.
The procedure was modified to assay a range 
of concentrations of Zwittergent 14, Triton X-100 and 
L-oC-lysolecithin (membranes treated for lOmin at room 
temperature followed by incubation of the extract with 
Biobeads SM2 as for Zwittergent 14 and Triton X-100) 
including lOOmM D-glucose in all the buffers. This 
produced proteoliposomes preloaded with lOOmM D-glucose. 
The proteoliposomes were diluted with 25ml of lOmM sodium 
phosphate buffer, O.lmM PMSF, O.lmM EDTA, lOOmM D-glucose 
pH7.4, 4°C, in a Beckman 25ml ultracentrifuge tube, 
and collected by centrifugation at 100,000g, 4°C in 
a Beckman L65 ultracentrifuge using a Beckman Ti 60 
rotor.
The proteoliposome pellet was resuspended with 
20pl of lOmM sodium phosphate buffer pH7.4, O.lmM PMSF, 
O.lmM EDTA, lOOmM D-glucose, 4°C, to give a homogeneous 
suspension of proteoliposomes. Proteoliposomes were 
kept on ice until required.
9.1.2 Non-detergent extracted proteins
T.b. brucei plasma membrane vesicles produced 
by the freeze/thaw procedure outlined previously, in
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lOmM sodium phosphate buffer pH7.4, O.lmM EDTA, O.lmM 
PMSF, lOOmM D-glucose, were added to preformed Soybean 
L-ct-lecithin vesicles, sonicated to clarity in lOmM sodium 
phosphate buffer pH7.4, O.lmM EDTA, O.lmM PMSF, lOOmM 
D-glucose to give a final protein concentration of lmg/ml 
and lipid concentration of 20mg/ml in a total volume 
of 1ml.
The mixture was frozen in ethanol/dry ice bath 
and thawed at room temperature. Proteoliposomes formed 
by the procedure were sonicated for 10 seconds, collected 
by ultracentrifugation as outlined previously, and 
resuspended with 20pl of lOmM sodium phosphate buffer 
pH7.4, O.lmM EDTA, O.lmM PMSF and lOOmM D-glucose.
9.2 DETERGENT DIALYSIS RECONSTITUTION PROCEDURE 
Method
This technique principally follows that of Shelton 
and Langdon (1983). Membranes (erythrocyte and T.b.brucei) 
were washed thrice in 10mM sodium phosphate buffer, O.lmM 
O.lmM EDTA, O.lmM PMSF , pH7.0, as outlined previously,
at 4°C. To 0.5ml of membrane (2.5 to 3.5 mg of protein/ml) 
was added 0.5ml of lOmM sodium phosphate buffer pH7.0,
O.lmM EDTA, O.lmM PMSF, 340mM N-octyl-p-D-glucopyranoside.
The mixture was stood on ice for 20min with occasional
\
inversion to mix, followed by centrifugation, 20,000c[,
4°C, 20min, in an OLE DICH refrigerated centrifuge, 
to remove insoluble material. The clear supernatant 
(approximately 1ml) was added to 1ml of lOmM sodium
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lipid. Soybean L-d-lecithin was sonicated to clarity, 
T.b.brucei whole lipid prepared as outlined previously, 
and the egg yolk L-«t-lecithin were both vortex mixed 
for lOmin and sonicated for 2h under nitrogen. The lipid 
solutions contained the lipid at 50mg/ml in double distilled 
water, 2mM mercaptoethanol.
The lipid and detergent extract was inverted 
to mix and stood on ice for 15min before being rapidly 
injected through a Sabre 0.6 x 30mm hypodermic needle 
on a 2ml plastic syringe, into 20ml of lOOmM potassium 
phosphate buffer pH7.0 containing lOOmM D-glucose at 
20°C. Resulting proteoliposomes were incubated at 20°C 
for 20min and collected by centrifugation at 100,000g, 
lh, 4°C in a Beckman L65 ultracentrifuge, and Ti 60 
rotor.
Proteoliposomes were resuspended with 20pl of 
lOOmM potassium phosphate buffer, pH7.0, containing 
lOOmM D-glucose and stored on ice until assayed.
9.3.2 Reconstitution from decanoyl-N-methyl-glucamid
and sodium cholate extracts of trypanosome plasma 
membranes
The reconstitution principle follows that outlined 
for n-octyl-p— D-glucopyranoside with several modifications. 
Trypanosome plasma membranes resuspended in lOmM sodium 
phosphate buffer pH7.4, O.lmM EDTA, O.lmM PMSF, lOOmM 
D-glucose, were incubated with decanoyl-N-methyl-glucamid 
(MEGA 10) at concentrations of 0, 0.25, 0.5 and 1.0%
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(w|v) detergent (protein concentration 2mg|ml, total 
volume 1ml) at 20°C for 20min, in lOmM sodium phosphate 
buffer, pH7. 4, O.lmM EDTA, O.lmM PMSF, lOOmM D-glucose. 
Incubation with sodium cholate was carried out at 0,
0.5, 1.0, 1.5 and 2.0% (w/v) sodium cholate at 4°C, 
with other conditions identical to decanoyl-N-methyl- 
-glucamid.
Insoluble material was removed by centrifugation, 
20,000g, lh, 4°C (for sodium cholate) and 20°C for decanoyl- 
N-methyl-glucamid. One millilitre of supernatant was 
added to 250(jl of Soybean L-oi-lecithin (20mg of lipid) 
sonicated to clarity in a Decon FS 100 bath type sonicator in 
lOmM sodium phosphate buffer, pH7.4, O.lmM EDTA, O.lmM 
PMSF, lOOmM D-glucose and allowed to stand at 4°C, lh, 
for sodium cholate extractions, and 20min, 20°C for 
decanoyl-N-methyl-glucamid (MEGA 10) extractions. After 
standing for the allotted times, the proteoliposomes 
were rapidly diluted by injecting the protein:lipid: 
detergent mixture into 20ml of lOmM sodium phosphate 
buffer pH7.4, O.lmM PMSF, O.lmM EDTA, lOOmM D-glucose, 
at room temperature (for both detergents). Proteoliposomes 
were collected by centrifugation, 100,000^, lh, 4°C, 
in a Beckman L5-65 ultracentrifuge and Beckman Ti60 
rotor, and resuspended in 20|j 1 of lOmM sodium phosphate 
buffer pH7.4, O.lmM EDTA, O.lmM PMSF, lOOmM D-glucose, 
and stored on ice until assayed.
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9.4 DIRECT INCORPORATION RECONSTITUTION PROCEDURE FOR 
TRYPANOSOME PLASMA MEMBRANE PROTEINS
The direct incorporation procedure is based 
on that developed by Eytan et al. (1975) utilising 
L-«t-lysolecithin from egg yolk.
Plasma membrane vesicles produced by the freeze/ 
thaw technique outlined previously, in lOmM sodium 
phosphate buffer pH7.4, O.lmM EDTA, O.lmM PMSF, lOOmM 
D-glucose, were added to a lipid mixture containing 
soybean L-ot-lysolecithin (10%(w/w)of the total 
phospholipids) in lOmM sodium phosphate buffer pH7.4,
O.lmM EDTA, O.lmM PMSF, lOOmM D-glucose, to give a finaj 
concentration of 20mg/ml and protein concentration of 
lmg/ml in 1ml.
After incubation for 12h at 4°C with gentle 
agitation, the proteoliposomes were diluted with 20ml of ice 
cold lOmM sodium phosphate buffer pH7.4, O.lmM EDTA,
O.lmM PMSF, lOOmM D-glucose, and collected by centrifugation 
at 100,OOOg, 4°C, lh, in a Beckman L65 ultracentrifuge.
The proteoliposome pellet was resuspended once again 
with 20|j 1 of the lOmM sodium phosphate buffer pH7.4, 
and collected as previously indicated. The resulting 
proteoliposomes were resuspended with 20pl of lOmM sodium 
phosphate buffer pH7.4, O.lmM EDTA, O.lmM PMSF, lOOmM 
D-glucose, and stored on ice until assayed.
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with 1ml of KRB pH8.0 (no D-glucose) and collected at
16,0002 av, 20sec, 4°C. Cells were resuspended by vortex 
with 30pl of KRB, and 20pl of these added to 5pl of
3
6- H-6-deoxy-D-glucose in another 4ml plastic tube at 
room temperature (20°C). 6-deoxy-D-glucose concentration 
was 129pM with a total radioactivity of 2.4pCi per tube.
The cells were allowed to accumulate 6-deoxy- 
D-glucose for lmin at room temperature before being 
diluted 1 in 20 with 475|j 1 of KRB, or KRB containing 
the inhibitor to be used. Time points were taken at 
various times between 3 and 60 secs by aliquotting 100pl 
of cell suspension into 2ml of ice cold KRB pH8.0,
0.1% (w/v) phloridzin (2.2mM) in a 4ml plastic centrifuge 
tube. Cells were collected at 16,0002.* 4°C, 20sec, the 
supernatant discarded and cell pellet resuspended by 
vortex with 1ml of ice cold KRB pH8.0, 0.1% (w/v) phloridzin. 
Cells were once again collected at 16,000£/4°C, 20sec, 
and the supernatant discarded.
Zero time points were determined by dispensing 
5pl of the cells immediately after the 60sec. pre-incubation 
straight into 2ml of ice cold KRB pH8.0, 0.1% (w/v) 
phloridzin and then washing as outlined above. Background 
contamination was determined by dispensing 5pl of cells 
treated as above, except 5pl of KRB replaced the 5pl
of 6-deoxy-D-glucose, straight into 2ml of ice cold
\
KRB pH8.0, 0.1% (w/v) phloridzin containing the 5pl 
of tritium labelled 6-deoxy-D-glucose. The cells were 
then washed as previously outlined.
After washing, 500pl of double distilled water
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was added to the cell pellet, and 450pl of the resuspended, 
lysed cells added to 5ml of PPO/toluene/Triton X-100 
scintillant in a scintillation vial.
Samples were stored overnight and counted in 
a LKB liquid scintillation counter.
10.2 ZERO-TRANS ENTRY SUGAR TRANSPORT INTO TRYPANOSOMES 
PROTOCOL
Isolated trypanosomes in KRB pH8.0, lOmM D-glucose
were dispensed into 4ml polypropylene centrifuge tubes 
7
to give 5 x 10 cells per tube. The cells were washed 
free of D-glucose by the addition of 1ml of ice cold 
KRB pH8.0, followed by centrifugation at 16,000g, 4°C,
20sec, in an OLE DICH refrigerated microcentrifuge.
The cell pellet was resuspended in 1ml of ice cold KRB 
by gentle vortex, and the cells collected as above.
Eighty microlitres of KRB (20°C) were added to the cell 
pellet, the tube gently vortexed, and the cell suspension 
added to 20^1 of 6-deoxy-D-glucose solution. The 20pl
3
consisted of 6- H-6-deoxy-D-glucose (1. 2jjCi) and 5jj1 
of 20 times concentrated unlabelled 6-deoxy-D-glucose 
taken to 20|j 1 with KRB pH8.0, to give a final 6-deoxy- 
D-glucose concentration of 129pM in the tube after 
addition of the cells.
Time points were measured from the moment of 
addition of cells to the 6-deoxy-D-glucose, and terminated 
by pipetting the total assay solution into 2ml of ice 
cold KRB pH8.0 containing 0.1% (w/v) phloridzin (2.2mM). 
Cells were collected by centrifugation at 16,000^, 20sec,
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4°C, and the supernatant aspirated off carefully to 
avoid leaving behind any droplets on the tube sides.
One ml of KRB pH8.0, 0.1%(w/v) phloridzin (4°C) was 
added, and the cell pellet resuspended by gentle vortex. 
Trypanosomes were collected by centrifugation as above, 
the supernatant aspirated off, and the cell pellet 
resuspended in 500^1 of double distilled water. Four 
hundred and fifty microlitres of lysed cells were added 
to 5ml of scintillant and radioactivity determined on 
a Packard scintillation counter.
Extracellular radiolabel was determined by direct 
addition of the cells resuspended in 80^1 of KRB pH8.0, 
to 2ml of KRB, 0.1% (w/v) phloridzin containing 20pl 
of 6-deoxy-D-glucose solution. This value for "zero" 
transport was subtracted from each time point in the 
assays. For time points less than 10 seconds a metronome 
counting two beats per second was used.
In assays where inhibitors were used, the inhibitor 
was included in the 20|j 1 of 6-deoxy-D-glucose solution 
such that the required concentration was achieved upon 
addition of 80jj1 of cells.
10.3 PLASMA MEMBRANE VESICLES AND RECONSTITUTED
PROTEOLIPOSOMES INFINITE-TRANS SUGAR TRANSPORT 
PROTOCOL
Trypanosome plasma membrane vesicles and 
reconstituted proteoliposomes produced as outlined 
previously, preloaded with lOOmM sugar (D-glucose,
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under tap pressure suction, by application to the centre 
of a 0.22|jm Millipore GSWP filter (presoaked in stopping 
solution) on a Millipore filter turret. Filters and 
vesicles were washed free of extravesicular radioactive 
sugar by the progressive application of 5ml of ice cold 
stopping solution, such that the portion of the filter 
to which the vesicles had been applied remained moist, 
until all of the 5ml had been applied.
After washing, the filters were taken from the 
turret, placed in a scintillation vial containing 5ml 
of scintillant, and stood overnight for complete 
extraction of the filter. Radioactivity was counted 
in a Packard liquid scintillation counter.
Zero time points and background radioactivity 
were determined by aliquotting 2pl of vesicles directly 
into 1ml of ice cold stopping solution. Two hundred 
microlitres of diluting buffer containing radiolabelled 
sugar was added to the stopped vesicles, and 1ml 
immediately filtered, washed, and radioactivity counted 
as outlined previously. These background values were 
subtracted from the assay values. For greater accuracy 
small volumes of vesicles were dispensed using a Ultipette 
l-10pl pipette.
To try to improve vesicle retention on the filters, 
a comparison was made between filters soaked in stopping 
buffer containing lmg/ml poly-L-lysine and filters soaked 
in stopping buffer only.
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10.4 PROTEOLIPOSOME ZERO-TRANS SUGAR TRANSPORT PROTOCOLS
10.4.1 Proteoliposomes produced by the freeze/thaw/ 
sonication method
14D-glucose transport assays included C 
radiolabelled D-glucose, 0.3pCi for erythrocyte derived 
proteoliposomes, and l.OyCi for trypanosomes plasma 
membrane derived proteoliposomes, 1.0 to 3.0mg of lipid 
and 30 to 87pg protein per assay.
Assays were started by the addition of 108pl 
of vesicles at 20°C to 12pl of D-glucose solution in 
lOmM buffer (Tris/HCl pH7.5 or sodium phosphate pH7.4).
The assay was terminated after the desired time by rapidly 
pipetting lOOpl of assay into 1ml of ice cold lOmM buffer 
(containing 05mM mercuric chloride for erythrocyte 
proteoliposomes).
Filtering, washing and liquid scintillation 
counting were carried out as outlined in the infinite- 
trans sugar transport protocol.
10.4.2 Proteoliposomes produced by the detergent dialysis 
method incorporating glucose oxidase and catalase
Five hundred microlitres of proteoliposomes 
in lOmM sodium phosphate buffer pH7.0, O.lmM PMSF,
O.lmM EDTA were dispensed into a Clark type oxygen 
electrode and allowed to reach 20°C. The volume was 
made up to 1ml with lOmM sodium phosphate buffer pH7.0, 
O.lmM PMSF, O.lmM EDTA, and ten times concentrated
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D-glucose solution, to give the required D-glucose 
concentration, at 20°C. The mixture was stirred gently 
during the assay and D-glucose transport into the 
proteoliposomes monitored by the reduction in oxygen 
according to the following scheme.
glucose
2 D-glucose + 2O2 --------► 2 D-gluconic acid + 21^02
oxidase
catalase 
2 H 202 ------------ ► 2H20 + 0 2
Oxygen consumption was traced on a Rikadenki 
chart recorder, from which the initial rates at a range 
of D-glucose concentrations were calculated.
Inhibition of D-glucose transport by p-chlorophenyl- 
mercaptosulphonic acid (p-CPMSA) was carried out by 
adding p-CPMSA in lOmM sodium phosphate buffer pH7.0,
O.lmM PMSF, O.lmM EDTA, to the proteoliposomes in the 
oxygen electrode, to give a final concentration of ImM.
After preincubation for lmin the assay was started by 
addition of 10 times concentrated D-glucose solution, 
to give the final desired D-glucose concentration.
RESULTS
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1.0 PRODUCTION OF A TIGHT FITTING POUNCE TYPE HOMOGENISER
Three designs of teflon homogeniser tip, a sphere , 
a rod (with rounded end), and a cone, were tested to 
produce optimum breakage of the swollen trypanosomes. 
Production of the sphere and rounded rod required that 
teflon be shaved from the tip such that the diameter 
of the rod or sphere decreased with each cut, fig. 16 
A and B. The lathe available was not sensitive enough 
to produce the optimum fit. Both the sphere and rod 
generated large amounts of friction when travelling 
down the homogeniser (making homogenisation difficult), 
without providing a small enough clearance between the 
tip and the glass pestle to satisfactorily break the 
swollen trypanosomes.
To overcome this problem the tip shape was 
altered to a cone. Teflon was removed from the surface 
opposite to the tip, ijs. not directly off the diameter 
of the cone, fig. 16 C -t With this procedure, removing 
a thin layer of teflon from the face opposite the tip, 
within the limits of the lathe available, removed a 
much smaller amount off the diameter of the cone. In 
this fashion a homogeniser tip capable of effectively 
breaking up to 95% of the swollen trypanosomes (as 
determined by light microscopy) with one stroke of the 
homogeniser was designed.
38 m m
<----  Direction of cut
< *
1 6mm





Fig. 16 Showing dimensions and direction of cut by 
the lathe to produce the optimum homogeniser tip for 
the round ended rod (A), the sphere (B) and the cone 
(C) .
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2.0 PLASMA MEMBRANE ISOLATION
The method of Voorheis (197 9) was used, but 
modified slightly in several aspects, for isolation 
and purification of the plasma membranes In the Tes 
buffer system the swelling of the trypanosomes was carried 
out with swelling buffer containing ImM Tes, to maintain 
buffering capacity in the cell suspension after dilution, 
and ImM EDTA and 2-mercaptoethanol to maintain their 
respective concentrations. Leupeptin was included in 
the swelling buffer to inhibit thiol proteases present 
(Voorheis, personal communication). An extra wash of 
pellet PI was included to remove free enzymes present 
because of the high number of cells used (2 to 4 x 10^) 
per experiment, and to provide a second opportunity 
for leupeptin to neutralise thiol proteases.
The Tes buffer system was replaced by phosphate 
buffered saline to provide a continuity of buffer systems 
based on phosphate, from the isolation of the trypanosomes 
to the reconstitution of the membrane proteins. The 
concentration of EDTA was decreased to O.lmM to avoid 
any disruption of membrane structure by chelation of 
divalent metal ions (particularly calcium), associated 
with maintaining membrane integrity. Mercaptoethanol 
was not used in case it protected the thiol proteases 
present.
Apart from the above, the isolation method 
followed that of Voorheis (1979). Fig. 17 shows a photograph 
of the 40-60% (w/v) sucrose gradient (the gradient
Dense band of plasma membranes 
at 51.3%(w/v)sucrose
Fig. 17 40-60% (w/v) sucrose gradient showing the band at 
51.3% (w/v) sucrose corresponding to the plasma 
membranes.
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included a 60% (w/v) sucrose cushion (5ml) but no 52% 
(w/v) sucrose layer). The dense band of plasma membranes 
is shown at 51.3% (w/v) sucrose.
Total protein estimations of the cell homogenate, 
pellet PI, supernatant SI, pellet P3 and pellet P4 (the 
final membrane pellet) from four experiments are given 
in milligrams of protein for every 1 x 1 0 ^  cells used 
in the purification, in the table below.








100 64.5 36.3 49.3 13.0
The protein banding patterns of whole cells 
and plasma membranes are shown in fig. 18.
2.1 MARKER ENZYME ACTIVITIES OF PLASMA MEMBRANE 
PURIFICATION FRACTIONS
The enzyme specific activities are expressed 
as pmol of substrate utilised/mg protein/min except 
for myokinase which represents in the case of ADP production, 
the formation of 2ADP, from ATP and A5MP, and in the 
case of ATP production, the formation of 1ATP from 2ADP.
B D
Fig. 18. 10-20% (w/v) SDS-PAGE gel of whole cells,
lane (A) and purified plasma membrane, 
lane (B). Lane D is the molecular weight 
markers, with molecular weights as 
indicated.
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Total enzyme activities are expressed in pmoles substrate/ 
min with the reservations outlined above for myokinase 
activity. Table 6 summarises the specific activities, 
total activities and % of the total enzyme activity, 
taking the homogenate value ± Triton X-100 0.1% (w/v) 
(whichever is larger) as the 100% value. For greater 
ease of reference the % total activity and specific 
activities have been drawn as bar charts in fig. 19.
Over 50% of the total pyruvate kinase and malate 
dehydrogenase activities in the homogenate were released 
into the SI fraction, with less than 15% being retained 
in the pellet PI. The specific activities of the enzymes 
also decreased to 25% or less of the homogenate value, 
whilst increasing in the supernatant fraction by a factor 
of 1.3. For pyruvate kinase,treatment of the pellet 
PI with DNAase reduced residual total activity to between 
48 and 60% of the PI value. This was reduced to 2.5% 
of the total homogenate value in pellet P4 with a specific 
activity 17% of the homogenate value. Some latency of 
pyruvate kinase existed in the pellet fractions producing 
no more than a 1.8-fold increase in activity when treated 
with Triton X-100. By contrast the addition of Triton 
X-100 to the homogenate and supernatant SI decreased 
the total activity ( to zero in SI) and may well have
inactivated the enzyme. It has been suggested by Flynn
\
and Bowman (1980) that pyruvate kinase is unstable in 
aqueous solution. Malate dehydrogenase mirrored pyruvate 
kinase in that total activity in the final pellet P4 
was only 2.0% of the homogenate value and the specific
Table 6 Specific activity, total activity and % total activity of marker enzymes in 
fractions taken from the plasma membrane purification procedure ± 0.1% (w/v) Triton 
X-100. (Spec. Act.=Mmoles substrate/mg protein/min & tot. act. = pmoles substrate/min) 
The number of determinations are in brackets. All replicate values have standard 










Spec act. 0.058 (3) 0.044 (3) 0.36(3) - 0.0077(1) 0.0088(1)
H Tot act 11.7 9.0 40.6 - 1.9 2.1
% Tot act 100 76.9 100 - 90.4 100
Spec act. 0.0061(2) 0.011(2) 0.09(3) - 0.0026 (1) 0.0069 (1)
PI Tot act 0.9 1.7 5.75 - 0.37 1.0
% tot act 7.7 14.5 14.2 - 17.6 47.6
Spec act 0.075(2) 0(3) 0.55 (3) - 0.0098(1) 0.0155(1)
SI Tot act 6.2 0 26.1 - 0.8 1.2 .
% tot act 53 0 64.3 - 38.1 57.1
Spec act 0.0038(2) 0.0058(2) - - - -
P3 Tot act 0.54 0.82 - - - -
%tot act 4.6 7.0 - - - -
Spec act 0.0055 (3) 0.0099(3) 0.02(3) - 0.002(1) 0.0048 (1)
P4 Tot act 0.16± 0.29 0.81 - 0.09 0.22
% tot act 1.4 2.5 2.0 - 4.3 10.5
Table 6 (continued) Values marked ° for myokinase represent the values for the production 
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Spec act 0.262(2) 1.19(3) 0.205(3) 0.347(3) 0.293 (3) 1.28 (3)
H tot act 54.4 247 42.6 71.8 61 264.8
% tot act 22.0 100 59.3 100 23.1 100
Spec act 0.373(3) 1.509(2) 0.187(2) 0.318(2) 0.346(1) 0.988(1)
PI Tot act 56.8 230.0 28.5 48.5 53 151
% tot act 23 93.1 39.7 67.5 20.1 57.2
Spec act 0.3 0.445 0.069 (2) 0.0724(2) 0.12(2) 0.305(2)
SI Tot act 24.7 36.6 5.6 6.0 10 25
% tot act 10 14.8 7.8 8.4 3.8 9.4
Spec act 0.174(2) 1.33(2) 0.142 (2) 0.259 (2) 0.292 (2) 0.72(2)
P3 Tot act 24.7 190 20.3 36.7 41.4 102.7
% tot act 10 76.9 28.3 51.1 15.7 38.9
Spec act 0.385(4) 1.18(3) 0.848 (3) 0.316 (3) 0.381(3) 1.49 (3)
P4 Tot act 11.1 34 2.5 9.2 11 43




































































Fig. 19 Bar charts showing % of total enzyme activity 
and specific activities of the enzymes in fractions 
taken from the plasma membrane purification procedure 
in the presence and absence □  of Triton X-100
0.1% (w/v).
Enzymes are hexokinase (A)
glycerol-3-phosphate dehydrogenase (B), 
phosphoglucoisomerase (C), 
myokinase (D),
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activity 5.6% of the homogenate value.
Glucose-6-phosphatase (G-6-Pase) and myokinase 
exhibited similar activity profiles through the plasma membrane 
purification procedure-In both cases homogenisation released 
more than 55% of the total enzyme activity into the 
supernatant SI, with specific activities 1.5 to 2.0 
times the homogenate value, in the presence of 0.1%
(w/v) Triton X-100. The residual total activity associated 
with the final plasma membrane pellet P4 was less than 
11% of the total homogenate activities for both enzymes, 
with specific activities 0.55 (G-6-Pase) and 0.7(myokinase) 
times that of the homogenate values. In the presence 
of Triton X-100 0.1% (w/v) all the fractions demonstrated 
latent G-6-Pase activity. This was largest in the pellets 
PI and P4 with a more than 2-fold increase in activity 
on addition of detergent. The measurement of ATP 
production from 2ADP was used as control experiment
to demonstrate true myokinase activity.
+ + 2+ #
The oligomycin sensitive Na K Mg stimulated 
ATPase (OL ATPase) and glycerol-3-phosphate oxidase 
(G-3-P oxidase) demonstrated similar activity profiles 
through the plasma membrane purification process. G-3-P 
oxidase was inactivated by 0.1% (w/v) Triton X-100 and 
for this reason both it, and OL ATPase were not assayed 
in the presence of detergent.
For both enzymes the pellet PI contained 25% 
or less of the total activity found in the homogenate, 
with specific activities 40% (G-3-P oxidase) and 0%
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(OL ATPase) of the homogenate value. OL ATPase was found 
primarily in the supernatant SI (82% of the total 
homogenate activity), however no activity for G-3-P 
oxidase could be found in the supernatant SI suggesting 
possible inactivation of the enzyme with time, once 
freed from the mitochondrion. No OL ATPase activity 
was found in the plasma membrane pellet P4, and only 
5.7% of the G-3-P oxidase, of a specific activity under 
half the value for the homogenate.
Hexokinase, glycerol-3-phosphate dehydrogenase 
(G-3-PDH) and phosphoglucoisomerase (PG-isomerase) 
exhibited latent activity in all fractions through the 
purification procedure. In the cases of hexokinase and 
PG-isomerase in pelletsPl and P4# Triton X-100 (0J%' (w/v)) induced 
an increase in activity of 3 to 4.6-fold. Significantly, 
for all three enzymes, greater than 51% of the total 
activity stayed with the plasma membrane pellet PI,and 
release of enzyme activity into the supernatant SI did 
not exceed 14.8% of the total homogenate value.
The specific activities of all three enzymes 
in the plasma membrane pellets PI, P3 and P4 remained 
approximately the same as that of the homogenate value 
throughout the purification procedure. The high total 
enzyme activities (retained in the plasma membrane 
pellets PI and P3) were, however, reduced significantly 
by the sucrose density gradient centrifugation step.
This resulted in less than 17% of the total activity 
of any of the three enzymes being retained in the final 
plasma membrane pellet, P4.
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oC -glucosidase activity was extremely low in all 
fractions and required an incubation time of 24h to allow 
accurate measurements to be taken. Sixty-eight percent of the 
total homogenate activity was retained in the plasma membrane 
pellet PI at a specific activity equivalent to that of the 
homogenate. Under 25% of the total activity was released into 
the supernatant SI. DNAase treatment and sucrose density 
gradient centrifugation decreased the total amount of enzyme 
activity in pellet P4 to 13.2% of that of the homogenate, but 
with a specific activity 12.1% higher than the homogenate 
value.
The ouabain sensitive Na+K+ATPase (OU ATPase) and 
dihydrolipoamide dehydrogenase (DHLIP DH) co-purified with 
the plasma membranes. DHLIP DH demonstrated significant 
activation, without detergents, through the plasma membrane 
isolation procedure. Eighty-one percent of the total OU ATPase 
activity was retained in pellet PI, and 126% of the total 
DHLIP DH activity. No detectable OU ATPase was found in the 
supernatant SI and DHLIP DH activity was 12.8% of the total, 
at a specific activity less than 1/3 that of the homogenate.
The retention of enzyme activity in pellet PI 
was mirrored by an increase in specific activity of 1.45 
(OU ATPase) and 2.6 (DHLIP DH) times the■homogenate 
value. In the final plasma membrane pellet P4 61% of 
the total OU ATPase and 139% of the total DHLIP DH 
activity were retained, with specific activities greater 
than 4.4-fold that of the homogenate value.
It should be noted that the activities quoted 
for the OU ATPase and OL ATPase represent the "best"
9 9
values obtained. Reproducibility and inhibition 
attributable to oligomycin and ouabain were extremely 
small compared to the background values, particularly 
in the more dilute homogenate and supernatant SI samples.
Alteration of the method of Post and Sen (1967) 
to include stabilisation of colour by addition of arsenite/ 
citrate solution as outlined for the G-6-Pase assay, 
did not improve the accuracy or reproducibility of the 
OL ATPase or OU ATPase.
Figure 20 is an electron micrograph of the final 
purified plasma membrane (x 50,000) demonstrating the 
cross-section of the flagella and pellicular microtubule 
array attached to the plasma membrane. These structures 
are similar to those shown by Voorheis et al. (1979)
which are definitive proof of plasma membranes.
Pellicular microtubules
Flagella cross section
Fig. 20 Electron micrograph (x50,000) of purified 
trypanosome plasma membranes demonstrating 
the pellicular microtubules and flagella 
cross section.
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2.2 DETERMINATION OF THE PHOSPHATE DONOR SPECIFICITY
AND THE Km AND Vmax FOR THE PLASMA MEMBRANE HEXOKINASE
Table 7 summarises the phosphate donors and
combinations of phosphate donors tested on the plasma
membrane and supernatant hexokinases in the presence and
absence of magnesium ions (5mM) and phenylarsine oxide
2 +(0.2mM). In the presence of Mg ions both ATP and ADP
donated a phosphate group to D-glucose. In the absence 
2 +of Mg phosphorylation of D-glucose by ADP did not
occur and phosphorylation by ATP was reduced to less
2 +than 10% of the value in the presence of Mg .Phosphoenol 
pyruvate (PEP), inorganic phosphate (Pi), pyrophosphate 
(PPi) and D-glucose-6-phosphate(G-6-P)did not donate 
phosphate to D-glucose unless used in combination with 
ADP or ATP. The hexokinase activity in supernatant SI 
demonstrated the same properties as those in the plasma 
membrane fraction.
Fig.21A and Fig. 22A show the production of 
D-glucose-6-phosphate with increasing D-glucose concentration 
for ATP and ADP respectively. The Km and Vmax for D-glucose 
phosphorylation in the presence of ATP and ADP were 
determined using the direct linear plot of Cornish-Bowden 
and Eisenthal (1974), Fig. 21B and 22B. The Km 
and Vmax for D-glucose with ATP as phosphate donor were 
48ymolar and 49.4nmol G-6-P/mg protein/min respectively, 
and for ADP as phosphate donor, 139|jmolar and 21.6nmol 
G-6-P/mg protein/min respectively. The difference in
Table 7. Combinations of possible phosphate donors to determine phosphate donor specificity 
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+ denotes production of D-glucose-6-phosphate 
- denotes no production of D-glucose-6-phosphate




















Fig.21A. nmol of G6P produced by plasma membrane hexokinase 
against time at 0.05mM( • ) ,0.5mM(O ) and 5.OmM(A )D-glucose, 
and Fig.21B, the direct linear plot of the data to determine 
Km and Vmax for D-glucose. ATP = phosphate donor.
0 20 40 
Time(seconds)
6 0




Fig.22A, Time course of G6P produced by plasma membrane 
hexokinase at 0.05mM( • ),0.5mM(o ) and 5.OmM(A )D-glucose, 
and Fig.22B, the direct linear plot of the data to determine 
Km and Vmax for D-glucose. ADP = phosphate donor.
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kinetic constants using ATP or ADP as the phosphate donor 
were likely to be due to the presence of myokinase in 
the plasma membrane preparation. This point is discussed 
further in the Discussion section 2.0.
The accuracy of the diethyl-ether extraction 
technique was tested by replacing trypanosome protein 
with an equal quantity of bovine serum albumin, and 
ATP and D-glucose by D-glucose-6-phosphate. The assayed 
D-glucose-6-phosphate agreed within 10% of the initial 
starting value.
2.3 RELEASE OF D1HYDROLIPOAMIDE DEHYDROGENASE FROM PLASMA
MEMBRANES AND RECONSTITUTION INTO PHOSPHOLIPID LIPOSOMES
Dihydrolipoamide dehydrogenase co-purified with 
the plasma membranes such that 139% of the homogenate 
total activity was recovered in the plasma membrane 
pellet P4.
Plasma membranes treated with increasing 
concentrations of potassium chloride up to 1.0M did 
not release more than 13.4% of the total DHLIP DH activity 
into the supernatant. This was mirrored by a retention 
of DHLIP DH activity in the pellets after treatment 
with increasing concentrations of KC1, fig. 23B.
Treatment of the plasma membranes with increasing 
Triton X-100 concentrations released DHLIP DH activity 
into the supernatant at concentrations greater than 










































1 . 00 0.050.01 0. 1 0.25 O.b 1. 00 0.50.15
Triton X 100 (% w/v) KC1(M)
Fig. 23 Total dihydrolipoamide dehydrogenase activity in the extracts (•) and pellets (A) of 
plasma membranes treated with Triton X-100 (A) and potassium chloride (B).
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with increasing Triton X-100 concentration, whilst activity 
in the post extraction pellets decreased with increasing 
detergent concentration, fig. 23A.
A peak of extraction as measured by total enzyme 
activity released into the supernatant was reached at 
0.5%' (w/v) Triton X-100 at which over 80% of the total
DHLIP DH activity (compared to the 0 Triton X-100 sample) 
was recovered in the supernatant. At 1.0%(w/v) Triton 
X-100 the activity found in the supernatant decreased 
dramatically, whilst retaining the activity in the post­
extraction pellet. This may be caused by inactivation 
of the enzyme at high detergent concentrations in aqueous 
solutions.
The optimum Triton X-100 extract of the dihydro­
lipoamide dehydrogenase activity (0.5%(w/v)Triton X-100) 
was reconstituted into phosphatidyl choline vesicles 
by the freeze/thaw sonication method. Fifteen percent 
of the total plasma membrane dihydrolipoamide dehydrogenase 
(21% of the homogenate value) was recovered in the 
proteoliposome pellet with a specific activity of 
0.037pmol NADH/mg protein/min, a figure 23% higher than 
the specific activity of the plasma membranes pellet 
P4 (specific activity 0.03|jmol NADH/mg protein/min.
The proteoliposomes containing dihydrolipoamide 
dehydrogenase reconstituted from the 0.5% (w/v) Triton 
X-100 extract retained 63% of the total dihydrolipoamide 
dehydrogenase activity after dilution (1:5), sonication, 
freezing and thawing, repeat sonication and further 
dilution, before collection by ultracentrifugation.
103
3.0 EFFECT OF ALKALI TREATMENT ON TRYPANOSOME PLASMA 
MEMBRANES
Increasing concentrations of sodium hydroxide 
(5, 10 and 15mM) resulted in increased disruption of 
the plasma membrane structure, such that the size of 
particulate matter observed under light microscopy (x400) 
decreased with increasing alkali. Total membrane protein 
recovered by ultracentrifugation after treatment ranged 
fromL4% (15mM NaOH) to 40% (5mM NaOH) of the total protein 
used, fig. 24. After undergoing the freeze/thaw vesiculation 
procedure total recoverable protein remained at 14% 
for 15mM NaOH treated membranes, but decreased for the 
lower concentrations of sodium hydroxide treatment to 
19% of the total for 5mM NaOH, and 15.4% of the total 
for lOmM NaOH treated membranes.
Dihydrolipoamide dehydrogenase activity, could 
not be measured in the lOmM and 15mM NaOH treated membranes 
and only 1.0% of the total initial activity could be 
found in the 5mM NaOH treated membranes.
Infinite-trans D-glucose transport assays produced 
no D-glucose influx into the membranes preincubated 
with lOOmM D-glucose/lOmM sodium phosphate buffer at 
room temperature, suggesting there were no vesicle bodies 
present.
The frozen and thawed alkali extracted membranes
did demonstrate D-glucose influx with time? however
fast initial filling of the vesicles followed by a decrease
to an equilibrium concentration did not occur. Influx 






























































Fig. 24. Bar chart showing total plasma membrane protein 
retained after alkali treatment(njand freeze/thaw treatment 
of alkali treated membranes(B) at 5mM NaOH (A), lOmM 
NaOH (B) and 15mM NaOH (C), including % total dihydrolipoamide 



















Fig. 25. Time course of infinite-trans D-glucose influx 
into vesicles from alkali ( 5mM (•), lOmM (■) and 15mM (A) 
sodium hydroxide) and freeze/thaw treated plasma membranes. 
All values ± SE no greater than 11% of the quoted value.
104
3.1 CALCIUM ION TREATMENT TO RELEASE THE PLASMA MEMBRANE 
PELLICULAR ARRAY, AND D-GLUCOSE TRANSPORT IN FREEZE/ 
THAW VESICLES FROM THE PROCESS
Trypanosome plasma membranes treated without 
calcium ions as a control experiment in the pellicular 
depolymerisation process, released 27% of the total 
protein into the supernatant after collection of the 
plasma membranes at 9,000g, bar chart fig. 26.
During the incubation of the membranes at 37°C 
the plasma membranes aggregated into large bodies, with 
significant observable small particles in the background. 
Defatted bovine serum albumin 1%(w/v) was added to 
the depolymerisation solutions to prevent aggregation 
(Voorheis, personal communication) by binding to fatty 
acid residues on the plasma membrane surface after release 
of the protein coat. The addition of BSA however did 
not prevent the plasma membrane aggregation. Microscopic 
examination showed the aggregated membranes and background 
small particles, as noted for the process in the absence 
of BSA. Twenty-four percent of the plasma membrane protein 
was released into the supernatant, as measured after 
collection of the plasma membranes at 9,000g. The release 
of protein into the supernatant was mirrored by the 
release of 19.5% of the total DHLIP DH activity into 
the supernatant, with or without BSA.
Addition of calcium . chloride to samples incubated 
with and without BSA at 0.1, 0.5 and l.OmM calcium 
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Fig. 26. Bar chart showing % of total plasma membrane protein in supernatants against increasing 
calcium chloride concentration in the presence(B) and absence(A)of B(wV)defatted BSA, after 
centrifugation at 9,000g,10min (□) and 20,OOOg,60min(0). The % of the total plasma membrane 
dihydrolipoamide dehydrogenase activity retained in the supernatants after centrifugation 
9 ,000cf, 10min(#) and 20,000^, 60min(B) under the same conditions are also included.
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2 +supernatant, figs. 26 A and B, such that at O.lmM Ca
(no BSA) 33.4% and O.lmM Ca^+ (BSA present), 30% of
the total protein was found in the supernatant fraction.
2 +These figures rose slightly with increasing Ca
concentration to reach 35.5% and 33.6% of the total
protein at l.OmM Ca^+, without and with BSA respectively.
In all cases the protein released into the supernatant
contained dihydrolipoamide dehydrogenase activity of
between 16.8 and 20.3% of the total, fig. 26A and B.
Each supernatant when centrifuged at 20,OOOg
yielded a further small pellet of material. Dihydrolipoamide
dehydrogenase activity decreased to between 1.5 and
2.6% of the total original activity, fig. 26A and B,
and a residual protein content in the supernatant of
between 4.5% (no calcium or BSA present) to 17.6%
2 +(l.OmM Ca , 1% (w/v) BSA) of the total starting protein, 
fig. 26A and B.
The maximum protein release occurred for l.OmM
2 +Ca in the presence of B BSA faV)where subtraction of
the final calcium free value in the presence of 1%BSA (w/v)
yielded a net protein release of 12.3% of the total.
Calcium ion concentrations above O.lmM in the presence 
and absence of BSA did not release a significantly greater 
quantity of protein into the supernatants.
Fig. 27 shows the influx of D-glucose into
2 +freeze/thaw produced vesicles made from the O.lmM Ca 
treated plasma membrane pellet, preloaded with lOOmM 
D-glucose. The figure demonstrates a leakage of D-glucose 























Fig. 27. Infinite-trans D-glucose influx into vesicles 
prepared by freezing and thawing of the O.lmM Ca2+ treated 
plasma membranes.
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D-glucose above the equilibrium value expected for a 
facilitated process using an infinite-trans protocol.
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4.0 EFFECT OF INCREASING OSMOLARITY ON THE PRODUCTION OF 
PLASMA MEMBRANE VESICLES AND D-GLUCOSE TRANSPORT 
IN THOSE VESICLES
Trypanosome plasma membranes were severely 
disrupted by the rapid freezing and thawing process 
yielding two populations. Firstly a population of small 
particles visible as background under light microscopy, 
and secondly a population of large pieces of residual 
plasma membrane material, clearly seen under light 
microscopy as aggregates.
Initial freezing and thawing of the plasma membranes 
and subsequent freezing and thawing of each large debris 
pellet, released a decreasing amount of protein into 
the respective supernatants. The range of phosphate 
buffer concentrations (5, 10, 30 and lOOmM) used in 
the freezing and thawing process tested the effect of 
increasing osmolarity and salt concentration on the 
vesiculation process.
Table 8 summarises the total protein used at 
each phosphate concentration, the total protein recovered 
in each supernatant (SI to S5), the sum of the supernatant 
total protein values (ST ), and percentage of the total 
protein they represent, the total protein recovered 
in the final plasma membrane vesicle pellet (P_) andr
the percentage this value represents of the initial 
total protein.
Total protein released into the supernatants (ST) 
was between 26.8% (lOOmM NaPi) and 30.2% (5mM NaPi) of
Table 8. Summary of the total protein (mg) and % total 
protein found in fractions taken from the freeze/thaw 
procedure at 5,10,30 and lOOmM sodium phosphate buffer.
Sodium phosphate buffer 
Fraction
5 10 30 100
Plasma membranes 25.1 24.75 24.9 24.6
Supernatant SI 4.1 3.3 3.4 2.9
Supernatant S2 1.6 1.6 1.5 1.3
Supernatant S3 0.9 0.9 1.0 1.1
Supernatant S4 0.7 0.6 0.7 0.7
Supernatant S5 0.3 0.4 0.5 0.6
Supernatant total ST 7.6 6.8 7.0 6.6
% total protein in ST 30.2 27.5 28.1 26.8
Vesicle total protein Pp 2.1 2.3 2.0 2.0
%total protein in PF 8.4 9.3 8.0 8.1
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the initial total protein, and in the final pellet Pp’, 
between 8.0% (30mM NaPi) and 9.3% (lOmM NaPi) of the 
total protein. In subsequent experiments using lOmM 
sodium phosphate buffer, the percentage yield of plasma 
membrane vesicles in terms of total protein was 9.7%±1.5%, 
and the yield of dihydrolipoamide dehydrogenase in terms 
of total activity was 8.4%±3.1%.
Fig. 28 compares the protein banding patterns 
of whole cells, plasma membranes and the plasma membrane 
vesicles (lOmM NaPi buffer) on SDS-PAGE 5% to 20% gels.
The most significant aspect of the patterns is the decrease 
in the intensity of the band at 57.5K, and the increase 
in the intensity of the protein bands at 42.5K and 40K.
The 57.5K protein band approximates to the 55K band 
of Dolan et al. (1986) , corresponding to tubulin found
in the plasma membrane pellicular microtubules, suggesting 
that the freeze /thaw procedure is releasing plasma membranes 
from the cytoskeleton.
D-glucose infinite-trans counterflow transport 
into the vesicles at each phosphate buffer concentration, 
with time, are shown in fig. 29. Extravesicular D-glucose 
concentration was ImM. All the vesicles regardless of 
buffer concentration demonstrate an accumulation of 
radiolabelled D-glucose above the equilibrium value 
with time. This effect could be negated by increasing 
the extravesicular D-glucose concentration to lOOmM, 
thus saturating the D-glucose transporter giving the 
gradual influx of radiolabelled D-glucose as shown for 
lOmM NaPi and lOOmM NaPi vesicles, fig. 29. These results
205K
1 1 6K
A B C D
Fig. 28 SDS-PAGE gel 5 to 20% acrylamide showing protein 
bands from whole trypanosomes (A), plasma 
membrane (B) and plasma membrane vesicles (C). 
Lane D is the molecular weight markers, with 
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Fig. 29. Infinite-trans D-glucose influx into vesicles 
preloaded with lOOmM D-glucose prepared in 5mM(O) , 
10mM(#), 30mM(n), and lOOmM(■) sodium phosphate buffer, 
at ImM extravesicular D-glucose (-- ) and lOOmM extra­
















suggest a facilitative transport system for D-glucose is 
present.
Maximum D-glucose accumulated in the vesicles 
at 2min with ImM extravesicular D-glucose concentration 
was 1.89nmoles/mg protein (lOOmM NaPi buffer) and the 
least 1.45nmoles D-glucose/mg protein at 5mM NaPi buffer. 
The accumulation of D-glucose over the first 10 seconds 
of incubation was 0.9nmoles/mg protein for lOmM sodium 
phosphate buffered vesicles and the least 0.66nmoles 
of D-glucose/mg protein for 30mM NaPi buffered vesicles.
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5.0 RECONSTITUTION OF TRYPANOSOME AND ERYTHROCYTE PLASMA 
MEMBRANE PROTEINS
The results from the reconstitution studies have 
been categorised according to the D-glucose transport 
assay used, ije. Zero-trans influx or inf inite-trans 
(counterflow) influx. These are then subdivided into 
the type of reconstitution process utilised.
5.1 ZERO-TRANS D-GLUCOSE INFLUX INTO RECONSTITUTED 
PROTEOLIPOSOMES
These studies utilised proteoliposomes with 
no intravesicular D-glucose preloading, relying on the 
measurement of the filling of the proteoliposomes and 
the kinetics of the process to determine if facilitated 
transport occurred.
5.1.1 Reconstitution by the freeze/thaw/sonication 
procedure
The percentage of the total protein extracted 
from human erythrocyte "ghosts"and trypanosome plasma 
membranes by Zwittergent 14 (2 and 3mM), Triton X-100 
(0.5% (w/v)) and n-octyl-p-D-glucopyranoside (50mM) are 
summarised in the table below.
Jembrane source 
Deterqent " ' 1---
Trypanosome Erythrocyte
Zwittergent 14 (2mM) 28-35 43.5
Zwittergent 14 (3mM) 32-45 47





For both erythrocyte "ghosts" and trypanosome 
plasma membranes Zwittergent 14 extracted the most total 
protein. The solubilisation of the erythrocyte "ghosts" 
protein by Triton X-100 and n-octyl-p-D-glucopyranoside 
was significantly lower than that stated by Kasahara 
and Hinkle (1976) in which Triton X-100 (0.5%(w/v)solubilised 
70% of the available protein and n-octyl-p-D-glucopyranoside 
56%. This discrepancy may well be a result of the gentle 
treatment of the membranes during extraction, ie. only 
inverting the tubes to mix.
Biobeads SM2 were found to be efficient in removing 
Zwittergent 14 and Triton X-100, but resulted in a loss 
of protein of between 6 to 15% of the total extracted 
protein. Dialysis of n-octyl-p-D-glucopyranoside extracts 
yielded no measurable loss of protein.
In assaying the proteoliposomes produced by 
this technique it was found that the most reproducible 
results were obtained if the lipid used in the 
reconstitution was sonicated to clarity before use.
This process could be hastened if the lipid was vortex 
mixed for 10 minutes before sonication.
Proteoliposomes formed from the well sonicated 
lipid entered the 0.22pm millipore filters within 5 
seconds of application, allowing fast and efficient 
washing of the trapped proteoliposomes. Use of liposomes 
not sonicated to clarity resulted in blocked filters, 
increasing washing and filtering times dramatically, or 
in the worst cases prevented filtration and washing 
totally.
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D-glucose concentrations of O.lmM to lOmM for 
erythrocyte derived proteoliposomes, and O.lmM to 20mM 
for trypanosome plasma membrane derived proteoliposomes 
were used to highlight the influx of D-glucose attributable 
to facilitated transport rather than leakage down the 
D-glucose gradient.
Fig. 30 shows the influx of O.lmM D-glucose 
into proteoliposomes derived from erythrocyte and 
trypanosome plasma membranes with time, for Zwittergent 
14 (2 and 3mM) , Triton X-100 (0.5%(w/v)and n-octyl-p-D- 
glucopyranoside (50mM) extracts.
The magnitude of the D-glucose transport with 
time for the erythrocyte derived proteoliposomes is 
of the same order as quoted by Kasahara and Hinkle (1976). 
In all cases the erythrocyte derived proteoliposomes 
demonstrate a rapid initial rate of filling, over the 
first 10 seconds, slowing as equilibrium is approached.
The trypanosome derived proteoliposomes demonstrate 
an almost linear rate of filling of the proteoliposomes 
with no initial rapid transport.
For all the detergent derived proteoliposomes 
the initial rate of filling of the proteoliposomes is 
greater for erythrocyte derived proteoliposomes, and 
is linear for the first 10 seconds of incubation. A 
ten second time point was therefore used to determine 
the initial rate of D-glucose influx for D-glucose 
concentrations above O.lmM.
Table 9 summarises the initial rates of D-glucose 
transport into the proteoliposomes formed from each
800
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Fig. 30. Zero-trans D-glucose transport into proteoliposomes 
derived from 0 .5%fwV)Triton X-100 (A), 2mM(B) and 3mM(C) 
Zwittergent 14 and n-octyl-B-D-glucopyranoside (D) extracts, 
from human erythrocyte (•) and trypanosome (■) plasma 
membranes at O.lmM D-glucose concentration.
Table 9 Summary of initial rates of D-glucose transport (nmol/mg protein/min) for proteoliposomes 
formed from detergent extracts of trypanosome and erythrocyte plasma membranes by the 
freeze/thaw/sonication technique.
D-glucose (mM)
Detergent Protein source .1 .2 .5 1.0 5.0 10.0 20.0
Zwittergent erythrocyte 1.981.1 4.321.51 16.210 19.641.71 94.311.64 136.7110.4 -
14 (2mM) trypanosome .961.04 - 6.21.74 - 36118.0 9015.8 192115.7
Zwittergent erythrocyte 1.571.14 - - 18.212.7 - 67.313.2 -
14 (3mM) trypanosome .91.17 - - 10.5611.59 35.616.6 92.3122.1 188115.3
TritonX-100 erythrocyte 2.671.11 - - 26.212.62 - 148.917.1 -
(0.5% (w/v) trypanosome 1.11.20 - - 8.413.1 - 97114.0 21815. 3
n-octy1-B-D- erythrocyte 2.310.9 - - 15.811.9 - 104117.7 -
glucopyran- 
oside (50mM)
trypanosome 1.21.33 — 9.911.4 — 10619.5 223126.3
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detergent extract of the erythrocyte and trypanosome 
plasma membranes. The initial rates of D-glucose transport 
into the proteoliposomes for 2mM Zwittergent 14 extracts, 
against increasing D-glucose concentration are plotted 
on Fig. 31.
In all cases the erythrocyte derived proteo­
liposomes exhibit increasing saturation of transport 
with increasing D-glucose concentration, suggesting 
a facilitative transport system is operational. The 
trypanosome derived proteoliposomes exhibit a linear 
response to increasing D-glucose concentrations, with 
no apparent saturation of D-glucose influx, suggesting that 
no facilitated D-glucose transport system is present.
5.1.2 Reconstitution by the n-octyl-B-D-glucopyranoside 
detergent dialysis procedure
Treatment of the erythrocyte ghosts with 340mM 
n-octyl—B-D-glucopyranoside extracted 57% of the erythrocyte 
plasma membrane protein. Unlike all the other D-glucose 
transport assays this technique relied upon the decrease 
in oxygen concentration caused by the activities of 
glucose oxidase and catalase inside the proteoliposomes. 
These enzymes yielded D-gluconic acid and 21^0, with 
the net usage of lC^ (see materials and methods section 
10.4.2) f in the presence of (transported) D-glucose 
and dissolved molecular oxygen. From the oxygen consumption, 
initial rates were calculated.




























Fig, 31 Zero-trans D-glucose transport* initial rate vs. D-glucose concentration for 
proteoliposomes produced by the freeze/thaw/sonication technique from 2mM Zwittergent 14 
extracts of human erythrocytes (•) and trypanosome (■) plasma membranes.
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against D-glucose concentration up to lOOmM are shown 
in figure 32A. Curve 1 represents the D-glucose influx 
into the proteoliposomes with no inhibitor present.
At D-glucose concentrations less than lOmM there is 
saturation of the influx with increasing concentration.
Above lOmM D-glucose the influx is linear with respect 
to D-glucose concentration. Curve 2 represents the 
influx of D-glucose into the proteoliposomes in the 
presence of ImM p-CPMSA.The linearity of the increase 
in rate with D-glucose concentration suggests the rate 
is a "leakage" component, subtraction of this curve 
from curve 1 gives the final curve, curve 3. This represents 
the inhibitable components of D-glucose influx ie. that 
attributable to the D-glucose transporter incorporated 
into the proteoliposomes. These results are in close 
agreement with those obtained by Shelton and Langdon 
(1983) in which 1.6mM phloretin was used in place of 
ImM p-CPMSA with the same results. The Km of this 
system was 14.3mM as determined by a Hanes plot, which 
compares favourably with the value of 15mM found by 
Shelton and Langdon (1983).
When erythrocyte "ghosts" were replaced by trypanosome 
membranes 41% of the total protein was extracted at 
340mM n-octyl-B-D-glucopyranoside. Fig. 32B demonstrates 
the influx of D-glucose into the proteoliposomes against 
D-glucose concentration. In contrast to the erythrocyte 
derived proteoliposomes no saturable component could 







































Fig. 32. Zero-trans D-glucose influx into proteoliposomes from n-octyl-B-D-glucopyranoside 
(340mM) extracts of erythrocyte (A) and trypanosome(B) plasma membranes. Curve 1 is the total 
D-glucose influx into the proteoliposomes. Curve 2 is the D-glucose influx into the 
proteoliposomes in the presence of ImM p-CPMSA and curve 3 is the saturable D-glucose influx 
achieved by subtraction of curve 2 from curve 1.
0 50 100 150 200
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For both the erythrocyte and trypanosome plasma 
membrane derived proteoliposomes in the presence or 
absenceof p-CPMSA addition of Triton X-100 to give 
a final concentration of 0.1% (w/v) activated the latent 
glucose oxidase and catalase activity inside the 
proteoliposomes.
5.2 INFINITE-TRANS (INFLUX COUNTERFLOW) D-GLUCOSE INFLUX 
INTO RECONSTITUTED PROTEOLIPOSOMES
The system of measuring D-glucose influx into 
proteoliposomes was altered to the infinite-trans (influx 
counterflow) protocol as opposed to the zero-trans 
protocol because it provided greater sensitivity in 
detecting true D-glucose transport, rather than non­
specific D-glucose influx.
Preloading of the proteoliposomes with lOOmM 
D-glucose competitively inhibited the radiolabelled 
D-glucose transported into the proteoliposomes from 
exiting again. This effectively produced a concentration 
of radiolabelled D-glucose inside the proteoliposomes 
above that of the equilibrium value, for as long as 
the intravesicular concentration of unlabelled D-glucose, 
and the ratio of unlabelled to labelled D-glucose inside 
the proteoliposomes remained high.
The second advantage of the system was the high 
internal (trans) D-glucose concentration compared with 
the external (cis) concentration, minimising the entrance 
of radiolabelled D-glucose by a leakage component against
116
the D-glucose concentration gradient.
Finally,the smaller amount of material and time 
required to undertake infinite-trans assays and the 
simplicity of the assays made them preferable to the 
zero-trans technique.
5.2.1 Freeze/thaw/sonication reconstitution of trypanosme 
plasma membrane proteins
Membrane proteins extracted with Zwittergent 14, 
lysolecithin and Triton X-100 were reconstituted by 
the freeze/thaw/sonication technique. Table 10 summarises 
the influx of D-glucose into proteoliposomes preloaded 
with lOOmM D-glucose, from the detergent extracts at 
various concentrations. None of the proteoliposomes 
regardless of detergent or detergent concentration 
demonstrated influx counterflow facilitated D-glucose 
transport. A comparison of the influx of D-glucose at 
ImM and lOOmM for 3mM Zwittergent 14 reconstituted extracts 
demonstrates a similar linear influx of D-glucose, with 
no apparent saturation at the higher concentration.
The values for influx into lysolecithin derived 
proteoliposomes are noticeably lower than those for 
other detergent extracts (and the lysolecithin 0 value).
This was probably caused by the presence of lysolecithin 
in the proteoliposomes assayed, which weakened the 
structures and resulted in breakage of the vesicles during 
washing and filtering. The low critical micelle concentration 
of lysolecithin made it extremely difficult to remove 
completely from the detergent extracts.
Table 10 Summary of the infinite—trans D-glucose influx (pmoles) into proteoliposomes prepared by 
the freeze/thaw sonication technique from detergent extracts of Triton X-100, Zwittergent 14 and 

















0.167 14.1 10.9 32 50 5580 3.0 1.2 1.4 1.4
2.0 20.3 24.4 69 95 11250 9.1 1.9 1.9 2.8
10.0 39.8 40.2 173 140 19620 18.6 3.1 3.8 14.0
30.0 90.0 88.0 294 257 25650 32.3 6.7 10.3 17.0
90.0 171.0 157.0 381 311 40500 85.0 11.3 13.5 27.5
150.0 - - 526 432 56250 - - - -
* Denotes lOOmM extravesicular D-glucose concentration.
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Figs. 33, 34 and 35 show the percentage of the 
total protein extracted by each detergent, the total 
dihydrolipoamide dehydrogenase activity retained in 
the extracts and the post extraction pellets, the 
percentage of the total protein reconstituted into the 
proteoliposomes, and the total dihydrolipoamide dehydrogenase 
activity reconstituted into the proteoliposomes.
Triton X-100 extracts demonstrate an increasing 
release of protein and dihydrolipoamide dehydrogenase 
with detergent concentration, reaching a peak at 0.5%
(w/v) Triton X-100. A maximum of 10% of the total protein 
was reconstituted into the proteoliposomes (0.5% (w/v)
Triton X-100 extract), retaining 15% of the total 
dihydrolipoamide dehydrogenase activity.
Both Zwittergent 14 and lysolecithin released 
greater amounts of protein from the membranes that Triton 
X-100. Concentrations of lysolecithin above 0.3% (w/v) 
did not release significantly greater amounts of protein, 
and total dihydrolipoamide dehydrogenase activity decreased in 
the supernatants. Total protein reconstituted was a 
maximum of 4% of the total (0.6%(w/v) extract) with the 
reconstituted dihydrolipoamide dehydrogenase activity 
not exceeding 2.5% of the total, both figures significantly 
lower than achieved with Triton X-100.
Zwittergent 14 extraction released a maximum 
of 50.6% of the total protein at lOmM, which was not 
significantly greater than that achieved at 3mM detergent 
(45%) . The 3mM Zwittergent 14 extract reconstitution 












Triton X 100 (% w/v)
Fig. 33. Triton X-100 extraction of trypanosome plasma 
membranes showing % total protein in extract (□), % 
of the total protein reconstituted by the freeze/thaw/ 
sonication method into proteoliposomes (E), total DHLIP 
DH activity in extracts (•), post extract pellets (a), 

































Fig. 34. Lysolecithin extraction of trypanosome plasma 
membranes showing % total protein in extract ( □ ) , % 
of the total protein reconstituted by the freeze/thaw/ 
sonication method into proteoliposomes ( E ), total DHLIP 
DH activity in extracts (•), post extract pellets (A), 


























































Fig. 35. Zwittergent 14 extracted trypanosome plasma 
membranes showing % total protein in extract ( □ ), % 
total protein reconstituted by the freeze/thaw/sonication 
method into proteoliposomes ( B ), total DHLIP DH activity 
in extracts (•), pbst extract pellets (A), and 
reconstituted proteoliposomes (■).
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total dihydrolipoamide dehydrogenase activity.
5.2.2 Detergent dilution reconstitution procedure
N-octyl-B-D-glucopyranoside (1.5% (w/v)) extracted 
47% of the total erythrocyte "ghost" protein. Four and 
a half percent of the protein was reconstituted into 
the proteoliposomes, which exhibited infinite-trans 
D-glucose facilitated transport, fig. 36. Substitution 
of trypanosome plasma membranes in place of erythrocyte 
"ghosts" released 31 to 38% of the total membrane protein. 
Total protein incorporated into the proteoliposomes 
ranged from 4.1 to 7.6% of the total protein. Fig. 37 
shows the infinite-trans D-glucose influx and ImM sucrose 
influx into proteoliposomes formed from the trypanosome 
lipid, «4.-lecithin and egg phosphatidyl choline preloaded 
with lOOmM D-glucose. The influx of D-glucose into the 
trypanosome and egg phosphatidyl choline lipid 
proteoliposomes is greater than those with L-ct-lecithin 
lipid; however, none show rapid accumulation of D-glucose 
above the equilibrium value expected of facilitated 
transport.
The higher values attained by trypanosome lipid 
and L-ot-lecithin may be a result of the larger size 
and lower homogeneity of the proteoliposome population, 
caused by the inability to sonicate the lipid to clarity 
before use.
The detergent dilution procedure was applied 
to the 2 other high critical micelle concentration 



















Fig. 36. Infinite-trans D-glucose transport into 
proteoliposomes formed by detergent dilution from 1.5% 
(w/v) n-octy1-B-D-glucopyranoside extract of erythrocyte 
"ghosts".
I
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Fig. 37. Infinite-trans D-glucose influx into proteoliposomes 
formed by the detergent dilution procedure in the presence 
of L-^-lecithin(•), egg yolk phosphatidyl choline(O) / 
trypanosome lipid(□), and ImM sucrose influx into trypanosome 
lipid detergent extract proteoliposomes (■). All values 
± SE of no greater than 13% of the given value.
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sodium cholate. Fig. 38 and 39 give the percentage of 
the total protein extracted at each detergent concentration, 
the total dihydrolipoamide dehydrogenase activity in 
the extract and residual pellet, the % of the total 
protein reconstituted, and the total dihydrolipoamide 
dehydrogenase reconstituted into the proteoliposomes.
Sodium cholate extracted a maximum of 43.4% 
of the total protein at 2.0% (w/v) detergent, however 
the release of protein and dihydrolipoamide dehydrogenase 
did not increase significantly above 1.0% (w/v) sodium 
cholate, fig. 38. Reconstitution of the 2.0% (w/v) extract 
incorporated 7.2% of the total protein and 11.3% of 
the total dihydrolipoamide dehydrogenase activity.
No sodium cholate reconstituted extract demonstrated 
the accumulation of D-glucose to a figure above the 
equilibrium value, followed by a decrease with time,
Table 11. Decanoyl-N-methyl-glucamid extracted a maximum 
of 37.5% of the total protein at 1.0 (w/v) detergent.
Above 0.25% (w/v) detergent however, total dihydrolipoamide 
dehydrogenase activity in both the extract and the residual 
post-extraction pellet decreased. Maximum protein was 
reconstituted into the proteoliposomes from the 0.5%
(w/v) extract (8.4% of the total) and 5.8% of the total 
dihydrolipoamide dehydrogenase activity. Infinite-trans 
D-glucose transport could not be detected in the 
proteoliposomes from any of the detergent extracts, 
and exhibited similar D-glucose influxes to those of 
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Sodium cholate (% w/v)
Fig. 38. Sodium cholate extraction of trypanosome plasma 
membranes showing % of the total protein in the extracts 
(□), % of the total protein reconstituted by the freeze/ 
thaw/sonication method into proteoliposomes (□), total 
DHLIP DH activity in extracts (•) , post extract pellets












Fig. 39. Decanoy1-N-methy1-glucamid (MEGA 10) extraction 
of trypanosome plasma membranes showing % total protein 
in the extracts (□), % of the total protein reconstituted 
by the freeze/thaw/sonication method into proteoliposomes
(B), total DHLIP DH activity in extracts (•), post extract 
pellets (▲), and reconstituted proteoliposomes (■).
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Table 11 Summary of the infinite-trans D-glucose influx(pmoles) into proteoliposomes formed by 
the freeze/thaw/sonication procedure applied to sodium cholate and decanoy1-N-methy1-glucamid 
extracts of trypanosome plasma membranes (all values + SE no greater than 16% of the quoted value).




26.630.2 27.30.167 58.3 32.3 24.6
44.814.129.0 35 48.195.0 65.0
18.8 23.0 13.2 73.349.0 50.3 69.7127 95.610.0
34.5 19.6 86.474.5 101.257.030.0 142 142
34.3 156121.5 36.2 55.076.0 83.590.0 163199
120
5.2.3 Direct incorporation of plasma membrane vesicles 
into L-d-lecithin vesicles
The proteoliposome pellet collected after the 
freezing and thawing of plasma membrane vesicles and 
L-ot-lecithin vesicles retained 54% of the total initial 
protein. Fig. 40 shows the infinite-trans D-glucose 
influx into the proteoliposomes with time. Accumulation 
of D-glucose did not demonstrate facilitated transport 
characteristics, but rather a non-specific influx 
component.
Proteoliposomes formed by incubation with 
lysolecithin retained 25% of the total initial protein 
and 17% of the total initial dihydrolipoamide dehydrogenase 
activity. Infinite-trans D-glucose transport exhibited 
a similar influx profile as those formed by the freeze/ 
thaw/sonication process, but did not demonstrate a 
facilitated D-glucose transport process, fig. 41.
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Fig. 40. Infinite-trans D-glucose influx into proteoliposomes 
formed by direct incorporation of plasma membrane vesicles 
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Fig. 41. Infinite-trans D-glucose influx into proteo­
liposomes formed by the direct incorporation of plasma 
membrane vesicles into L-«4-lecithin vesicles in the 
presence of lysolecithin.
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6.0 SUGAR TRANSPORT IN TRYPANOSOME PLASMA MEMBRANE VESICLES
Initial D-glucose transport studies were performed, 
using the zero-trans protocol, ie. no preloading of 
the vesicles with unlabelled sugar. Under this regimen 
the total counts found in the plasma membrane vesicles 
was very low. This made determination of influx rates 
very problematical since even small aberrations produced 
significant fluctuations in values, and determination 
of the ideal time for measurement of initial rates and 
reproducibility of results was extremely difficult. 
Transferral to the infinite-trans (influx counterflow) 
protocol with trans D-glucose concentration lOOmM, and 
cis concentration ImM overcame the problems associated 
with the zero-trans protocol.
Figure 42 demonstrates the time course for 
accumulation of radiolabelled D-glucose in the plasma 
membrane vesicles preloaded with lOOmM D-glucose, with 
extravesicular concentration of ImM D-glucose. Also 
shown are the time courses for vesicles containing lOOmM 
D-glucose but with,
(a) lOOmM D-glucose extravesicular concentration, and
(b) ImM extravesicular D-glucose and lOOmM mannitol 
in all buffers (including stopping buffer).
At ImM D-glucose extravesicular concentration 
the vesicles demonstrate an accumulation of radiolabelled 
D-glucose to a concentration above the equilibrium value, 
subsequently decreasing to the equilibrium value with 
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Fig. 42. Time course for infinite-trans counterflow 
D-glucose transport into plasma membrane vesicles at ImM 
D-glucose (•— • ), ImM D-glucose, lOOmM mannitol (▲— A), 
and lOOmM D-glucose (■— ■) extravesicular concentration. 
All values ± SE of 13% or less.
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a gradual influx of radiolabelled D-glucose with time 
and an initial 10 second value less than 100 times the 
value for 10 seconds at ImM D-glucose, suggesting 
saturation of the influx process.
The final plot of ImM D-glucose influx with 
lOOmM mannitol present, is similar in size and shape 
to that obtained without the mannitol present. This 
indicates there is not a major osmotic effect inducing 
D-glucose influx.
The influx of radiolabelled ImM D-glucose was 
linear for the first 10 seconds of the time course, 
and so this time point was chosen to calculate the initial 
rates of D-glucose transport with increasing extravesicular 
D-glucose concentrations of 1 to lOOmM.
The internal volume available for D-glucose 
accumulation was calculated from the total cpm of the 
sample at equilibrium after 90 minutes incubation, and 
the total radiolabel present in the total assay volume 
of 200pl. These gave an internal volume of 0.029 + 0.0025p1 
per 2pl of plasma vesicles, equivalent to 5.07+0.84pl 
per milligram of protein present.
An attempt to increase the entrapment of plasma 
membrane vesicles in the 0.22pm millipore filters by 
pre-soaking with poly-L-lysine (as suggested by Franzusoff 
and Cirillo (1983a) on the plasma membrane vesicles 
produced from yeast) did not improve the retention? 
using the criterion of increased counts trapped on the 
filters as the definitive measurements rather than 
trapped protein.
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The infinite-trans sugar transport profiles 
for 1-deoxy-D-glucose (1D0G) and 6-deoxy—D-glucose (6D0G) 
are shown in fig, 43 A and B. These exhibit the same 
time course characteristics as D-glucose suggesting 
a facilitated transport process.
6.1 DETERMINATION OF THE MICHAELIS CONSTANT (Km) AND
Vmax FOR SUGAR TRANSPORT IN PLASMA MEMBRANE VESICLES
The Km and Vmax for sugar transport using the 
infinite-trans protocol were calculated from the Hanes- 
Woolf plot of [S]/V vs. [S3. The best fit of the data 
was determined using the least squares method, computed 
according to the program devised by Cleland (1967).
This program fitted the raw data to 3 rate equations 
to determine,
1) The kinetic constants with no treatment of the data,
2) If the raw data included a leakage or non-saturable 
component, which could then be allowed for in the 
raw data, and the kinetic constants calculated from 
the residual saturable transport component,
3) If the raw data included 2 saturable transport components,
for which the kinetic constants of both could be calculated. 
Figs. 44, 45 and 46 represent the Hanes-Woolf 
plots for D-glucose, 1-deoxy-D-glucose and 6-deoxy-D- 
glucose as fitted to the data by the computer program 
of Cleland (1967). In all three cases no "leakage” 
(non-specific transport) or dual transport processes 
could be detected. The best fit of the data was found
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Fig. 43. Infinite-trans (influx counterflow) sugar 
transport into plasma membrane vesicles with time for 
ImM 1DOG (A) and ImM 6D0G (B). All values ± SE of 18% 
or less.
2.5 n
Fig. 44. Hanes plot for D-glucose to determine the Km and Vmax for D-glucose
transport into plasma membrane vesicles preloaded with lOOmM D-glucose.
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Fig. 45 Hanes plot for 1-deoxy-D-glucose (1DOG) to determine the Km and 






Fig. 46. Hanes plot for 6-deoxy-D-glucose (6DOG) to determine the Km and 
Vmax for 6DOG transport into plasma membrane vesicles preloaded 
with lOOmM 6DOG.
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using the untreated values.
The Km and Vmax of D-glucose, 1D0G and 6D0G 
are shown in the table below.






6 DOG 16.16+3.8 53.67+8.26
6.2 INHIBITION OF INF INITE-TRANS SUGAR TRANSPORT IN PLASMA 
MEMBRANE VESICLES BY CARBOHYDRATES
Table 12 summarises the percentage inhibition 
of infinite-trans sugar transport into plasma membrane 
vesicles preloaded with lOOmM sugar (either D-glucose,
1D0G or 6DOG) with extravesicular sugar concentration 
ImM and inhibitor concentration 25mM unless otherwise 
stated.Phloridzin was used at 2.2mM (lg/1) because of 
its insolubility above that figure.
All values are the % inhibition after 2 minutes 
of incubation, as these represent the maximum accumulation 
of sugar substrate inside the vesicles.
The patterns of inhibition of D-glucose, 1D0G 
and 6D0G were consistent for most of the inhibitors
Table 12 Summary of the % inhibition of ImM sugar (D-glucose, 
1D0G and 6D0G) infinite-trans transport, by inhibitor 






D-glucose 1DOG 6 DOG
Substrate(100) 89.71.98 7711.4 69.910.35
D-glucose(25) 58.3+6.8 41.513.2 58.412.5
D-galactose(25) 51+1.3 - 33123.3
D-mannose(25) 34.3+3.0 35+2.1 32+1.8
D-glucosamine
(25) 59.5+4.6 3812.1 41.812.6
1DOG(25) 49.0+4.9 40+4.2 52.2+4.7
6DOG (25) 48.0+3.5 34 + 11 47.6+7.6
Maltose(25) 16.518.8 33.315.5 18.010.7
5-thio-D-
glucose(25) 50.5111.7 47.516 41.1+4.0
N-acetyl-D-
glucosamine(25) 26.6+4.1 38.517.4 42.713.4
Mannitol(25) 0 0 0
3-O-methy1-D-
glucose(25) 4312.8 3712.1 51.211.1
D-fructose(25) 25.51.13 - -
Glycerol(25) 0 - -
Phloridzin(2.2) 15.913.0 2312.1 0
A - denotes no observation.
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tested. In all cases lOOmM sugar gave the greatest 
inhibition of filling ranging from 69.9% for 6-deoxy- 
D-glucose to 89.7% for D-glucose. Neither mannitol nor 
glycerol produced any inhibition. D-fructose, maltose 
and phloridzin induced moderate inhibition of transport 
of 33.5% or less for D-glucose, 1D0G and 6D0G.
Inhibition of 1D0G varied from that of 6D0G 
and D-glucose in that it was inhibited less by D-glucose, 
1D0G, 6D0G, and D-glucosamine than were D-glucose and 
6DOG, and was inhibited to a greater extent by maltose.
D-glucose, D-galactose, D-glucosamine, 5-thio- 
D-glucose, 1D0G, 6D0G, D-mannose, N-acetyl—D-glucosamine 
and 3-0-methyl-D-glucose all gave greater than 26.6% 
inhibition. D-mannose (with the exception of N-acetyl- 
D-glucosamine inhibition of D-glucose transport) gave 
a lower inhibition of D-glucose, 1D0G and 6D0G transport 
than N-acetyl-D-glucosamine or D-glucosamine.
6.3 INHIBITION OF INFINITE-TRANS D-GLUCOSE TRANSPORT 
IN PLASMA MEMBRANE VESICLES BY CHEMICAL MODIFYING 
AGENTS
D-glucose transport was inhibited by 2,4,dinitro- 
fluorobenzene, 2-hydroxy-5-nitrobenzyl bromide, and 
by N-ethylmaleimide in the plasma membrane vesicles 
without preincubation with inhibitor. The inhibitor 
was added to the vesicles with the diluting buffer. 
Inhibition by mercuric chloride could not be measured 
because it had the effect of "clumping" the vesicles
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together at concentrations as low as 0.5mM, producing 
erratic and nonsensical results.
Fig. 47 shows graphically the % inhibition of 
D-glucose transport by all these inhibitors at the 2 
minute incubation time point. N-ethylmaleimide and
2,4 dinitrofluorobenzene inhibited transport by up to 
34% with inhibition increasing with increasing inhibitor 
concentration. In contrast, 2-hydroxy-5-nitrobenzyl 
bromide demonstrated greater inhibition which began 
to plateau after 2mM inhibitor, reaching a maximum value 





















Fig. 47. % inhibition of infinite-trans D-glucose (ImM)
transport at increasing inhibitor concentrations for
2,4 dinitrofluorobenzene (■), 2-hydroxy-5-nitrobenzyl
bromide (a ), and N-ethylmaleimide (•) . All values ± SE








7.0 INHIBITION OF 6DOG TRANSPORT BY CHEMICAL MODIFYING 
AGENTS IN INTACT VIABLE TRYPANOSOMES
Viable trypanosomes preincubated with 2-hydroxy- 
5-nitrobenzyl bromide at 3mM final concentration transported 
6DOG (zero-trans) into themselves at a rate less than 
8% of that achieved in the absence of inhibitor, fig.
48. Preincubation for as little as 1 minute almost 
totally inhibited influx? however under microscopic 
investigation no lysis of the trypanosomes could be 
observed, and 90% retained their motility. The motility 
decreased until 10 minutes of preincubation at which time 
no motility could be observed. These cells still appeared 
intact as determined by microscopic observation.
Efflux of 6DOG from preloaded trypanosomes was 
inhibited by 2,4-dinitrofluoro benzene:, 2-hydroxy-5- 
nitrobenzyl bromide and by n-ethylmaleimide . Fig. 4 9 
shows the efflux of 6DOG over a 90 second period with 
and without 3mM inhibitor.
Greatest inhibition of efflux was found with 
2-hydroxy-5-nitrobenzyl bromide in which after 30 seconds 
less than 10% of the total 6DOG had effluxed. This 
increased to 42.5% of the total at 90 seconds. The initial 
inhibitions of 2,4-dinitrofluorobenzene and N-ethyl­
maleimide up to 10 seconds were similar? however after 
this point 2,4-diriitrofluorobenzene inhibited cells 
continued to efflux and after 90 seconds the total 6DOG 
entrapped in the trypanosomes was similar to that of 
the control experiment (no inhibitor). Efflux after
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Fig. 48. Zero-trans 6D0G influx into trypanosomes in 
the absence of inhibitor (•), in the presence of 3mM 
2-hydroxy-5-nitrobenzy1 bromide after lmin preincubation 




















T i m e ( s e c o n d s )
Fig. 49. 6D0G efflux from preloaded trypanosomes with 
time in the presence of no inhibitor (•), 3mM 2-hydroxy- 
5-nitrobenzyl bromide (O), 3mM N-ethylmaleimide (□) 
and 3mM 2,4-dinitrofluorobenzene (■) •
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10 seconds in the presence of N-ethylmaleimide slowed 
considerably and after 90 seconds the total 6DOG remaining 
in the trypanosomes was comparable to that of the cells 
treated with 2-hydroxy-5-nitrobenzyl bromide.
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8.0 EFFECT OF DIHYDROLIPOAMIDE, NAD* AND PHENYL ARSINE
OXIDE ON INFINITE-TRANS D-GLUCOSE TRANSPORT IN PLASMA 
MEMBRANE VESICLES
The kinetic constants of D-glucose infinite- 
trans-transport were determined using the Hanes-Woolf 
plot as fitted to the rate equation by the method of 
Cleland (1967). The best fit of the data used the 
unaltered values, ije. no leakage or dual transport 
systems could be detected.
Plasma membrane vesicles preloaded with 5mM 
NAD+ and lOOmM D-glucose exhibited infinite-trans D-glucose 
transport with a Km of 27.0+3.34mM and Vmax of 
141.67+12.14nmol D-glucose/mg protein/min, fig.50. These 
values are in excess of those quoted previously for 
preloaded vesicles without 5mM NAD+, of Km=15.66mM and 
Vmax=62.9nmol/mg protein/min.
Addition of dihydrolipoamide (ImM) to the NAD+ 
and D-glucose preloaded vesicles reduced the Km to 
22.1±2.56mM and the Vmax to 76.95±5.9nmol/mg protein/min, 
fig. 51.
Application of the Students T-test to the Kms 
for D-glucose transport in the (NAD+ preloaded) plasma 
membrane vesicles, in the presence and absence of 
dihydrolipoamide produced a value of P <0.25. This suggests 
that the Kms are significantly different and dihydro­
lipoamide is altering the binding properties of the 
transporter. For absolute certainty, however, a value 






Fig. 50. Hanes plot to determine the Km and Vmax for infinite-trans D-glucose





Fig. 51. Hanes plot to determine the Km and Vmax for infinite-trans D-glucose 
transport into plasma membrane vesicles preloaded with 5mM NAD+ and 
lOOmM D-glucose in the presence of ImM dihydrolipoamide.
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stated beyond doubt that the difference in Kms represent 
an alteration of D-glucose binding by the D-glucose 
transporter as a result of dihydrolipoamide.
When 200pM phenylarsine oxide replaced ImM 
dihydrolipoamide the Km decreased to 13.87±2.24mM and 
the Vmax to 50.01±5.77nmol/mg protein/min, fig. 52, 
figures comparable to those obtained in the absence 
of 5mM NAD+ preloading.
8.1 EFFECT OF DIHYDROLIPOAMIDE AND PHENYLARSINE OXIDE 
ON 6DOG TRANSPORT IN WHOLE VIABLE TRYPANOSOMES
The zero-trans influx transport of 6DOG into 
the trypanosomes was not inhibited to any significant 
degree (as compared to a control experiment with no 
inhibitor present) by either dihydrolipoamide (ImM) 
or phenyl arsine oxide (lOOyM) , fig. 53.
The efflux of 6DOG from the trypanosomes was 
inhibited by phenylarsine oxide and dihydrolipoamide, 
fig. 54. In the absence of inhibitor efflux was rapid 
over the first 10 seconds of incubation with over 75% 
of the total 6DOG released by the cells. This was 
followed by a slow phase of release reaching a minimum 
after 60 seconds incubation.
In the presence of dihydrolipoamide (ImM) and 
phenylarsine oxide (200|jM, used singly in separate assays), 
less than 50% of the total 6DOG was released after 10 
seconds incubation. With increasing time, dihydrolipoamide 
treated cells released the 6DOG, such that after 60
0 13.0 26.0
D glucose (mM)
Fig. 52. Hanes plot to determine Km and Vmax for infinite-trans D-glucose 
transport into plasma membrane vesicles preloaded with 5mM NAD + 









































Fig. 53. Zero-trans 6DOG transport into trypanosomes 
in the absence of inhibitor (•), presence of ImM 





































Fig. 54. Efflux of radiolabelled 6DOG from trypanosomes 
in the absence of inhibitor (•), presence of ImM 
dihydrolipoamide (■) and lOOpM phenylarsine oxide (a ).
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seconds the total trapped 6D0G was comparable with 
that trapped in the absence of inhibitor. Phenylarsine 
oxide, however, inhibited the efflux of 6D0G such that 
after 60 seconds over three times as much 6DOG was 
retained in the trypanosomes compared to the control 




The mammalian bloodstream form of T.b.brucei 
is entirely dependent on D-glucose for its energy supply. 
It has no energy reserves and does not oxidise fatty 
acids or amino acids (Fairlamb, 1982) • D-glucose transport 
has not been extensively studied in the organism though 
Gruenberg et al. (1978) stated that D-glucose transport 
was the rate limiting step in glycolysis. This 
observation presents the D-glucose transporter as an 
ideal site for the action of trypanocidal drugs.
The aim of this thesis was to study the isolated 
D-glucose transporter to avoid complications of cell 
metabolism, cell lysis and cell death. To this end the 
plasma membranes were prepared according to the method of 
Voorheis (1979) utilising a very tight fitting Dounce 
homogeniser. This disrupted the trypanosomes with one 
stroke, diminishing the loss of plasma membrane material 
through separation from the microtubular array, caused 
by repeated strokes of a looser fitting homogeniser 
(Voorheis et al., 1979).
The plasma membranes were the source of the 
D-glucose transporter and were treated to allow 
vesiculation and thus the study of the transporter in 
its native environment. More importantly the plasma 
membranesand any successfully treated plasma membranes
represented a source of D-glucose transporters for
\
solubilisation, ultimate purification, and reconstitution 
to study its activity.
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1.0 PLASMA MEMBRANE PURITY
The marker enzymes for the cytoplasm, mitochondria, 
endoplasmic reticulum, glycosomes and plasma membrane 
were all found in varying degrees with the final plasma 
membrane pellet P4.
Cytosolic contamination, as represented by 
pyruvate kinase, was small with 2.5% of the total activity 
remaining with the final pellet. The activation of the 
enzyme by Triton X-100 may represent entrapment of the 
enzyme in the plasma membrane during the homogenisation 
process. Low cytosolic contamination was confirmed by 
malate dehydrogenase (90% of which is cytoplasmic in 
the bloodstream form (Opperdoes et al., 1981)).
The remaining 10% of the malate dehydrogenase
activity in the whole cells is associated with the
mitochondrion (Opperdoes et al., 1981). The low recovery
of malate dehydrogenase (2% of the total enzyme activty),
+ + 2 +
the complete absence of oligomycm sensitive Na K, Mg 
stimulated ATPase and only 5.7% of the total glycerol-3- 
phosphate oxidase activity (both of which are 
mitochondrial markers, Opperdoes et al., 1977b) in the 
final membranes suggests minimal mitochondrial 
contamination.
The enzyme ot-glucosidase has been put forward 
as a plasma membrane marker enzyme (Steiger et al.,
1980), however only 13.2% of the total activty was 
recovered with the final plasma membrane pellet. Though 
co-purifying with the plasma membrane fraction in the
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subcellular fractionation of Steiger et al* (1980), 
the enzyme could be released totally by the action of 
0.1% (w/v) Triton X-100 (Steiger et al., 1980). This 
suggests that the enzyme is not strongly attached to 
the plasma membrane, if it is attached at all, since 0.1% 
(w/v) Triton X-100 removed only approximately 33% of 
the total dihydrolipoamide dehydrogenase activity from 
the plasma membranes in this thesis. Its use as a 
definitive plasma membrane marker was therefore not 
possible.
D-glucose-6-phosphatase (10.5% of the total
activity) was recovered in the plasma membranes. This
enzyme has been suggested to be a marker enzyme for 
* •
— the trypanosome endoplasmic reticulum (Voorheis et al., 
1979) , however Steiger et al. (1980) have suggested 
that D-glucose-6-phosphatase activity is in fact 
attributable to acid phosphatase, which is located in 
the endoplasmic reticulum and flagellar pocket. The 
latter site would explain the D-glucose-6-phosphatase 
activity associated with the plasma membranes, with 
enzyme latency caused by disruption of the flagellar 
pocket during homogenisation.
Myokinase activity ( 6.8% of the total activity) 
was recovered with the final plasma membrane pellet 
P4. Two major sites have been suggested for myokinase; 
one in the mitochondria, and the second in the glycosome 
(Opperdoes et al., 1981). As already noted the 
mitochondrial marker enzymes suggest very little 
mitochondrial contamination of the plasma membranes,
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and it therefore seems likely that the activity is 
associated with the glycosomal form,
Hexokinase, glycerol-3-phosphate dehydrogenase 
and phosphoglucoisomerase are all glycosomal enzyme 
markers (Opperdoes and Borst, 1977c). A maximum of 
16.3% (phosphoglucoisomerase) of the total enzyme 
activity remained with the plasma membrane pellet at 
specific activities approximately the same as those 
of the homogenate. In all other enzyme markers assayed, 
excluding «C-glucosidase and dihydrolipoamide dehydrogenase, 
specific activity in the plasma membranes was lower 
than the homogenate value.
Two explanations are possible for these 
observations. Glycosomes equilibrate at a sucrose gradient 
density of 1.23g/cm3 (Opperdoes et al., 1977b,c) and 
plasma membranes at 1*243g/cm3 (Voorheis et al., 1979), 
it is possible therefore that glycosomal contamination 
represents a cross over of the two bands. The second 
explanation is that some glycosomes or enzyme complexes 
are tightly bound to the plasma membranes, either 
naturally, or as a result of the homogenisation process.
In the former explanation the sucrose densities 
of 1.23g/cm3 and 1.243g/cm3 correspond approximately 
to 48.5% (w/v) sucrose and 51.3% (w/v) sucrose at 4°C, 
ie. a difference of 2.8% (w/v) sucrose. On a continuous 
gradient in the centrifuge tubes used this corresponds 
to a separation of the bands of approximately 1cm. No 
discernible band was seen 1cm above the plasma membrane 
band, and hence it is unlikely that an overlap of the
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bands occurred.
The evidence suggests therefore that the latter 
explanation of some tightly bound glycosomes or enzyme 
complexes attached to the plasma membrane is more likely.
In the original purification of plasma membranes 
by Voorheis et al. (1979), hexokinase contamination 
was removed by raising the ionic strength of the 
homogenate by additions of potassium chloride. The major 
difference between the original Voorheis et al. (1979) 
technique and that reported here, is the initial removal 
of the hexokinase. This difference may be a facet of 
the different homogenisers employed and the hydrophobicity 
of the hexokinase, glycerol-3-phosphate dehydrogenase, 
phosphoglucoisomerase (Misset and Opperdoes, 1984)>
and/or the glycosomal contamination.
The activity of the plasma membrane marker, 
ouabain sensitive Na+K+ATPase as used by Voorheis et 
al. (1979) for the identification of the plasma membranes, 
proved extremely difficult to measure accurately and 
consistently. Steiger et al. (1980) were unable to 
measure any ouabain sensitive ATPase activity in the 
same organism and determined that ATP hydrolysis was 
a function of acid phosphatase activity carried over 
in the procedure. The co-purification of 10.5% of the 
total D-glucose-6-phosphatase activity with the plasma 
membranes explain^ the high background ATPase activity 
which made detection of small amounts of ouabain 
sensitive ATPase difficult to measure.
137
The plasma membranes are therefore essentially 
free of cytoplasmic and mitochondrial contamination 
but retain some contamination by glycosomal enzymes.
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2.0 HEXOKINASE ACTIVITY AND FUNCTION
A significant amount of hexokinase activity 
was found to remain with the plasma membranes after 
the purification procedure.
It has been suggested that hexokinase is involved 
in the D-glucose transport system of yeast (Van Steveninck 
& Rothstein, 1965? Jaspers et al., 1975? Tijssen et 
al., 1984). Accumulation of phosphorylated 2-deoxy— 
D-glucose against a concentration gradient was balanced 
by a concomittant decrease in cellular ATP, orthophosphate 
and polyorthophosphate (Jaspers et al., 1975).
The hexokinase associated with the trypanosome
plasma membranes demonstrated specificity for ATP and
2 ♦ADP as the phosphate donor in the presence of Mg 
Phosphoenolpyruvate, orthophosphate and pyrophosphate 
did not donate a phosphate group to the D-glucose. The 
Km for D-glucose with A1P as a phosphate donor was 48pM, 
a figure approximating to that of yeast hexokinase (O.lmM, 
Bergemyer, 1974a).
The ability of ADP to act as a phosphate donor 
can be explained by the presence of myokinase activity 
which is able ( as shown in the marker enzyme assay) 
to catalyse the formation of ATP from ADP, which could 
then be used to phosphorylate D-glucose by hexokinase.
The increased Km and decreased Vmax for the production 
of D-glucose-6-phosphate is a result of the reliance 
on myokinase to produce the ATP required. The specific 




was 0.037|Jmoles ATP/mg protein/min compared to the specific 
activity of the hexokinase in the plasma membrane pellet 
P4 of 1.18pmoles D-glucose-6-phosphate/mg protein/min. 
Effectively, therefore, ATP would not be available in 
saturating quantities as it was in the hexokinase assay 
where ATP was the phosphate donor. It would therefore 
be expected that the kinetic constants Km and Vmax would 
be altered when ADP was the phosphate donor. Overall 
therefore the hexokinase activity would appear to be 
classical hexokinase activity.
Game et al. (1986) demonstrated that 1-deoxy- 
D-glucose was not phosphorylated to any extent by the 
trypanosome hexokinase in vitro. In vivo however, 
approximately 50% of the 1-deoxy-D-glucose transported * 
into the cell was in the phosphorylated form (Game,
1988) indicating that 1-deoxy-D-glucose was a substrate 
for hexokinase or another phosphorylating process. Game 
(1988) also demonstrated that 6-deoxy-D-glucose was 
a substrate for the D-glucose transporter, though it 
cannot be phosphorylated in the C6 position. Transport 
of 6-deoxy-D-glucose into yeast lost the high affinity 
component of transport (Bisson & Fraenkel, 1983a) 
indicating that the kinase was required for high affinity 
transport but not by direct phosphorylation of the substrate 
as 6-deoxy-D-glucose cannot be phosphorylated in the 
C6 position. A similar process could occur in the 
trypanosome.
Hexokinase involvement in transport processes 
would require its presence in the cytosol or associated 
with the plasma membrane. Bisson and Fraenkel (1983b)
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postulated that a small fraction of the yeast hexokinase
\
was tightly bound to the plasma membrane or that there 
was a loose association with some membrane component 
that performs the recognition of the external sugar.
In the isolated trypanosome plasma membranes, 
the hexokinase associated with the plasma membranes 
appears to be the result of contamination by glycosomes 
or enzyme complexes. However, it cannot be ruled out 
that a small amount of hexokinase associated with the 
plasma membrane is involved in D-glucose transport.
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3.0 PIHYDROLIPOAMIDE DEHYDROGENASE:ASSOCIATION WITH 
THE PLASMA MEMBRANE
Dihydrolipoamide dehydrogenase activity was 
found to co-purify with the purified plasma membranes, 
with some activation during the procedure.
Maximum, though not complete solubilisation 
of the enzyme activity was achieved at 0.5% (w/v) Triton 
X-100, a detergent concentration used for almost complete 
solubilisation of the erythrocyte membrane (Kasahara 
& Hinkle (1976); in contrast high sal£ had very little 
effect on releasing the enzyme. The enzyme was readily 
reconstituted into phosphatidyl choline vesicles by 
both detergent dilution and freeze/thaw/sonication 
procedures, with percentage total activity similar to 
the percentage of the total protein recovered in the 
proteoliposomes•
Significantly the reconstituted enzyme was firmly 
attached to the proteoliposomes, staying associated 
through further sonication, dilution and freezing and 
thawing procedures. The above suggests that the enzyme 
is attached to the plasma membrane by a hydrophobic 
interaction, and from the amount of Triton X-100 required 
to release it, either an integral membrane protein, 
or attached covalently to lipids embedded in the membrane, 
released by Triton X-100.
3.1 Possible roles for dihydrolipoamide dehydrogenase 
It has been suggested that dithiol-disulphide
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interchanges play a role in membrane related processes 
such as solute transport and energy transduction (Robillard 
& Konings, 1982). It is possible that these interractions 
are mediated through a co-factor such as lipoamide, 
and the dihydrolipoamide dehydrogenase, since the enzyme 
has now been found in the plasma membranes of E.coli 
(Owen et al., 1980), adipocyte plasma membranes (Karim, 
A.R., Holman, G.D. and Danson, M.J., unpublished data), 
and in thermoacidic archaebacterium (Smith et al., 1987). 
Preliminary experiments have demonstrated the presence 
of lipoic acid in T.b.brucei (Danson, M.J. and Stephenson* 
K., unpublished data), but not its location in the cell.
The exact role of dihydrolipoamide dehydrogenase 
in the plasma membranes, and lipoic acid (exact location 
unknown) in the trypanosome is not clear. Richarme (19 85) 
demonstrated that lipoic acid deficient E.coli had a 
60 to 80% reduction in protein dependent transport of 
ribose, galactose and maltose. In E.coli with lipoic 
acid present, arsenical (sodium arsenate and sodium 
arsenite) produced the same results as lipoic acid 
deficiency, but had no effect on lipoic acid deficient 
E.coli.
Further to the above, Richarme and Heine (1986) 
demonstrated that addition of dihydrolipoate and 3-acetyl 
NAD+ to toluene/EDTA treated E.coli reactivated the 
galactose and maltose binding protein dependent transport 
lost during the toluene/EDTA treatment. No stimulation 
was observed in cells under the same conditions which 
were deficient in the galactose and maltose binding
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protein dependent system.
D-glucose transport in the plasma membrane 
vesicles was affected by NAD+, dihydrolipoamide and 
phenylarsine oxide. The Km of D-glucose transport in 
the absence of NAD+ preloading in the vesicle was 15.66mM 
with Vmax 62.9nmol/mg protein/min. Preloading the vesicles 
with NAD+ almost doubled the Km (27.0mM) and more than 
doubled the Vmax (141.67nmoles/mg protein/min). Addition 
of dihydrolipoamide decreased the Km to 22.1mM and 
Vmax to 76.95nmol D-glucose/mg protein/min. The significance 
of the change in Km is debatable as demonstrated by 
the Students T-test result (see Results Section 8.0), 
however, the Vmax is significantly reduced. Phenylarsine 
oxide decreased both the Km and the Vmax (to 13.87mM 
and 50.01nmol D-glucose/mg protein/min respectively).
These values approximate to those of the vesicles without 
NAD+ preloading.
The last result with phenylarsine oxide tends 
to suggest that the perturbation of the D-glucose transporter 
is not at the site of the D-glucose transporter but 
in a protein associated with it, since the NAD+ effect 
was regulated by it. Experiments on whole cells did 
not prove conclusive. Inhibition of 6-deoxy-D-glucose 
efflux from preloaded trypanosomes was achieved by both 
dihydrolipoamide and phenylarsine oxide, the degree 
of which may represent the irreversible binding of the 
arsenical. In intact cells, however, no significant 
inhibition of zero-trans influx was observed.
Preliminary experiments on intact trypanosomes 
involving preincubation with arsenical reagents by
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Arnold, M., Holman, G., and Eisenthal, R.S., demonstrated,
1) Phenylarsine oxide, and aminophenyldichloroarsine 
inhibited initial zero-trans entry of 6-deoxy-D-glucose 
by 50 to 80%, but acetylaminophenylarsine oxide proved 
ineffective.
2) Addition of lOmM D-glucose to arsenical incubation 
did not decrease the arsenical inhibition.
3) The decrease in D-glucose uptake by phenylarsine 
oxide was accompanied by a similar but less marked 
inactivation of the enzyme, dihydrolipoamide dehydrogenase.
None of the above is definitive proof that 
dihydrolipoamide dehydrogenase is associated with D-glucose 
transport in the trypanosomes. The effects of NAD+, 
dihydrolipoamide and phenylarsine oxide could be explained, 
however, if they interfered with or altered the action 
of dihydrolipoamide dehydrogenase in the plasma membrane, 
rather than directly with the D-glucose transport 
transporter, by affecting a dithiol group essential 
for D-glucose transporter viability, not accessible 
to the chemical modifiers.
A second r’ole for dihydrolipoamide dehydrogenase 
could be a proton pumping one. The action of 
dihydrolipoamide dehydrogenase producing NADH and a 
proton at the plasma membrane would simplify the pumping 
of a proton across the membrane. This could be important 
to the cells for two reasons.
i) It has been suggested that the activity of the lactose 
transporter in E.coli can be altered by changing the 
redox state of the carrier (Konings et al., 1982). It 
is possible, therefore, that dihydrolipoamide dehydrogenase
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activity is connected to D-glucose transport indirectly 
by production of a proton gradient.
ii) If pyruvate is removed from the cell in the negatively 
charged state, the pumping out of the cell of a proton 
would balance the charge left inside the cell.
From the results in this thesis no definitive 
statement can be made on the proton pumping hypothesis. 
However, it was significant that preloading of the cells 
with NAD+ which created a charge gradient between the 
inside and outside of the plasma membrane vesicles 
significantly altered the Km and Vmax of the D-glucose 
transport process. Addition of dihydrolipoamide would 
allow more proton pumping which may explain the decrease 
in Vmax and slight decrease in Km. On this basis however 
it is difficult to see why arsenical should remove the 
NAD+ effect on D-glucose transport in the plasma membrane 
vesicles.
Van Schaftingen et al. (1987), found that the
effect of melarsen oxide on trypanosomes was not attributable 
to inhibition of the glycolytic flux. Its role may 
therefore be in the inhibition of dihydrolipoamide 
dehydrogenase, and its possible roles in D-glucose 
transport, proton pumping or maintenance of the oxidation 
state of vicinal thiols.
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4.0 PLASMA MEMBRANE TREATMENT
Alkali, calcium ions and freeze/thaw treatments 
of the plasma membranes were carried out to produce 
fragments or whole plasma membranes devoid of cytoskeleton 
and amenable to vesiculation without detergent extraction, 
hence maintaining the transporter in an environment 
as close to its natural one as possible.
Both the alkali and calcium ion treatments proved 
ineffective in providing an active D-glucose transport 
system, alkali treatment being particularly disruptive 
in its effect on the plasma membranes. This technique 
has been successfully applied to erythrocyte "ghosts"
♦
by Gorga et al. (1981) suggesting that the technique 
itself was not at fault but rather the disruption of 
the plasma membranes and the consequences of this on 
the D-glucose transporter environment and possible 
relevant protein:protein interractions, essential for 
activity. This view is supported by the inactivation 
of dihydrolipoamide dehydrogenase which would appear 
to be closely associated with the plasma membranes.
Calcium ion treatment of the plasma membranes 
also resulted in an inactivated D-glucose transporter.
The process itself did not produce the required micro­
tubule free plasma membranes as achieved by Dolan et 
al. (1986). Raising the calcium ion concentration to 
ImM as used to depolymerise the microtubules of Distigma 
proteus (Murray, 1984) had no effect on microtubule 
release. A possible explanation is the "clumping" of 
the microtubules observed during the treatment. This
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process would prevent calcium ions from reaching their
\
point of action or allow only partial depolymerisation 
of the microtubules.
The freeze/thaw technique proved the only process 
to produce a functional D-glucose transporter. Unlike 
the alkali and calcium ion treatments, freezing and 
thawing did not require chemical action on the plasma 
membranes. It is possible, therefore, that the environment 
of the D-glucose transporter on the plasma membrane 
and/or protein:protein interractions were maintained 
such that the D-glucose transporter could function.
The major drawback of this process was its relative 
inefficiency in releasing the plasma membrane as vesicles. 
It was hoped that changing the ionic strength might 
release greater amounts of plasma membrane as vesicles, 
but more importantly lead to greater vesiculation and 
larger internal volumes to trap radiolabelled D-glucose. 
This was not the case and variation of ionic strength 




5.0 RECONSTITUTION OF THE ERYTHROCYTE AND TRYPANOSOME 
PLASMA MEMBRANE PROTEINS
5.1 Detergent extract reconstitution
The reconstitution of the membrane proteins from 
the trypanosome and erythrocyte plasma membranes was 
undertaken using a wide variety of detergents and 
reconstitution techniques, and two methods of assay, 
zero-trans and infinite-trans sugar transport.
Detergent dialysis of erythrocyte n-octyl-p-D- 
glucopyranoside extracts and freeze/thaw reconstitution 
of erythrocyte membranes extracted with n-octyl-p—D- 
glucopyranoside (removed by dialysis), Zwittergent 14 
and Triton X-100 all proved successful in reconstituting 
the erythrocyte D-glucose transporter. These results 
demonstrate the reconstitution procedures themselves 
were capable of reconstituting membrane proteins, and 
in a functional state.
The results obtained with the erythrocytes could 
not be repeated with the trypanosome plasma membranes. 
Trypanosome plasma membrane protein and active 
dihydrolipoamide dehydrogenase were found associated 
with proteoliposomes formed by each reconstitution 
procedure, however, no D-glucose transport was found. 
Since the techniques employed had proved successful 
on the erythrocyte' D-glucose transporter it would appear 
that inactivation of the D-glucose transporter was 
occurring at some point in the isolation of the plasma 
membranes or during the reconstitution procedure.
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Inactivation during plasma membrane isolation is not 
credible because vesicles from the freeze/thaw treated 
plasma membranes demonstrated D-glucose transport? 
therefore inactivation was occurring during solubilisation 
and reconstitution.
The type of detergent and concentration have 
proved critical for effective reconstitution of membrane 
proteins. Banejee et al. (1977) demonstrated that 
preparations of the Pi/OH transporter of bovine heart 
mitochondrion were, variable with cholate and deoxycholate, 
but reproducible and stable when extracted with n-octyl- 
p-D-glucopyranoside and Triton X-100. Similarly, Navarette 
and Serrano (19 83) demonstrated that only Zwittergent 
14 and lysolecithin effectively solubilised oat root 
ATPase, but only lysolecithin produced a stable enzyme 
during the purification and reconstitution procedure 
(Serrano, 1984) .
Solubilisation of the trypanosome plasma membranes 
utilised n-octyl-p-D-glucopyranoside, Triton X-100, 
sodium cholate, Zwittergent 14, decanoyl-N-methyl-glucamid 
and L-^C-lysolecithin to provide detergents that were 
non-ionic (high and low critical micelle concentration), 
ionic, charged but electrically neutral, and lipid-like.
In no case was D-glucose transport activity found in 
the reconstituted extracts.
Apart from reconstitution technique and detergent 
several other factors have proved crucial to effective 
reconstitution of membrane proteins. These include lipid 
type used in the reconstitution process, lipid to protein
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ratios and stabilising chemicals such as glycerol.
The lipid used predominantly in the reconstitution 
process was L-o6-lecithin derived from soybeans. This 
lipid source was a mixture of lipids containing only 
21% phosphatidyl choline and was therefore more likely 
to contain factors required for D-glucose transporter 
viability than pure lipid sources, ie. the pure egg 
phosphatidyl choline. In the reconstitution of E.coli 
lactose transporter Newman and Wilson (1980) demonstrated 
a requirement for E.coli lipid in the reconstitution 
process for lactose transporter viability. The 
reconstitution of the trypanosome membrane proteins 
in trypanosome lipid by the detergent dilution procedure 
was ineffective, and use of the trypanosome lipid 
discontinued because of the difficulty in obtaining the 
large quantities required, and the problem of sonicating 
the lipid to clarity for efficient reconstitution and 
replication.
In the reconstitution of other membrane proteins 
several other factors have proved important for membrane 
protein function and integrity. Calcium or magnesium 
ions were required for the reconstitution of adipocyte 
D-glucose transporter activity (Carter-Su et al., 1980), 
protein:lipid ratios of 1:45 were required for optimal 
activity in the reconstitution of the purified Na+K+ATPase 
of Electrophorus electricans and Sgualus acanthias 
(Hokin and Dixon, 1979), and the presence of 20% (v/v) 
glycerol in buffers for optimum stability of oat root 
ATPase during solubilisation and reconstitution (Vara 
and Serrano, 1982) .
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Apart from altering the buffer system of the 
reconstitution process from Tris/HCl to phosphate buffer 
(hence avoiding pH change with temperature), no attempt 
was made to vary the lipidrprotein ratios, add divalent
?
metal ions, or add stabilising compounds such as glycerol.
It may well prove that alterations or addition of these 
factors will prove crucial to effective reconstitution 
of a viable trypanosome D-glucose transporter.
5.2 Non-detergent extract reconstitution
Non-detergent extract reconstitution was applied 
to plasma membrane vesicles which had a functional 
D-glucose transporter present. This had two advantages: 
firstly it avoided solubilisation with detergents ( a 
possible cause of inactivation of the D-glucose 
transporter), and secondly provided a much larger 
internal volume to allow kinetic studies without the 
pre-requisite preloading of the vesicles with D-glucose.
Reconstitution without detergents has been applied 
successfully to erythrocyte membranes by Wheeler (1986) 
and to yeast plasma membranes by Franzusoff and Cirillo 
(1983b), and Ongjoco et al. (1987). In the case of yeast 
plasma membranes, D-glucose transport in plasma membrane 
vesicles was increased 10-fold by the reconstitution 
process (Franzusoff and Cirillo , 1983b).
The proteoliposomes derived from the reconstitution 
of the trypanosome plasma membrane vesicles did not 
demonstrate the overshoot phenomenom of D-glucose transport, 
but rather the leakage of D-glucose. A similar effect
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was noted for the transport of L-glucose in the 
reconstituted yeast plasma membranes of Franzusoff and 
Cirillo (19 83b). In the yeast proteoliposome case, however, 
the L-glucose "leakage" was only a fraction of D-glucose 
transport activity, hence the process was useful for 
measuring D-glucose transport activity.
The trypanosome plasma membrane vesicles before 
reconstitution demonstrated a maximum infinite-trans 
D-glucose accumulation of 1.69nmoles D-glucose/mg protein; 
after two minutes incubation. A transport rate of this 
magnitude would be masked by the leakage component of 
the reconstituted proteoliposomes (assuming no increase 
in transport rate). It is probable, therefore, that 
the D-glucose transporter was functional, but its activity 
was not detected under the conditions used. There is 
no reason to suppose that the freeze/thaw conditions 
used to make the proteoliposomes should inactivate the 
D-glucose transporter.
A similar D-glucose infinite-trans D-glucose 
transport time course was obtained with proteoliposomes 
formed from the fusion of plasma membrane vesicles and 
L-ot-lecithin vesicles by L-*»C-lysolecithin. This technique 
has proved successful in reconstituting cytochrome 
oxidase (Eytan et al., 1975), however, as stated previously 
for the direct membrane protein incorporation by the 
freeze/thaw/sonication method, the transport component 
of D-glucose influx could easily be masked by the "leakage" 
component of D-glucose influx. It is also possible that 
the presence of L-c(.-lysolecithin, though lipid-like
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in its structure , inactivated the D-glucose transporter, 
and no facilitated transport of D-glucose was occurring 
at all.
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6.0 SUGAR SPECIFICITY AND KINETICS OF THE PLASMA MEMBRANE 
VESICLE D-GLUCOSE TRANSPORTER
The availability of plasma membrane vesicles 
with an active D-glucose transporter allowed the study 
of the transport of metabolisable sugars, i.e. D-glucose 
and 1-deoxy-D-glucose, and the inhibition of transport 
of sugars by other metabolisable, or partially metabolisable 
compounds.
The Km's of the substrates D-glucose (15.66mM), 
1-deoxy-D-glucose (17.26mM) and 6-deoxy-D-glucose (16.16mM) 
were considerably greater than those values obtained 
in intact trypanosomes, D-glucose 0.3 87mM, 6DOG 1.54mM 
(Game, 1988) and 1DOG 4.03mM (Game et al., 1986). An 
apparent increase in Km in vesicle systems has been 
found in reconstituted yeast and erythrocyte D-glucose 
transporters. Ongjoco et al. (1987) reconstituted the 
yeast D-glucose transporter and found the Km was 8.0mM, 
considerably higher than the high affinity transporter 
(Km = 0.5 to l.OmM), but close to the Km of the low 
affinity D-glucose transporter (Km = 10 to 50mM). In 
the reconstitution of the band 3 of erythrocytes by 
Shelton and Langdon (1983), the Km of the D-glucose 
transporter was 15mM, a figure approximating to that 
found in erythrocyte "ghosts" (Km = lOmM) and erythrocyte 
membrane vesicles *(Km = 10.9mM) by Taverna and Langdon 
(1973), all of which exceed the Km of 1.6mM in intact 
erythrocytes (Lacko et al., 1972).
The Vmax for D-glucose transport into the plasma
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membrane vesicles was 62.9nmol/mg protein/min, similar 
to that for 6-deoxy-D-glucose transport of 53.67nmol/ 
mg protein/min. These values can be compared with the 
Vmax of 6-deoxy-D-glucose transport in intact trypanosomes 
as determined by Game (1988), by conversion of the plasma 
membrane vesicle system Vmax units into mMsec  ^ (as 
used by Game, 1988). The Vmax in intact trypanosomes 
of 6-deoxy-D-glucose transport is 0.401mMsec  ^ (Game,
1988), which compares favourably with 0.21mMsec  ^
and 0.18mMsec  ^ for D-glucose and 6-deoxy-D-glucose 
transport in the vesicle system (taking the internal 
vesicle volume to be 5.07pl/mg protein as determined 
in this thesis). In the reverse calculation, ie. converting 
the Vmax for 6-deoxy-D-glucose in the trypanosomes as 
determined by Game (1988) into nmoles 6D0G/mg protein/min, 
the Vmax of 0.401mMsec  ^becomes 33.Inmoles 6D0G/mg 
protein/min (taking the internal volume of the 
trypanosomes available to substrate to be 1.2pl per
g
1 x 10 cells (Game, 1988), and the total protein in
g
1 x 10 cells to be 0.872mg as determined by the author). 
These Vmax values are similar suggesting that the 
D-glucose transporter in the plasma membranes is functioning 
as it would in the intact trypanosomes.
The technique of using plasma membrane vesicles 
to determine D-glucose flux is not widespread and 
comparisons are therefore difficult. In erythrocyte 
membrane vesicles produced by endocytosis of erythrocyte 
"ghosts", the maximum rate of D-glucose accumulation 
was almost identical to that of erythrocytes and
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erythrocyte "ghosts" (Taverna & Langdon, 1973) , a similar 
finding to that in the trypansomes.
The higher Km than expected suggests that either 
the isolation of the plasma membranes and their subsequent 
vesiculation altered the D-glucose transporter substrate 
binding, or the D-glucose transporter binding is only 
optimum in an intact cell environment. Based on the 
results presented in this thesis no definitive answer 
can be provided ? however, in reconstituted erythrocyte 
"ghosts" Wheeler (1986) suggested that ATP affected 
D-glucose transport by altering the membrane structure.
It is possible,therefore, that intracellular events 
or components could determine the Km of the trypanosome 
D-glucose transporter.
6.1 Comparison of inhibition of 6D0G transport in intact 
trypanosomes and plasma membrane vesicles
The inhibition of 6D0G transport in the plasma 
membrane vesicles allows a comparison of the D-glucose 
transporter inhibition characteristics with intact 
trypanosomes as determined by Game (1988). It should 
be noted that the values of the % inhibitions were carried 
out with an inhibitor concentration of 25mM. This 
concentration will be above or below the Ki for each 
individual inhibitor, resulting in different saturations 
of the D-glucose transporter by each inhibitor. This 
will effect the competition with the 6-deoxy-D-glucose 
substrate (ImM). Having said this one would expect that 
substrates with similar Kis in the inhibition of 6-deoxy- 
D-glucose transport in intact trypanosomes, would produce
157
similar % inhibitions of 6-deoxy-D-glucose transport 
in the plasma membrane vesicles.
Plasma membrane vesicle 6D0G transport.was inhibited 
to a similar extent by D-galactose and D-mannose, 33% 
and 32% respectively, whereas in intact trypanosomes 
the Ki's of the two sugars were >250mM and 0.67mM 
respectively. In intact trypanosomes 3-0-methyl-D-glucose 
and 5-thio-D-glucose demonstrated Ki's of 15.38mM and 
11.67mM respectively, considerably greater than the 
Ki's of D-glucose at 0.9mM. Inhibition of the plasma 
membrane vesicle D-glucose transporter by the three 
sugars was in the range 41% (5-thio-D-glucose) to 58.4% 
(D-glucose), but not the several orders of magnitude 
seen in the intact cells.
A similar trend was observed with D-glucosamine 
and N-acetyl-D-glucosamine, both of which inhibited 
intact cells with Ki's of 21.34mM and ll.llmM respectively, 
figures comparable to the Ki's of 3-0-methyl-D-glucose 
and 5-thio-D-glucose. The inhibition of 6D0G transport 
in the plasma membrane vesicles by D-glucosamine and 
N-acety1-glucosamine were 41.8% and 42.7%, respectively, 
values approximating to that achieved by 3-0-methyl- 
D-glucose and 5-thio-D-glucose. In this case the inhibition 
characteristics of the two systems are similar. However, 
the inhibitions in the vesicle system are approximately 
equal in value to that of D-glucose inhibition, a situation 
patently not the case in the intact cells where D-glucose 
is a far more potent inhibitor of 6D0G transport.
Glycerol did not inhibit D-glucose transport
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in the plasma membrane vesicles consistent with Games'
(1988) observation in intact cells. This result is in 
contrast to that of Ruff and Read (1974) who demonstrated 
inhibition of sugar uptake by glycerol in T.eguiperdum, 
and Southworth and Read (1969 and 1970) who found a 
similar effect in T.b.gambiense. Game (1988) suggested 
that these findings were a result of long incubation 
and processing times employed in these studies. Under 
the conditions employed only phosphorylated metabolites 
would be retained in the cells depleting ATP levels 
by the action of glycerol kinase (Opperdoes and Borst, 
1977c). Phosphorylation of other substrates would not 
occur and this apparent inhibition of substrates would 
not be observed.
Both maltose and D-fructose inhibited the D-glucose 
transporter in the intact cells and plasma membrane 
vesicles. Maltose can be considered a C4 modified D-glucose 
molecule. In the intact cells, the Ki for maltose was 
16.48mM, considerably lower than that for D-galactose 
(Ki = >250mM), a situation reversed in the plasma membrane 
vesicles, where maltose was a poorer inhibitor than 
D-galactose.
D-fructose, though a sugar metabolised by the 
cell, was not as efficient an inhibitor as any of the 
other sugars (inhibition of 25.5% in the plasma membrane 
vesicles). This may well be a result of a requirement 
for a pyranose ring structure for sugar transport, a 
configuration that can only be resembled by D-fructose 
in an open chain configuration.
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Phloridzin which contains a phloretin moiety 
on the Cl position of D-glucose was a potent inhibitor 
of transport in the intact cells and achieved 15.9% 
inhibition of transport in the plasma membrane vesicles. 
Though this figure is low compared to the other sugars 
tested, the phloridzin concentration (2.2mM) was less 
than one tenth that of the other inhibitors because 
of its low solubility. Phloridzin was therefore the 
most effective inhibitor tested. Game (1988) has suggested 
that the inhibition is a result of the phloretin 
interracting with the transporter rather than the D-glucose 
portion of the compound.
6.2 D-glucose transporter binding requirement
The number of inhibitors tested on the plasma 
membrane vesicle system does not allow a comprehensive 
comparison of the D-glucose transporter with other 
D-glucose transporters, or a definitive analysis of 
binding requirements at each carbon position of D-glucose, 
however several observations can be made.
C2 analogues of D-glucose, D-mannose, D-glucosamine 
and N-acetyl-D-glucosamine all gave greater than 26.6% 
inhibition of D-glucose transport and greater than 32% 
inhibition of 6D0G transport. This suggests there is 
some spatial freedom around the C2 position, a freedom 
also found in the 'erythrocyte and adipocyte D-glucose 
transporters (Barrett et al., 1973? Holman et al., 1981) 
and intact trypanosomes (Game, 1988), but markedly 
different from the intestinal sodium cotransport system
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(Crane, 1960), which requires an absolute D-glucose 
configuration at C2.
The C3 analogue tested, 3-0-methyl-D-glucose, 
was a strong inhibitor of D-glucose transport in the 
vesicles, but was a much poorer inhibitor in the intact 
trypanosomes (Game, 1988). The vesicle system is acting 
in a similar manner to the erythrocyte and adipocyte 
D-glucose transporters where 3-0-methyl-D-glucose is 
rapidly transported (Whitesell & Glie.man, 1979? Glieman 
et al., 1972). At C3 there is spatial freedom not found 
in the intact trypanosome transporter.
D-galactose and maltose (C4) both inhibited 
D-glucose transport into the vesicles. D-galactose is 
also an inhibitor of the human erythrocyte transporter 
(Barrett et al., 1973) and in this respect the vesicle 
transporter is acting more like the erythrocyte 
transporter than the intact trypanosome transporter, 
where D-galactose is a poor inhibitor. It appears, 
therfore, that the requirement for an hydroxyl group 
at C4 has been decreased in the vesicle transporter.
The C5 analogue, 5-thio-D-glucose, was a good 
inhibitor of D-glucose transport equivalent to 1DOG 
and 6DOG in magnitude. This suggests that the ring 
oxygen is not vital to binding of D-glucose to the 
transporter, an observation also made in intact 
trypanosomes (Game; 19 88).
Only 1DOG and 6DOG were tested for Cl and C6 
requirements. Their inhibition of D-glucose transport 
was equivalent to D-glucose and thus the loss of hydroxyl
groups at Cl and C6 have not affected binding and 
transport. A similar observation was made in the intact 
cells (Game, 1988).
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7.0 EFFECT OF CHEMICAL MODIFYING INHIBITORS ON THE 
PLASMA MEMBRANE D-GLUCOSE TRANSPORTER
Inhibition of D-glucose transport in the plasma 
membrane vesicles was achieved by 2,4-dinitrofluorobenzene, 
N-ethylmaleimide and 2-hydroxy-5-nitrobenzyl bromide.
N-ethylmaleimide specifically labels reactive 
sulphydryl groups and non-specifically some oC-amino 
groups and imidazole rings, and 2,4-dinitrofluorobenzene 
labels N terminal amino groups and the -NI^ of lysine. 
Neither inhibitor achieved greater than 34% inhibition 
of D-glucose transport at inhibitor concentrations up 
to 5mM. The D-glucose transporter would therefore not 
appear to contain any amino groups or sulphydryl groups 
(accessible to the modifying agents) involved in the 
transport process either in the active site or 
maintaining protein configuration.
The inhibitor 2-hydroxy-5-nitrobenzyl bromide 
which is specific for tryptpphan residues was a superior 
inhibitor to the two inhibitors mentioned above. At 
2mM inhibitor 46% inhibition of D-glucose was achieved, 
rising to 69.5% inhibition at 5mM inhibitor. If the 
freeze/thaw vesiculation process produces vesicles with 
a 50:50 orientation of inside/out to outside/in vesicles 
the 46% inhibition represents almost total inhibition 
of one set of the vesicle population. Inhibition rising 
to 69.5% at 5mM inhibitor represents inhibition of the 
external and internal sites as inhibitor crosses the 
vesicle bilayer.
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Inhibition of the intact trypanosome D-glucose 
transporter was total when preincubated with the 2-hydroxy 
5-nitrobenzyl bromide and efflux inhibited such that 
after 90 seconds 57.5% of the total label was trapped 
in the trypanosomes. This second assay measures D-glucose 
transport in trypanosomes with no preincubation in the 
presence of inhibitor? rather, inhibitor is added to 
the cells upon addition of diluting buffer. The almost 
immediate inhibition of efflux upon inhibitor addition 
and the inhibition characteristics in the vesicle system 
suggest that the inhibition is of a tryptophan residue 
on the external site of the D-glucose transporter. The 
association of enzyme activity with tryptophan residues 
has been noted in enzymes such as lysosyme (Witkop,
1968) from hen's egg in which the action of 2-hydroxy- 
5-nitrobenzyl bromide reduced the enzymes activity by 
90% when alkylating tryptophan residue 6.
The inhibition of efflux of 6DOG from the intact 
trypanosomes by N-ethylmaleimide . though comparable 
to that of 2-hydroxy-5-nitrobenzyl bromide, did not 
produce the same result in the plasma membrane vesicle 
system. Its activity cannot, therefore, be definitively 




The future of this work lies in the effective 
solubilisation and reconstitution of the D-glucose 
transporter, involving a stepwise process.
1) The removal of the cytoskeleton from the plasma 
membranes needs to be perfected to provide plasma membranes 
more amenable to vesiculation and in large enough quantities 
to allow transport studies. These plasma membrane vesicles 
could then be tested for the effect of protective agents 
such as mercaptoethanol, D-glucose and glycerol, or 
addition of lipids or cholesterol to optimise D-glucose 
transport activity.
2) Based on the specificity studies of Game (1988) and 
the inhibition studies in the plasma membrane vesicle 
system, carbon C2 of the D-glucose ring has the spatial 
freedom for modification. A label based on the spatial 
freedom of C2 would provide a means of detecting D-glucose 
binding by the D-glucose transporter through all treatments, 
and this would aid identification of harmful or helpful 
conditions or chemical agents. This would be particularly 
useful in the reconstitution of the D-glucose transporter, 
identifying whether solubilisation by detergent, 
detergent removal, or reconstitution involving sonication 
and/or freeze/thaw procedures are harmful.
3) The role of dihydrolipoamide dehydrogenase requires 
further investigation. It is very difficult to design 
experiments that conclusively link it to a role in 
D-glucose transport. However, its attachment to the
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plasma membrane could be investigated particularly to 
determine if it is an integral membrane protein or not. 
The enzymes possible role as a proton pump could be 
investigated using the reconstituted protein, which 
was successfully reconstituted in L-ct-lecithin vesicles.
\
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Dihydrolipoamide dehydrogenase from
Characterization and cellular location
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Dihydrolipoamide dehydrogenase has been discovered in the bloodstream form o f  the eukaryotic African 
parasite, Trypanosoma brucei. The enzyme catalysed the stoichiometric oxidation o f  dihydrolipoam ide by 
N A D + and exhibited a hyperbolic dependence o f  catalytic activity on the concentrations o f  both  
dihydrolipoamide and N A D+. Chemical m odification with the tervalent arsenical reagent p- 
aminophenyldichloroarsine indicates the involvem ent in catalysis o f  a reversibly reducible disulphide bond. 
Plasma-membrane sheets were purified from T. brucei, and it was shown that virtually all the dihydrolipoamide 
dehydrogenase remained closely associated with this membrane preparation. T. brucei apparently lacks the 
2-oxoacid dehydrogenase multienzyme com plexes o f  which dihydrolipoamide dehydrogenase is usually an 
integral com ponent. In the context o f  this absence, the possible function o f  trypanosomal dihydrolipoamide 
dehydrogenase is discussed, with particular reference to its cellular location in the plasma membrane.
EXPERIM ENTAL
Materials
Chemicals used were o f  analytical grade or the finest 
grade commercially available. N A D +, N A D P + and 
N A D H  were from Boehringer, M annheim, Germany; 
N b s2 and type II-S soya-bean L-a-phosphatidylcholine 
were from Sigma Chemical Co., Poole, Dorset, U .K .;  
DL-lipoamide was from BD H  Chemicals, Poole, Dorset, 
U .K .; and high-purity Triton X-100 was from Pierce and 
Warriner (U .K .), Chester, U .K . DL-Dihydrolipoamide 
was prepared by the reduction o f  DL-lipoamide with 
N aB H 4 (Reed et al., 1958), and p-am inophenyl- 
dichloroarsine (H 2N PhA sC l2) was synthesized as des­
cribed by Stevenson et al. (1978).
Growth and preparation o f cells
Cells o f the long slender form o f  T. brucei were 
isolated from the blood o f  Wistar rats infected with 
1 x 107—3 x 107 cells o f  strain M ITat 1.1 by intraperitoneal 
injection as described by Eisenthal & Panes (1985) and 
were further purified by chrom atography on D EA E- 
cellulose (Lanham & Godfrey, 1970).
Cell extraction
Cells (approx. 0.1 g wet wt.) were resuspended in 1 ml 
o f  50 mM-potassium phosphate (pH 7 .0 )/2  mM-EDTA. 
The suspension was sonicated at 0 °C for 3 x 30 s at 40 W 
with a 3 mm probe on an ultrasonic disintegrator; the 
cell debris was removed by centrifugation for 3 min at 
10000 g  (rav 5.5 cm) and the supernatant stored at 4 °C.
Enzyme assays
Dihydrolipoam ide dehydrogenase was assayed at 
30 °C in 50 mM-potassium phosphate (pH 7 .0 )/2  mM- 
ED TA containing 0.4 mM-dihydrolipoamide and 1 mM- 
N A D +. The reaction, in a final volum e o f 1 ml, was
Abbreviation used: H2NPhAsCl2, />-aminophenyldichloroarsine. 
t  To whom all correspondence should be addressed.
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Dihydrolipoamide dehydrogenase (EC 1.8.1.4) cata­
lyses the N A D +-dependent oxidation o f  dihydro­
lipoamide [reviewed by Williams (1976)]:
Dihydrolipoamide +  N A D + lipoamide +  N A D H  +  H +
The enzyme fulfils this function in the pyruvate 
dehydrogenase, 2-oxoglutarate dehydrogenase and 
branched-chain 2-oxo acid dehydrogenase com plexes and 
is an integral com ponent o f  each o f  these multienzyme 
structures. However, we have reported previously 
(Danson, 1984; D anson et al., 1984, 1986) that, although  
archaebacteria do not possess these 2-oxo acid dehydro­
genase complexes, they do have a dihydrolipoamide 
dehydrogenase, although its function in vivo remains 
unclear.
In the present paper we report our investigation o f  
dihydrolipoamide dehydrogenase in the eukaryotic 
African parasite, Trypanosoma brucei. The bloodstream  
form o f this trypanosome is totally dependent on 
glycolysis for ATP production, as it has no lipid or 
carbohydrate reserves and the m itochondrion does not 
possess a com petent citric acid cycle (reviewed by 
Fairlamb, 1982). Thus it does not have the NA D-linked  
2-oxo acid dehydrogenase com plexes, and under aerobic 
conditions glucose is metabolized almost completely to 
pyruvate, approx. 2 mol o f  pyruvate being produced per 
mol o f  glucose (Fairlamb, 1982). T. brucei therefore 
provides us with a eukaryotic organism in which to look  
for the presence o f dihydrolipoamide dehydrogenase in 
the absence o f  the 2-oxo acid dehydrogenase complexes. 
We not only report its presence and enzym ological 
characteristics, but also show that it is associated with the 
plasma membrane o f the trypanosome. The functional 
significance o f  its presence and cellular location is 
discussed.
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started with enzyme and its progress was monitored by 
the increase in A 3i0.
Malate dehydrogenase was assayed at 30 °C in 
50 mM-potassium phosphate (pH 7 .0)/2  mM-EDTA con ­
taining 0.1 mM-NADH and 0.2 mM-oxaloacetate. The 
reaction, in a final volum e o f  1 ml, was started with 
enzyme and its progress was monitored by the decrease
- ^ 3 40 -
Chemical modification with H2NPhAsCl2
Modification o f  dihydrolipoamide dehydrogenase 
with 0.5 mM-H2N PhA sC l2 was carried out at 4 °C in 
50 mM-potassium phosphate (pH 7 .0 )/2  mM-EDTA and 
in the presence and absence o f  50 /^m-N A D H .
Preparation of trypanosomal plasma membrane
Sheets o f  plasma membrane from T. brucei were 
prepared as described by Voorheis et al. (1979). In 
outline, this procedure was as follows. Fresh try­
panosomal cells were resuspended in 10 ml o f  Tes 
buffer (2mM-Tes, pH 7.5, containing 150mM-KCl, 
1 mM-EGTA, 1 mM-2-mercaptoethanol and 0.1 mM- 
phenylmethanesulphonyl fluoride). The cells were swelled 
by the addition o f  up to 30 ml o f distilled water 
containing 0.1 mM-phenylmethanesulphonyl fluoride 
and 10 /zg o f  leupeptin/m l (4 °C) and were then 
homogenized in a tight-fitting glass Dounce hom o­
genizes Immediately after cell breakage, the ionic 
strength o f  the hom ogenate was restored by the addition  
o f  2 ml o f 3 m-KCI for every 40 ml o f  homogenate. The 
homogenate was then centrifuged at 7500 # av for 10 s to 
give a supernatant (Sx) and pellet (Px). Pellet Px was 
washed in the Tes buffer containing 10 /ig  o f  leupeptin/m l 
and was then treated with D N A ase as described by 
Voorheis et al. (1979). The pellet (P2), collected by 
centrifugation (as above), was resuspended in 40% (w /v )  
sucrose in Tes buffer and centrifuged at 7 0 0 0 0 # av for 
3 h on a linear 40-60%  sucrose gradient in the same 
buffer. Plasma-membrane sheets comprised the m ost 
prominent dense band; these were removed, washed 
three times in Tes buffer and finally resuspended in 
50 mM-potassium phosphate (pH 7.0)/2  mM-EDTA. 
Assays o f  dihydrolipoamide dehydrogenase and malate 
dehydrogenase were carried out on the day o f  the 
preparation.
Preparation of Triton extract
Plasma membranes were incubated with 0.5% (w /v )  
Triton X-100 in 10 mM-Tris/HCl buffer, pH 7.4, for 
20m in  at 4 °C. After centrifugation at 2 0 0 0 0 #  for 
60 min, the supernatant was treated with Bio-Beads SM-2 
for 16 h (0.3 g wet wt. o f  beads/m l) at 4 °C.
Protein determination
Protein was measured by the method o f Markwell 
et al. (1981). Interference by the presence o f  Triton X-100  
was overcome by the addition o f  3% (w /v) SDS  
(Carruthers & M elchior, 1984).
RESULTS
Presence of dihydrolipoamide dehydrogenase in T. brucei
Dihydrolipoamide dehydrogenase activity was detec­
ted in cell-free extracts o f  T. brucei at a specific activity 
o f  0.03 /rniol o f  N A D H  produced/m in per mg o f  
protein. The rate o f  production o f  N A D H  was directly
M. J. Danson and others
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Fig. 1. Purification of plasma-membrane sheets of T. brucei and 
cellular location of dihydrolipoamide dehydrogenase and 
malate dehydrogenase
Plasma-membrane sheets from T. brucei were purified, and 
the enzymic activities of dihydrolipoamide dehydrogenase 
(H) and malate dehydrogenase (□ )  were assayed, as 
described in the Experimental section. The enzymic 
activities are expressed as a percentage of their values 
in the unfractionated homogenate (dihydrolipoamide 
dehydrogenase, 0.74 /unol of NADH produced/min; 
malate dehydrogenase, 40.6 fimo\ of NADH oxidized/ 
min). (A) Unfractionated cell homogenate; (B) pellet P^ 
(C) supernatant Sx; (D) final washed pellet of plasma 
membranes; (E) Triton X-100 extract of purified plasma 
membranes, after removal of detergent with Bio-Beads.
proportional to the am ount o f  enzyme extract in the 
assay, and all activity was destroyed on boiling the 
extract for 10 min. The enzyme was specific for N A D +, 
no activity being detectable when N A D P + was sub­
stituted for N A D+. The stoichiometry o f  the reaction 
was measured by m onitoring N A D H  production at 
340 nm and by titrating unchanged dihydrolipoamide 
with S^'-dithiobis-^-nitrobenzoic acid); 1.06 (± 0 .0 6 )  
mol o f  N A D H  was produced/m ol o f  dihydrolipoamide 
oxidized.
These data represent the first report o f  dihydro­
lipoamide dehydrogenase activity in a eukaryotic organ­
ism which lacks the N A D -linked 2-oxo acid 
dehydrogenase multienzyme complexes.
Cellular location of dihydrolipoamide dehydrogenase
Plasma-membrane sheets were prepared from T. brucei 
by the method o f  Voorheis et al. (1979) as described in 
the Experimental section. The enzymic activities o f  
dihydrolipoamide dehydrogenase and o f  malate dehydro­
genase were measured in the homogenate, supernatant 
(Sx) and pellet (Px) arising from differential centrifugation 
o f  this homogenate, and in the final washed pellet o f  
plasma membranes. The data are given in Fig. 1. In 
agreement with the results reported by Voorheis et al. 
(1979), the membranes were essentially free o f  malate 
dehydrogenase, less than 2% o f  the original enzyme 
activity o f the hom ogenate being found in the final 
preparation. In direct contrast (Fig. 1), the dihydro-
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Fig. 2. Chemical modification of T. brucei dihydrolipoamide 
dehydrogenase with H 2NPhAsCI2
Purified plasma membranes o f T. brucei were incubated at 
4 °C in 50 mM-potassium phosphate (pH 7.0)/2 mM- 
EDTA, in the presence o f 0.5 mM-H2NPhAsCl2 (A), 
50//M-NADH ( # )  or 0.05 mM-H2NPhAsCl2 and 
50 //m-NADH (O)- Dihydrolipoamide dehydrogenase was 
assayed spectrophotometrically at 340 nm as described in 
the Experimental section.
lipoam ide dehydrogenase was co-purified with the 
plasm a m em branes, with only 10% o f  the activity being 
retained in the supernatant (S x). This observation, that 
the enzym e is retained with the mem brane sheets 
through a number o f  purification procedures and  
washing steps, strongly suggests a close interaction o f  
dihydrolipoam ide dehydrogenase with trypanosom al 
plasm a membrane.
Treatm ent o f  the purified plasm a m em brane with 0.5%  
(w /v ) Triton X -100 resulted in ^  80% o f  the dihydro­
lipoam ide dehydrogenase being recovered in the super­
natant after centrifugation and rem oval o f  the detergent 
by Bio-Beads (Fig. 1).
To provide a positive identification o f  the nature o f  the 
m embrane in the final w ashed pellet, we have m onitored  
throughout the preparation the ouabain-sensitive  
N a + ± K +-stim ulated A T Pase, which V oorheis e t al. 
(1979) find to be associated with the plasm a m em brane. In 
our hands, the activity o f  this enzym e is both variable and  
very difficult to m easure in the presence o f  com paratively  
large am ounts o f  other phosphatases. N evertheless, we 
find this A TPase to be retained in pellet P x, and up to 
60% o f  the hom ogenate activity to be in the final 
m em branes. H owever, because o f  the difficulties we have 
encountered in assaying this enzym e, we would not wish  
to use these data alone as positive evidence for the 
presence o f  plasm a m em branes. Therefore we have 
subjected the final preparation to  electron-m icroscopic 
exam ination. The purified m em brane was observed to  
contain  the pellicular m icrotubular array which V oorheis 
et al. (1979) state is a m arker for ‘ the unequivocal 
identification o f  the isolated m em brane material being  
derived exclusively from  the plasm a m em brane’. On this 
basis, the plasm a m em brane in our preparation is 
confirmed.
Kinetic properties o f dihydrolipoamide dehydrogenase
In both sonicated cell-free extracts and purified plasm a  
m em brane, the enzym e show ed a hyperbolic dependence
Table 1. Kinetic properties of T. brucei dihydrolipoamide 
dehydrogenase
Sonicated cell-free extracts were prepared and plasma 
membranes were purified as described in the Experimental 
section. The Km for dihydrolipoamide was determined at 
a fixed N A D + concentration of 1 mM; the for N A D + 
was determined at a fixed dihydrolipoamide concentration 




0.18 (± 0 .04) mM 0.13 (±0 .03) mM
(dihydrolipoamide)
Km (NAD+) 0.35 (± 0 .03) mM 0.28 ( +  0.05) mM
Sp. activity 0.029 0.229
(//mol/min
per mg of protein)
o f  rate on each substrate. The data were analysed by the 
direct linear plot (Eisenthal & C ornish-B ow den, 1974), 
and the kinetic constants determ ined are sum m arized in 
Table 1. There were no significant differences in K m 
values between the tw o enzym e preparations, although  
the specific activity in the plasm a m em brane was 8-fold  
greater than that observed in the sonicated cell-free 
extracts. This increase in specific activity com pares 
with reported values o f  15-fold for ouabain-sensitive 
N a + ± K +-stim ulated A T Pase and 5-fold for adenylate 
cyclase (V oorheis et al., 1979).
Chemical modification o f dihydrolipoamide 
dehydrogenase with H 2N P hA sC l2
The catalytic m echanism  o f  dihydrolipoam ide de­
hydrogenase norm ally involves the alternate oxidation  
and reduction o f  an intrachain disulphide bond  
(W illiam s, 1976). Thus its ligands dihydrolipoam ide 
and N A D H  will render the active-site disulphide bond  
susceptible to dithiol-specific tervalent arsenicals 
(A dam son & Stevenson, 1981; A dam son e t al., 1984), a 
phenom enon which is characteristic o f  this enzym e and 
which m ay be used to help establish that the observed  
enzym ic activity is the result o f  a true dihydrolipoam ide 
dehydrogenase.
In accordance with the norm al catalytic m echanism , 
the enzym e from  both  cell-free extracts and purified 
plasm a m em brane was rapidly inactivated by 
H 2N P h A sC l2 in the presence o f  N A D H  (Fig. 2), whereas 
the reagent alone caused no significant loss o f  enzym ic 
activity.
D IS C U S S IO N
The data in the present paper constitute the first report 
o f  the presence o f  d ihydrolipoam ide dehydrogenase in 
T. brucei. The significance o f  this d iscovery stem s from  a 
num ber o f  observations. Firstly, the bloodstream  form  o f  
T. brucei does not have the pyruvate dehydrogenase and 
2-oxoglutarate dehydrogenase com plexes (Fairlam b, 
1982; M. J. D anson  & R. Crisp, unpublished work). In 
organism s which do possess these m ultienzym e system s, 
dihydrolipoam ide dehydrogenase is an integral co m ­
ponent o f  such com plexes, and therefore its presence in
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T. brucei suggests that this enzyme may have an addi­
tional metabolic role, which remains to be elucidated. 
This is the first time that the enzyme has been found in the 
absence o f the 2-oxo acid dehydrogenase complexes in a 
eukaryotic organism, although we have previously 
reported a similar situation in the halophilic (Danson  
et al., 1984, 1986), thermoacidophilic and methano- 
genic (Danson, 1984) archaebacteria. We have purified 
dihydrolipoamide dehydrogenase from Halobacterium  
halobium (Danson et al., 1986) and find it to be 
remarkably similar to its counterpart in non-archae- 
bacterial species in subunit arrangement and in its 
catalytic and kinetic properties. Similarly, in the present 
paper, we demonstrate that dihydrolipoamide dehydro­
genase from T. brucei specifically catalyses the stoichio­
metric oxidation o f  dihydrolipoam ide by N A D +, and we 
provide evidence from chemical modification studies that 
a reversibly reducible disulphide bond is essential to 
catalysis, as has been found in other dihydrolipoamide 
dehydrogenases (Williams, 1976).
It should be noted that Ryley (1962) found that 
oxidized lipoic acid increased the rate o f oxidation o f  
N A D H  by hom ogenates o f  Trypanosoma rhodesiense, 
indicating the presence o f  dihydrolipoamide dehydro­
genase in this trypanosome. However, the organism can 
also metabolize pyruvate to CO a and it may be that the 
enzyme is functioning in its recognized role in pyruvate 
oxidation in T. rhodesiense, a situation not occurring in 
T. brucei.
A second significant factor is that T. brucei dihydro­
lipoamide dehydrogenase appears to be located speci­
fically in the plasma membranes o f  the organism. Our 
evidence for this com es from the co-purification o f  the 
enzyme with the plasma membrane. Moreover, in 
preliminary experiments, we have shown, by the method  
o f  Kasahara & Hinkle (1977), that dihydrolipoamide 
dehydrogenase, extracted from the purified plasma 
membranes with Triton X-100, can be reconstituted into  
soya-bean L-a-phosphatidylcholine liposom es to a speci­
fic activity the same as that in the purified membranes 
(K. Conroy, M. J. Danson, R. Eisenthal & G. Holm an, 
unpublished work).
This is the first time that a eukaryotic dihydro­
lipoamide dehydrogenase has been reported to be 
membrane-associated, and such an attachment may 
suggest a function specific to that location. Indeed, 
evidence has been presented (Richarme, 1985; Richarme 
& Heine, 1986) that lipoic acid and dihydrolipoamide 
dehydrogenase may be involved in the Escherichia coli 
binding-protein-dependent transport o f  galactose and 
maltose. In this system, the enzyme is distinct from the 
L pd  gene product, which functions in the 2-oxo acid 
dehydrogenase com plexes (Richarme & Heine, 1986). 
Additionally, it has been observed that the dithiol-specific 
tervalent arsenical phenylarsine oxide inactivates insulin- 
stimulated hexose transport by 3T3-L1 adipocytes (Frost 
& Lane, 1985). These authors noted that this inactivation  
o f  hexose transport had similar characteristics to the 
inactivation o f  2-oxo acid dehydrogenases by the same 
arsenical (reacting with the lipoyl groups on the 
acetyltransferase com ponent); however, the site o f  
reaction o f  phenylarsine oxide with the adipocytes has 
not yet been defined.
An assay for the transport o f  glucose into T. brucei has 
now been developed (Game et al., 1986). It should 
therefore be possible to determine the effects o f  tervalent
arsenical reagents on this system and so to investigate 
whether or not dihydrolipoam ide dehydrogenase is 
associated with transport in trypanosomes. It would also 
be o f  interest to look for the presence and cellular 
location o f the enzyme’s normal substrate, lipoic acid, in 
T. brucei. To this end, we have developed a method using 
g.l.c.-m ass spectrometry to detect lipoic acid as its 
oxidized lipoate methyl ester (Danson et al., 1985).
In conclusion, there is growing evidence that dihydro­
lipoamide dehydrogenase has a cellular function in 
addition to its established role in the 2-oxo acid 
dehydrogenase complexes. It is considered that further 
studies o f the enzyme in the archaebacteria and T. brucei, 
where the multienzyme com plexes are not found, will be 
valuable in identifying this new function.
This work was supported by a Natural Sciences and 
Engineering Research Council of Canada grant to K.J.S. 
M.J.D. acknowledges financial support in the form of Travel 
Fellowships from the Royal Society, Great Britain (1985) and 
from the British Council (1986), an International Scientific 
Exchange Award from the National Sciences and Engineering 
Research Council of Canada (1985) and a grant 
(G R /D /17793) from the Science and Engineering Research 
Council of Great Britain. A.McQ. was supported by a summer 
temporary employment program, Province of Alberta (Man­
power), Canada; K. C. acknowledges the award of a First-Class 
Bursary from the University of Bath and the help of Dr. Paul 
Voorheis (Trinity College, Dublin) with the preparation of the 
plasma membranes and of Kate Powell with the electron 
microscopy. We thank Dr. Geoffrey Holman and Dr. Robert 
Eisenthal for their considerable help and advice, and we are 
grateful to Kim Cornell and Robin Crisp for skilled technical 
assistance.
REFERENCES
Adamson, S. R. & Stevenson, K.J. (1981) Biochemistry 20, 
3418-3424
Adamson, S. R., Robinson, J. A. & Stevenson, K. J. (1984) 
Biochemistry 23, 1269-1274 
Carruthers, A. & Melchior, D. L. (1984) Biochemistry 23, 
2712-2718
Danson, M. J. (1984) Abstr. FEBS Meet. 16th VIII-004 
Danson, M. J., Eisenthal, R., Hall, S., Kessell, S. R. & 
Williams, D. L. (1984) Biochem. J. 218, 811-818 
Danson, M. J., Carles, C., McQuattie, A., O’Connor, T. J. & 
Stevenson, K. J. (1985) Abstr. Annu. Meet. Alberta Heritage 
Found. Med. Res. 5th p. 9 
Danson, M. J., McQuattie, A. & Stevenson, K. J. (1986) 
Biochemistry 25, 3880-3884 
Eisenthal, R. & Cornish-Bowden, A. (1974) Biochem. J. 139, 
715-720
Eisenthal, R. & Panes, A. (1985) FEBS Lett. 181, 23-27 
Fairlamb, A. (1982) Trends Biochem. Sci. 7, 371-374 
Frost, S. C. & Lane, M. D. (1985) J. Biol. Chem. 260, 
2646-2652
Game, S., Holman, G. & Eisenthal, R. (1986) FEBS Lett. 194, 
126-130
Kasahara, M. & Hinkle, P. C. (1977) J. Biol. Chem. 252, 
7384-7390
Lanham, S. M. & Godfrey, D. G. (1970) Exp. Parasitol. 28, 
521-524
Markwell, M. A. K., Haas, S. M., Tolbert, N. E. & Bieber, 
L. L. (1981) Methods Enzymol. 72, 296-363
1987
Dihydrolipoamide dehydrogenase from Trypanosoma brucei 665
Reed, L. J., Koike, M., Levitch, M. E. & Leach, F. R. (1958) 
J. Biol. Chem. 232, 143-158 
Richarme, G. (1985) J. Bacteriol. 162, 286-293 
Richarme, G. & Heine, H.-G. (1986) Eur. J. Biochem. 156, 
399-405
Ryley, J. F. (1962) Biochem. J. 85, 211-223
Stevenson, K. J., Hale, G. & Perham, R. N. (1978) Bio­
chemistry 1 7 ,2189-2192
Williams, C. H., Jr. (1976) Enzymes 3rd Ed. 13, 89-173
Voorheis, H. P., Gale, J. S., Owen, M. J. & Edwards, W. (1979) 
Biochem. J. 180, 11-24
Received 6 October 1986/22 December 1986; accepted 12 January 1987
Vol. 243
622nd MEETING, LEICESTER 1073
deposition. Our failure to demonstrate any reduction in the 
amount o f mixed muscle protein does not preclude the 
possibility that chronic ethanol ingestion in rats may reduce 
the amount o f specific myofibrillar proteins as suggested in 
alcoholic patients (Martin et al., 1984).
In conclusion, the chronically treated ethanol-fed rat is a 
suitable model to study skeletal muscle myopathy. Anatom­
ically distinct muscles provide a useful basis to examine 
types I and II fibres and demonstrate contrasting responses 
to treatment.
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Sugar transport in Trypanosoma brucei
KEVIN CONROY, ROBERT EISENTHAL,
STEPHEN GAME and GEOFFREY HOLMAN  
Department o f Biochemistry, University o f  Bath,
Bath BA2 7A Y, Avon, U.K.
The bloodstream form o f Trypanosoma brucei is dependent 
on glucose metabolism for energy production. Glycolysis is 
thought to be localized mainly if not totally in the glycosome 
(Opperdoes & Borst, 1977) and much has been reported on 
the functional features o f this organelle (Opperdoes, 1985). 
Much less attention has been directed at the initial step of 
glucose metabolism, i.e. the transport o f sugar across the 
plasma membrane. The results o f Gruenberg et al. (1978) 
indicated that glucose transport is likely to be the rate- 
limiting step in glucose metabolism, but those studies 
involved the use o f 2-deoxyglucose which is known to be a 
substrate for hexokinase. Recently Game et al. (1986) 
reported that 1-deoxy-D-glucose may be a suitable analogue 
for studying sugar transport in T. brucei. Their results 
on 1-deoxy-D-glucose influx demonstrated that the V for 
trypanosome sugar transport is slower than that for 
mammalian systems. However, attempts to characterize 
efflux and exchange kinetics o f 1-deoxy-D-glucose effect 
were frustrated by a slow but significant phosphorylation of 
the analogue.
Game et al. (1986) also reported that 6-deoxy-D-glucose 
was an effective inhibitor o f  1-deoxy-D-glucose uptake. As 
this analogue is unlikely to undergo any metabolism, we 
have investigated the kinetics o f its uptake and efflux in 
intact cells and have also studied D-glucose transport in 
vesicles prepared from trypanosome plasma membranes.
6-Deoxy-D-glucose was synthesized from 6-chloro-a- 
methyl-D-glucoside (Evans & Parrish, 1972) which was 
converted to the 6-iodo compound and then catalytically 
reduced with tritium gas (Amersham). This tritiated product 
was hydrolysed to remove the glycosidic methyl group and 
the resultant [6-3H]deoxy-D-glucose was then purified by 
paper chromatography.
Kinetic parameters for 6-deoxy-D-glucose were deter­
mined at 20°C. Net influx and efflux showed similar Km and 
Vmax values (Table 1) indicating the transport system is 
kinetically symmetric. An equilibrium exchange experiment 
in which isotope exchange flux was studied in cells pre­
equilibrated with non-labelled 6-deoxy-D-glucose also 
showed comparable kinetic parameters (Table 1). Thus the 
system does not show accelerated exchange. An integrated 
rate equation was used to determine the infinite-c/s Km. This 
experiment confirmed kinetic symmetry for the transport of 
6-deoxy-D-glucose.
We have also studied hexose transport in purified plasma 
membranes. Vesicles were prepared by a freeze-thaw 
procedure. The freeze-thaw protocol was found to be essen­
tial to remove cytoskeletal components associated with the 
plasma membrane sheets. We have found that an infinite- 
trans protocol is most useful for studying the kinetics of 
transport in this isolated membrane system. In this 
procedure vesicles are loaded with lOOmM-D-glucose and 
then diluted into a buffer containing radiolabelled D-glucose 
at a range o f concentrations. The high concentration of 
D-glucose inside traps (by counterflow) the radiolabelled 
D-glucose as it enters the vesicles. The estimated Km is shown 
in Table 1. The Km o f 14mM is considerably higher than the 
affinity constant estimated by using intact cells and further 
experiments will investigate the reasons for the difference.
We are pleased to acknowledge financial support by the Wellcome 
Trust.
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Infinite- trans entry in vesicles
2.17 ±0.068 
6.063 ±  1.227 
6.212 ±  1.197 
3.0 ±  0.332 
14.33 +  2.55
0.279 ±0.006 
0.863 ±  0.109 
0.601 ±  0.052 
0.965 +  0.067
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Proteolytic degradation of mucus in the colon
DAVID A. HUTTON, A D R IA N  ALLEN,
WILLIAM J. CUNLIFFE and 
JEFFREY P. PEARSON
Department o f Physiological Sciences, Medical 
School University, Framlington Place,
Newcastle Upon Tyne NE2 4HH, U.K.
A continuous adherent layer o f insoluble mucus gel is found 
on the colonic mucosal surface, mean thickness 150 ±  
110/un in the rat (Sakata & Engelhardt, 1981). Such a 
mucuos layer will provide a protective barrier against harm­
ful agents in the lumen and mechanical damage from motile 
forces o f digestion. The protective gel layer is formed by 
polymeric glycoproteins which are fragmented by proteases 
to dissolve the mucous layer (mucolysis) (Allen et al., 1984; 
Bell et al., 1985). Recent studies o f proteolytic activity in 
stools (using non-mucous protein substrates) showed that 
inflammatory bowel disease patients had significantly 
higher levels o f activity compared to non-symptomatic 
controls (Corfield et al., 1986). If such proteolytic activity 
reflects excessive mucolytic activity (mucous degrading) 
then this may be an important factor in disruption o f the 
colonic mucosal barrier in inflammatory bowel disease. 
Here we demonstrate mucolytic activity in human faecal 
extracts from non-inflammatory bowel disease patients.
Glycoproteins from pig and human colonic mucous and 
pig gastric mucuous were extracted in proteinase inhibitors 
[l.OmM-phenylmethylsulphonyl fluoride (PMSF), 5 0 mM- 
iodoacetamide, 100mM-a-aminohexanoic acid, 5mM-benz- 
amidine HC1, l.Omgl 1 soybean trypsin inhibitor and 
10mM-Na2 EDTA in 0.5M-Tris/HCl pH 8.0] and purified by 
two successive equilibrium centrifugation steps in 3.5 m- 
CaCl2. Purified glycoproteins were largely excluded (>  60%) 
from Sepharose CL-2B and were fragmented into smaller 
species, included on Sepharose CL-2B, by reduction (0.2 m- 
mercaptoethanol 48 h, 4°C) and exhaustive proteolysis 
[1 :100 (w/w) papain: glycoprotein, 48 h, 60°C]. This frag­
mentation was reflected by a substantial drop in solution 
viscosity (approximately 10-fold on papain digestion o f pig 
colonic mucous glycoprotein at 4 mg m l-1).
Human faecal extracts (from non-inflammatory bowel 
disease patients) were obtained by suspending samples o f 
stool in 4 vol. o f m /  15 m phosphate buffer pH 7.5, containing 
50mM-NaCl and centrifuging at 10000# for 15 min at 4°C. 
Protease activity was measured by a sensitive trinitro­
benzene sulphonic acid assay for formation o f new peptide 
iV-terminals at pH 7.5 and 37°C using succinyl albumin or 
purified mucous glycoprotein as substrate (Hutton et al., 
1986). Protolytic action on succinyl albumin by the extracts 
was inhibited by soybean trypsin inhibitor and PMSF 
(1 mM) [but not by iodoacetamide (50 mM) or Na2 EDTA  
(10 mM)] suggesting that the activity was due to a trypsin­
like serine-dependent protease. Subsequently, levels o f  
faecal protease activity (against succinyl albumin) were 
quantified as equivalents o f porcine pancreatic trypsin
Abbreviation used: PMSF, phenylmethyl sulphonyl fluoride.
(Sigma) activity by weight. On this basis, faecal protease 
activity was completely inhibited by soybean trypsin 
inhibitor [1 : 1 (w/w) inhibitor: faecal protease activity] and 
the synthetic polyacrylate Carbomer 934P [1000:1 (w/w) 
polyacrylate: faecal protease activity], PMSF [100:1 (w/w)] 
inhibited activity by ~ 60% . Mucolytic activity o f the 
faecal extracts was assayed by monitoring the fall in 
specific viscosity of solutions o f purified mucous glyco­
proteins, as a function o f time, on incubation with faecal 
extract at pH 7.5 and 37°C. Mucolysis was also followed by 
measuring the increase in free A-terminals and the amount 
of glycoprotein included in Sepharose CL-2B. In this 
manner, extracts were shown to proteolytically digest puri­
fied pig gastric and colonic mucous glycoproteins. For 
example, incubation of purified pig colonic muous glyco­
protein with extract [0.1% enzym e: glycoprotein (w/w)] 
induced a rapid fall in the specific viscosity o f the glyco­
protein in the first 15 min o f digestion (74.5% of the fall in 
specific viscosity after complete digestion) followed by a 
slower fall over the subsequent 48 h. This fall in viscosity 
was accompanied by an increase in the proportion o f glyco­
protein included on Sepharose CL-2B this being 35% at 
time 0, and 77% and 89% after 15 min and 24 h, respective­
ly. Decrease in viscosity was also mirrored by an increase in 
the number o f free A-terminals and a 50% drop in specific 
viscosity corresponded to 3.1 x  10“5 mol o f peptide bonds 
cleaved. The synthetic polyacrylate Carbomer 934P [1200:1 
(w/w) polyacrylate: faecal protease activity] inhibited 
mucolysis by 45%.
The polyacrylate Carbomer 934P, in addition to inhibit­
ing degradation o f mucus, was shown to have a potential 
role in strengthening the protective mucous barrier. 
Carbomer 934P synergistically increased the viscosity of 
purified undegraded colonic mucous glycoproteins from 
both man and pig. Thus, viscosity o f glycoprotein/carbomer 
mixtures (GC) was substantially greater than the sum of the 
individual viscosities (G +  C). This synergistic increase in 
viscosity was approximately 460% at concentrations of 
glycoprotein and carbomer o f 4 mg ml ' and 2 mg ml ' 1, 
respectively.
These studies demonstrate endogenous mucolytic activity, 
by proteases, exists in the lumen o f the colon in vivo. Such 
mucolysis may be an important factor in disruption o f the 
colonic mucous barrier in disease.
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